Compositions and methods for controlling insects

Abstract

Novel insecticidal polypeptides that are active against lepidopteran insect pests are disclosed. Nucleic acid molecules encoding the novel insecticidal proteins are also provided. The nucleotide sequences encoding the insecticidal polypeptides can be used to transform prokaryotic and eukaryotic organisms to express the insecticidal proteins. Methods of making the insecticidal proteins and methods of using the insecticidal proteins, for example in transgenic plants to confer protection from insect damage, are also disclosed.

Description

[0001] Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0002] COMPOSITIONS AND METHODS FOR CONTROLLING INSECTS

[0003] RELATED APPLICATION INFORMATION

[0004] This application claims priority to US Application No. 63 / 713,099, filed on October 29, 2024, the contents of which are incorporated by reference herein.

[0005] STATEMENT REGARDING ELECTRONIC FILING OF A SEQUENCE LISTING

[0006] [1] A Sequence Listing in XML format, submitted under 37 C.F.R. § 1.831(a), entitled “83365-SequenceListing_9Oct25.xml”, approximately 140 kilobytes in size, generated on October 9, 2025 and filed via EFS-Web, is provided in lieu of a paper copy. This Sequence Listing is hereby incorporated herein by reference into the specification for its disclosures.

[0007] FIELD OF THE INVENTION

[0008] [2] This invention relates to pesticidal proteins and the nucleic acid molecules that encode them, as well as compositions and methods for controlling agriculturally-relevant pests of crop plants.

[0009] BACKGROUND

[0010] [3] Bacillus thuringiensis (Bt) is a gram-positive spore forming soil bacterium characterized by its ability to produce crystalline inclusions that are specifically toxic to certain orders and species of plant pests, including insects, but are harmless to plants and other nontarget organisms. For this reason, compositions comprising Bacillus thuringiensis strains, or their insecticidal proteins can be used as environmentally acceptable insecticides to control agricultural insect pests or insect vectors of a variety of human or animal disease.

[0011] [4] Crystal (Cry) proteins from Bt have potential insecticidal activity against predominantly Lepidopteran, Dipteran, and Coleopteran pest insects. These proteins also have shown activity against pests in the Orders Hymenoptera, Homoptera, Phthiraptera, Mallophaga, Attorney Docket No. : PAT- 111602-WO-SEC- 1 and Acari, as well as other invertebrate orders such as Nemathelminthes, Platyhelminthes, and Sarcomastigorphora (Feitelson, J. 1993. The Bacillus Thuringiensis Family Tree. In Advanced Engineered Pesticides. Marcel Dekker, Inc., New York, N.Y.).

[0012] [5] The terms “Cry toxin” and “delta-endotoxin” have been used interchangeably with the term “Cry protein”. Current nomenclature for Cry proteins and genes is based upon amino acid sequence homology rather than insect target specificity (Crickmore et al. (1998) Microbiol. Mol. Biol. Rev. 62:807-813). In this more accepted classification, each toxin is assigned a unique name incorporating a primary rank (an Arabic number), a secondary rank (an uppercase letter), a tertiary rank (a lowercase letter), and a quaternary rank (another Arabic number).

[0013] [6] Cry proteins are globular protein molecules which accumulate as protoxins in crystalline form during the sporulation stage of Bt. Without wishing to be bound by theory, it is believed that after ingestion by a pest, the crystals are typically solubilized to release protoxins and the released protoxins are processed by proteases in the insect gut, for example trypsin and chymotrypsin, to produce a protease-resistant core Cry protein toxin. This proteolytic processing involves the removal of amino acids from different regions of the various Cry protoxins.

[0014] [7] The toxin portions of Cry proteins generally have 5 conserved sequence blocks, and three conserved structural domains (see, for example, deMaagd et al. (2001) Trends Genetics 17: 193-199). The first conserved structural domain, called Domain I, typically consists of seven alpha helices and is involved in membrane insertion and pore formation. Domain II typically consists of three beta-sheets arranged in a Greek key configuration, and domain 111 typically consists of two antiparallel beta-sheets in “jelly-roll” formation (deMaagd et al., 2001, supra). Domains II and III are involved in receptor recognition and binding and are therefore considered determinants of toxin specificity. The carboxy terminal (C-terminus) portion of the protein, known as the protoxin segment stabilizes crystal formation.

[0015] [8] Careful selection and reassembly of the protoxin segment and toxin domains I, II, and III of any two or more toxins that are different from each other is useful in efforts to find effective insecticidal chimeric proteins that have different specificities from their parent molecules. It is known in the art that this reassembly often results in the construction of proteins that exhibit faulty crystal formation, or a complete lack of detectable insecticidal activity directed Attorney Docket No. : PAT- 111602-WO-SEC- 1 towards a target insect species. This is a result of the complex nature of protein structure, oligomerization, and activation needed to produce an insecticidal chimeric protein.

[0016] [9] Numerous commercially valuable plants, including common agricultural crops, are susceptible to attack by plant pests including insect and nematode pests, causing substantial reductions in crop yield and quality. For example, plant pests are a major factor in the loss of the world's important agricultural crops. Insect pests are also a burden to vegetable and fruit growers, to producers of ornamental flowers, and to home gardeners.

[0017]

[0010] Insect pests are mainly controlled by intensive applications of chemical pesticides, which are active through inhibition of insect growth, prevention of insect feeding or reproduction, or cause death. Biological pest control agents, such as Bacillus thuringiensis strains expressing pesticidal toxins such as Cry proteins, have also been applied to crop plants with satisfactory results, offering an alternative or compliment to chemical pesticides. The genes coding for some of these Cry proteins have been isolated and their expression in heterologous hosts such as transgenic plants have been shown to provide another tool for the control of economically important insect pests.

[0018]

[0011] Good insect control can thus be reached, but certain biologicals have a very narrow spectrum of activity, and the continued use of certain biological control methods heightens the chance for insect pests to develop resistance to such control measures. This has been partially alleviated by various resistance management practices such as refuges, but there remains a need to develop new and effective methods for controlling insect pests using insecticidal control agents that can target a wider spectrum of economically important insect pests and / or have a different mode of action than existing insecticidal proteins. Providing a distinct mode of action should efficiently control insect pests that are or could become resistant to existing products. Furthermore, these control methods need to provide an economic benefit to farmers and minimize the burden on the environment.

[0019] SUMMARY OF THE INVENTION Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0020]

[0012] This disclosure provides polypeptides that are insecticidal against at least a lepidopteran pest, e.g., against fall armyworm (FAW, Spodoptera frugiperda) and uses of such polypeptides and related nucleic acids in compositions and methods, such as in plants or in methods of controlling a lepidopteran pest.

[0021]

[0013] In some embodiments, the chimeric protein is insecticidal against a lepidopteran pest. In some embodiments, the chimeric protein is insecticidal against one or more of fall armyworm (FAW, Spodoptera frugiperda), soybean looper (SBL; Pseudoplusia includens), or velvet bean caterpillar (Anticar sia gemmatalis), Southwestern com borer (SWCB, Diatraea grandiosella), Southern armyworm (SAW, Spodoptera eridania), and Sugarcane borer (SCB, Diatraea saccharalis) .

[0022]

[0014] Accordingly, in some aspects, the disclosure provides a polypeptide comprising an amino acid sequence of any one of SEQ ID NOs: 1, 2, 3, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 49, 50, 51, or 52. In some embodiments, the polypeptide comprises SEQ ID NO: 1. In some embodiments, the polypeptide comprises SEQ ID NO:4. In some embodiments, the polypeptide comprises SEQ ID NO: 20. In some embodiments, the polypeptide comprises a domain I derived from a CrylA-like protein (e.g. a CrylAh-like protein), a domain II derived from the CrylA-like protein, and a domain III derived from a CrylC protein (e.g., a CrylCa protein). In some embodiments, the polypeptide comprises a domain III derived from a CrylF protein (e.g., a CrylFa protein). In some embodiments, the polypeptide comprises a C-terminal tail from a CrylA-like protein (e.g., the CrylAh-like protein or a Cryl Ab protein). In some embodiments, the polypeptide is insecticidal against a lepidopteran pest. In some embodiments, the polypeptide is insecticidal against one or more of fall army worm (FAW, Spodoptera frugiperda) , European corn borer (ECB; Ostrinia nubilalis), soybean looper (SBL; Pseudoplusia includens), velvet bean caterpillar (Anticar sia gemmatalis). In some embodiments, the polypeptide consists of any one of SEQ ID NOs: 1, 2, 3, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 49, 50, 51, or 52.

[0023]

[0015] In other aspects, the disclosure provides a chimeric Cry protein wherein a portion of the C-terminal pro-toxin tail is absent. In some embodiments, the chimeric protein is no more than 1200 amino acids, 1150 amino acids, 1100 amino acids, 1050 amino acids, 1025 amino acids, 1000 amino acids, 990 amino acids, 980 amino acids, 970 amino acids, 960 amino acids, 959 amino acids, 958 amino acids, 957 amino acids, 956 amino acids, 955 amino acids, 954 Attorney Docket No. : PAT- 111602-WO-SEC- 1 amino acids, 953 amino acids, 952 amino acids, 951 amino acids, 950 amino acids, 925 amino acids, 900 amino acids, 890 amino acids, 880 amino acids, 870 amino acids, 860 amino acids, 859 amino acids, 858 amino acids, 857 amino acids, 856 amino acids, 855 amino acids, 850 amino acids, 840 amino acids, 825 amino acids, 800 amino acids, 775 amino acids, 750 amino acids, 725 amino acids, 700 amino acids, 699 amino acid, 698 amino acids, 697 amino acids, 696 amino acids, 695 amino acids, 694 amino acids, 693 amino acids, 692 amino acids, 691 amino acids, 690 amino acids, 680 amino acids, 670 amino acids, 660 amino acids, 650 amino acids, 625 amino acids, or 600 amino acids in length. In some embodiments, the chimeric protein comprises any one of SEQ ID NOs: 14, 15, 16, 17, 19, 20, 21, or 22. In some embodiments, the C-terminus is truncated by 524 amino acids. In some embodiments, the C-terminus is truncated by 535 amino acids. In some embodiments, the chimeric protein comprises SEQ ID NOs: 14 or 16 and is no more than 634 amino acids in length. In some embodiments, the chimeric protein comprises SEQ ID NOs: 15 or 17 and is no more than 645 amino acids in length. In some embodiments, the C-terminus is truncated by 536 amino acids. In some embodiments, the C- terminus is truncated by 547 amino acids. In some embodiments, the chimeric protein comprises SEQ ID NOs: 19 or 21 and is no more than 646 amino acids in length. In some embodiments, the chimeric protein comprises SEQ ID NOs: 20 or 22 and is no more than 657 amino acids in length.

[0024]

[0016] In other aspects, the disclosure provides a chimeric protein wherein a portion of the N-terminus is absent. In some embodiments, the chimeric protein comprises any one of SEQ ID NOs: 13, 14, 15, 18, 19, 20, or 21 and the N-terminus is truncated by 25 amino acids. In other aspects, the disclosure provides a chimeric protein wherein a portion of the N-terminus as well as a portion of the protoxin tail is absent. In some embodiments, the chimeric protein comprises SEQ ID NOs 14 or 15. In some embodiments, the chimeric protein comprises SEQ ID NO: 19 or 20. In some embodiments, the chimeric protein comprises SEQ ID NO:20.

[0025]

[0017] A further aspect of the present disclosure is a nucleic acid comprising a coding sequence that encodes the polypeptide of any one of the above-mentioned embodiments, or any other embodiment herein. In some embodiments, the coding sequence comprises a nucleotide sequence of any one of SEQ ID NOs:5, 6, 7, 8, 9, 10, 11, 12, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, or 44. In some embodiments, the coding sequence is codon optimized for expression in a plant (e.g., a maize plant). In some embodiments, the Attorney Docket No. : PAT- 111602-WO-SEC- 1 coding sequence is operably linked to a heterologous promoter, e.g., a plant-expressible heterologous promoter. In some embodiments, the heterologous promoter is a pollen free promoter.

[0026]

[0018] A still further aspect of the present disclosure are vectors comprising any of the described nucleic acid molecules and transgenic host cells comprising any of the described polypeptides or any of the described the nucleic acid molecules. Tn other aspects, the disclosure provides a transgenic host cell, comprising the polypeptide of any one of the above-mentioned embodiments, or any other embodiment herein, or the nucleic acid of any one of the above- mentioned embodiments, or any other embodiment herein. In some embodiments, the transgenic host cell is a plant cell. In some embodiments, the plant cell is a monocot cell. In some embodiments, the plant cell is a maize cell. In some embodiments, the plant cell is a dicot cell. In some embodiments, the plant cell is a bush bean cell. In some embodiments, the plant cell is a soybean cell. In some embodiments, the transgenic host cell is a bacterial cell. In some embodiments, the bacterial cell is an Agrobacterium, Bacillus, or an Escherichia coli cell.

[0027]

[0019] In other aspects, the disclosure provides a composition comprising the polypeptide of any one of the above-mentioned embodiments, or any other embodiment herein. In some embodiments, the composition further comprises an agriculturally acceptable carrier.

[0028]

[0020] Additional aspects of the present disclosure are plants comprising the polypeptide of any one of the above-mentioned embodiments, or any other embodiment herein or the nucleic acid of any one of the above-mentioned embodiments, or any other embodiment herein. In some embodiments, the plant is a monocot. In some embodiments, the plant is a maize plant. In some embodiments, the plant is a dicot. In some embodiments, the plant is a soybean plant.

[0029]

[0021] In other aspects, the disclosure provides a seed of the plant of any one of the above- mentioned embodiments, or any other embodiment herein.

[0030]

[0022] The present disclosure also provides a method of producing a transgenic plant, the method comprising the steps of introducing into a plant cell any of the described nucleic acid molecules, selecting a plant cell comprising the nucleic acid molecule; and regenerating a plant from the selected plant cell. Also provided is a method for producing a transgenic plant comprising the steps of sexually crossing a first parent plant with a second parent plant, where Attorney Docket No. : PAT- 111602-WO-SEC- 1 the first or second parent plant comprises a polypeptide or nucleic acid molecule of the disclosure and selecting a progeny plant with enhanced insecticidal properties, wherein the selected progeny plant comprises the nucleic acid molecule. In some embodiments, the method further comprises selfing the progeny plant, thereby producing a plurality of second generation progeny plants; and selecting from the second generation progeny plants a plant with enhanced insecticidal properties, wherein the selected second generation progeny plants comprise the nucleic acid molecule.

[0031]

[0023] The disclosure also provides a method of identifying a candidate insecticidal toxin, the method comprising the steps of providing a three-dimensional structure of a polypeptide comprising any one of SEQ ID NOs: 1, 2, 3, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21, or 22, identifying active regions or positions within the polypeptide amino acid sequence that contribute to insecticidal activity, computationally generating a plurality of putative toxin amino acid sequences, wherein the active regions or positions are maintained and at least one other portion of the polypeptide amino acid sequence is modified to include at least one modification relative to the polypeptide amino acid sequence, predicting three-dimensional structures for the plurality of putative toxin sequences, evaluating whether the three-dimensional structures of the plurality of putative toxin sequences, optionally by evaluating structural quality, energy minimization, and / or predicted insecticidal activity; and selecting candidate insecticidal toxins based on the evaluation.

[0032]

[0024] The disclosure is also related to methods of controlling a lepidopteran pest comprising delivering to the pest the polypeptide of any one of the above-mentioned embodiments, or any other embodiment herein. In some embodiments, the polypeptide is delivered by feeding. In some embodiments, the feeding comprises the pest feeding on a plant part that comprises the polypeptide. In some embodiments, the lepidopteran pest is one or more of fall armyworm (FAW, Spodoptera frugiperda), European com borer (ECB; Ostrinia nubilalis), soybean looper (SBL; Pseudoplusia includens), velvet bean caterpillar (VBC, Anticarsia gemmatalis), Southwestern corn borer (SWCB, Dicitraea grcmdiosella), Southern army worm (SAW, Spodoptera eridania), and Sugarcane borer (SCB, Diatraea saccharalis) .

[0033]

[0025] In other aspects, the disclosure provides use of the sequence of anyone of SEQ ID NOs: 1 to 44 in a bioinformatic analysis to identify an insecticidal protein (e.g., insecticidal Attorney Docket No. : PAT- 111602-WO-SEC- 1 against one or more of fall armyworm (FAW, Spodoptera frugiperda), European corn borer (ECB; Ostrinia nubilalis), soybean looper (SBL; Pseudoplusia includens), velvet bean caterpillar (VBC, Anticarsia gemmatalis), Southwestern corn borer (SWCB, Diatraea grandiosella), Southern armyworm (SAW, Spodoptera eridania), and Sugarcane borer (SCB, Diatraea saccharalis) .

[0034]

[0026] In other aspects, the disclosure provides use of a polypeptide comprising the amino acid sequence of any one of SEQ ID NOs: 1, 2, 3, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 49, 50, 51, or 52 in an insect bioassay to identify an insecticidal protein (e.g., insecticidal against one or more of fall armyworm (FAW, Spodoptera frugiperda), European corn borer (ECB; Ostrinia nubilalis), soybean looper (SBL; Pseudoplusia includens), velvet bean caterpillar (VBC, Anticarsia gemmatalis), Southwestern corn borer (SWCB, Diatraea grandiosella), Southern army worm (SAW, Spodoptera eridania), and Sugarcane borer (SCB, Diatraea saccharalis) .

[0035] BRIEF DESCRIPTION OF THE SEQUENCES IN THE SEQUENCE LISTING

[0036] SEQ ID NO: 1 is the amino acid sequence of engineered IC3009.

[0037] SEQ ID NO: 2 is the amino acid sequence of engineered IC3011.

[0038] SEQ ID NO: 3 is the amino acid sequence of engineered IC3012.

[0039] SEQ ID NO: 4 is the amino acid sequence of engineered IC3O13.

[0040] SEQ ID NO: 5 is the nucleotide sequence of engineered IC3009.

[0041] SEQ ID NO: 6 is the nucleotide sequence of engineered IC3011.

[0042] SEQ ID NO: 7 is the nucleotide sequence of engineered IC3012.

[0043] SEQ ID NO: 8 is the nucleotide sequence of engineered IC3013.

[0044] SEQ ID NO: 9 is a maize codon optimized nucleotide sequence for IC3009.

[0045] SEQ ID NO: 10 is a maize codon optimized nucleotide sequence for IC3011.

[0046] SEQ ID NO: 11 is a maize codon optimized nucleotide sequence for 1C3012. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0047] SEQ ID NO: 12 is a maize codon optimized nucleotide sequence for IC3013.

[0048] SEQ ID NO: 13 is the amino acid sequence of engineered IC3009 M26.

[0049] SEQ ID NO: 14 is the amino acid sequence of engineered IC3009 M26 T634.

[0050] SEQ ID NO: 15 is the amino acid sequence of engineered IC3009 M26 R645.

[0051] SEQ ID NO: 16 is the amino acid sequence of engineered IC3009 T634.

[0052] SEQ ID NO: 17 is the amino acid sequence of engineered IC3009 R645.

[0053] SEQ ID NO: 18 is the amino acid sequence of engineered IC3013 M26.

[0054] SEQ ID NO: 19 is the amino acid sequence of engineered IC3013 M26 D646.

[0055] SEQ ID NO: 20 is the amino acid sequence of engineered IC3013_M26_R657.

[0056] SEQ ID NO: 21 is the amino acid sequence of engineered IC3013 D646.

[0057] SEQ ID NO: 22 is the amino acid sequence of engineered IC3013 R657.

[0058] SEQ ID NO: 23 is the nucleotide sequence of engineered IC3009 M26.

[0059] SEQ ID NO: 24 is the nucleotide sequence of engineered IC3009_M26_T634.

[0060] SEQ ID NO: 25 is the nucleotide sequence of engineered IC3009 M26 R645.

[0061] SEQ ID NO: 26 is the nucleotide sequence of engineered IC3009 T634.

[0062] SEQ ID NO: 27 is the nucleotide sequence of engineered IC3009 R645.

[0063] SEQ ID NO: 28 is the nucleotide sequence of engineered IC3013 M26.

[0064] SEQ ID NO: 29 is the nucleotide sequence of engineered IC3013 M26 D646.

[0065] SEQ ID NO: 30 is the nucleotide sequence of engineered IC3013_M26_R657.

[0066] SEQ ID NO: 31 is the nucleotide sequence of engineered IC3013 D646.

[0067] SEQ ID NO: 32 is the nucleotide sequence of engineered IC3013 R657.

[0068] SEQ ID NO: 33 is a maize codon optimized sequence of engineered IC3009 M26. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0069] SEQ ID NO: 34 is a maize codon optimized sequence of engineered IC3009 M26 T634.

[0070] SEQ ID NO: 35 is a maize codon optimized sequence of engineered IC3009 M26 R645.

[0071] SEQ ID NO: 36 is a maize codon optimized sequence of engineered IC3009 T634.

[0072] SEQ ID NO: 37 is a maize codon optimized sequence of engineered IC3009 R645.

[0073] SEQ ID NO: 38 is a maize codon optimized sequence of engineered IC3013 M26.

[0074] SEQ ID NO: 39 is a maize codon optimized sequence of engineered IC3013 M26 D646.

[0075] SEQ ID NO: 40 is a maize codon optimized sequence of engineered IC3013 M26 R657.

[0076] SEQ ID NO: 41 is a maize codon optimized sequence of engineered IC3013 D646.

[0077] SEQ ID NO: 42 is a maize codon optimized sequence of engineered IC3013 R657.

[0078] SEQ ID NO: 43 is a maize codon optimized sequence of engineered IC3009.

[0079] SEQ ID NO: 44 is a maize codon optimized sequence of engineered IC3013.

[0080] SEQ ID NO: 45 is the nucleotide sequence of SbCTP15, the transit peptide of the sorghum Sobic.004G202200 gene

[0081] SEQ ID NO: 46 is the amino acid sequence of SbCTP15

[0082] SEQ ID NO:47 is the nucleotide sequence of OsCTP6, the transit peptide of the rice 0s01t0802100 gene, encoding the N-terminal domain of GHMP kinase

[0083] SEQ ID NO: 48 is the amino acid sequence of OsCTP6

[0084] SEQ ID NO: 49 is the amino acid sequence of the transit peptide SbCTP15 fused with IC3013_M26_R657

[0085] SEQ ID NO: 50 is the amino acid sequence of the transit peptide SbCTP15 fused with full length IC3013

[0086] SEQ ID NO: 51 is the amino acid sequence of the transit peptide xOsCTP6 fused with IC3013_M26_R657 Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0087] SEQ ID NO: 52 is the amino acid sequence of the transit peptide xOsCTP6 fused with full length IC3013

[0088] DETAILED DESCRIPTION

[0089]

[0027] This description is not intended to be a detailed catalog of all the different ways in which the invention may be implemented, or all the features that may be added to the instant invention. For example, features illustrated with respect to one embodiment may be incorporated into other embodiments, and features illustrated with respect to a particular embodiment may be deleted from that embodiment. Thus, the invention contemplates that in some embodiments of the invention, any feature or combination of features set forth herein can be excluded or omitted. In addition, numerous variations and additions to the various embodiments suggested herein will be apparent to those skilled in the art in light of the instant disclosure, which do not depart from the instant invention. Hence, the following descriptions are intended to illustrate some particular embodiments of the invention, and not to exhaustively specify all permutations, combinations and variations thereof.

[0090]

[0028] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention.

[0091]

[0029] All publications, patent applications, patents and other references cited herein are incorporated by reference in their entireties for the teachings relevant to the sentence and / or paragraph in which the reference is presented.

[0092]

[0030] Nucleotide sequences provided herein are presented in the 5’ to 3’ direction, from left to right and are presented using the standard code for representing nucleotide bases as set forth in 37 CFR §§1.821 - 1.825 and the World Intellectual Property Organization (WIPO) Standard

[0093] ST.25, for example: adenine (A), cytosine (C), thymine (T), and guanine (G).

[0094]

[0031] Amino acids are likewise indicated using the WIPO Standard ST.25, for example: alanine (Ala; A), arginine (Arg; R), asparagine (Asn; N), aspartic acid (Asp; D), cysteine (Cys; C), glutamine (Gin; Q), glutamic acid (Glu; E), glycine (Gly; G), histidine (His; H), isoleucine Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0095] (He; 1), leucine (Leu; L), lysine (Lys; K), methionine (Met; M), phenylalanine (Phe; F), proline (Pro; P), serine (Ser; S), threonine (Thr; T), tryptophan (Trp; W), tyrosine (Tyr; Y), and valine (Vai; V).

[0096]

[0032] Unless the context indicates otherwise, it is specifically intended that the various features of the invention described herein can be used in any combination. Moreover, the present invention also contemplates that in some embodiments of the invention, any feature or combination of features set forth herein can be excluded or omitted. To illustrate, if the specification states that a composition comprises components A, B and C, it is specifically intended that any of A, B or C, or a combination thereof, can be omitted and disclaimed singularly or in any combination.

[0097] Definitions

[0098]

[0033] For clarity, certain terms used in the specification are defined and presented as follows:

[0099]

[0034] As used herein and in the appended claims, the singular forms “a,” “an,” and “the” include plural reference unless the context clearly dictates otherwise. Thus, for example, reference to “a plant” is a reference to one or more plants and includes equivalents thereof known to those skilled in the art, and so forth.

[0100]

[0035] As used herein, the word “and / or” refers to and encompasses any and all possible combinations of one or more of the associated listed items, as well as the lack of combinations when interpreted in the alternative, “or.”

[0101]

[0036] The term “about” is used herein to mean approximately, roughly, around, or in the region of. When the term “about” is used in conjunction with a numerical range, it modifies that range by extending the boundaries above and below the numerical values set forth. In general, the term “about” is used herein to modify a numerical value above and below the stated value by a variance of 20 percent, preferably 10 percent up or down (higher or lower). With regard to a temperature the term “about” means ± 1 °C, preferably ± 0.5°C. Where the term “about” is used in the context of this invention (e.g., in combinations with temperature or molecular weight values) the exact value (i.e., without “about”) is preferred. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0102]

[0037] As used herein, phrases such as “between about X and Y”, “between about X and about Y”, “from X to Y” and “from about X to about Y” (and similar phrases) should be interpreted to include X and Y, unless the context indicates otherwise. Units, prefixes and symbols may be denoted in their SI accepted form. Unless otherwise indicated, nucleic acids are written left to right in 5' to 3' orientation; amino acid sequences are written left to right in N- terminus to C-terminus orientation, respectively. Amino acids may be referred to herein by either their commonly known three letter symbols or by the one-letter symbols recommended by the IUPAC-IUB Biochemical Nomenclature Commission. Nucleotides, likewise, may be referred to by their commonly accepted single-letter codes.

[0103]

[0038] “Activity” of the pesticidal proteins of the invention means that the pesticidal proteins function as orally active pest (e.g. insect) control agents, have a toxic effect (e.g., inhibiting the ability of the insect pest to survive, grow, and / or reproduce), and / or are able to disrupt or deter pest feeding, which may or may not cause death of the insect. When a pesticidal protein of the disclosure is delivered to the pest, the result is typically death of the pest, or the pest does not feed upon the source that makes the pesticidal protein available to the pest. “Pesticidal” is defined as a toxic biological activity capable of controlling a pest, such as an insect, nematode, fungus, bacteria, or virus, preferably by killing or destroying them. “Insecticidal” is defined as a toxic biological activity capable of controlling insects, preferably by killing them. A “pesticidal agent” is an agent that has pesticidal activity. An “insecticidal agent” is a pesticidal agent that has insecticidal activity.

[0104]

[0039] An “assembled sequence,” “assembled polynucleotide,” “assembled nucleotide sequence,” and the like, according to the disclosure is a synthetic polynucleotide made by aligning overlapping sequences of polynucleotides or portions of sequenced polynucleotides, i.e. k-mers (all the possible subsequences of length k from a read obtained through DNA sequencing), that are determined from genomic DNA using DNA sequencing technology. Assembled sequences typically contain base-calling errors, which can be incorrectly determined bases, insertions and / or deletions compared to a native DNA sequence comprised in a genome from which the genomic DNA is obtained. Therefore, for example, an “assembled polynucleotide” may encode a protein and according to the disclosure both the polynucleotide and the protein are not products of nature but exist only by human activity. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0105]

[0040] A "coding sequence" is a nucleic acid sequence that is transcribed into RNA such as mRNA, rRNA, tRNA, snRNA, sense RNA or antisense RNA which is then preferably translated in an organism to produce a protein.

[0106]

[0041] The term “chimeric polynucleotide” or “chimeric protein” (or similar terms) as used herein refers to a molecule comprising two or more polynucleotides or proteins, or fragments thereof, of different origin assembled into a single molecule. The term “chimeric construct”, “chimeric gene”, “chimeric polynucleotide” or “chimeric nucleic acid” refers to any construct or molecule that contains, without limitation, (1) polynucleotides (e.g., DNA) , including regulatory and coding polynucleotides that are not found together in nature (i.e., at least one of the polynucleotides in the construct is heterologous with respect to at least one of its other polynucleotides), or (2) polynucleotides encoding parts of proteins not naturally adjoined, or (3) parts of promoters that are not naturally adjoined. Further, a chimeric construct, chimeric gene, chimeric polynucleotide or chimeric nucleic acid may comprise regulatory polynucleotides and coding polynucleotides that are derived from different sources, or comprise regulatory polynucleotides and coding polynucleotides derived from the same source, but arranged in a manner different from that found in nature. In some embodiments of the disclosure, the chimeric construct, chimeric gene, chimeric polynucleotide or chimeric nucleic acid comprises an expression cassette comprising a polynucleotide of the disclosure under the control of regulatory polynucleotides, particularly under the control of regulatory polynucleotides functional in plants or bacteria. The word “chimeric” and “hybrid,” with respect to a polynucleotide or protein, are used interchangeably herein.

[0107]

[0042] In the context of the present disclosure, a “chimeric” protein is a protein created by fusing all or a portion of at least two different proteins. A chimeric protein may also be further modified to include additions, substitutions and / or deletions of one or more amino acids. In some embodiments of the present disclosure, the chimeric protein is a chimeric Cry protein comprising all or a portion of two different Cry proteins fused together in a single polypeptide. In some embodiments, the chimeric Cry protein further comprises additional modifications such as additions, substitutions, and / or deletions of one or more amino acids. A “chimeric insecticidal protein” is a chimeric protein that has insecticidal activity. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0108]

[0043] As used herein, a “codon optimized” sequence means a nucleotide sequence wherein the codons are chosen to reflect the particular codon bias that a host cell or organism may have. This is typically done in such a way so as to preserve the amino acid sequence of the polypeptide encoded by the nucleotide sequence to be optimized. In certain embodiments, the DNA sequence of the recombinant DNA construct includes sequence that has been codon optimized for the cell (e.g., an animal, plant, or fungal cell) in which the construct is to be expressed. For example, a construct to be expressed in a plant cell can have all or parts of its sequence (e.g., the first gene suppression element or the gene expression element) codon optimized for expression in a plant. See, for example, U.S. Pat. No. 6,121,014, which is incorporated herein by reference. In some embodiments, the polynucleotides of the disclosure are codon-optimized for expression in a plant cell (e.g., a dicot cell or a monocot cell) or bacterial cell.

[0109]

[0044] To “control” insects means to inhibit, through a toxic effect, the ability of insect pests to survive, grow, feed, and / or reproduce, and / or to limit insect-related damage or loss in crop plants and / or to protect the yield potential of a crop when grown in the presence of insect pests. To “control” insects may or may not mean killing the insects, although in some embodiments of the disclosure, “control” of the insect means killing the insects.

[0110]

[0045] The terms “comprises”, “comprising”, “includes”, “including”, “having” and their conjugates mean including “but not limited to”. These terms when used in this specification, specify the presence of stated features, integers, steps, operations, elements, or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, or groups thereof. The term “consisting of means “including and limited to”.

[0111]

[0046] As used herein, the transitional phrase “consisting essentially of’ (and grammatical variants) means that the scope of a claim is to be interpreted to encompass the specified materials or steps recited in the claim” and those that do not materially alter the basic and novel characteristic(s)” of the claimed invention. Thus, the term “consisting essentially of’ when used in a claim of this invention is not intended to be interpreted to be equivalent to “comprising.”

[0112]

[0047] In the context of the disclosure, “corresponding to” or “corresponds to” means that when the amino acid sequences of a reference sequence are aligned with a second amino acid Attorney Docket No. : PAT- 111602-WO-SEC- 1 sequence (e.g. variant or homologous sequences), different from the reference sequence, the amino acids that “correspond to” certain enumerated positions in the second amino acid sequence are those that align with these positions in the reference amino acid sequence but that are not necessarily in the exact numerical positions relative to the particular reference amino acid sequence of the disclosure.

[0113]

[0048] As used herein, the term “Cry protein” means an insecticidal protein of a Bacillus thuringiensis crystal delta-endotoxin type. The term “Cry protein” can refer to the protoxin form or any insecticidally active fragment or toxin thereof including partially processed and the mature toxin form (e.g., without the N-terminal peptidyl fragment and / or the C-terminal protoxin tail).

[0114]

[0049] To “deliver” or “delivering” a composition or toxic protein means that the composition or toxic protein comes in contact with an insect, which facilitates the oral ingestion of the composition or toxic protein, resulting in a toxic effect and control of the insect. The composition or insecticidal protein may be delivered in many recognized ways, e.g., through a transgenic plant expressing the insecticidal protein, formulated protein composition(s), sprayable protein composition(s), a bait matrix, or any other art-recognized toxin delivery system.

[0115]

[0050] The term “domain” refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are likely essential in the structure, stability or function of a protein. Identified by their high degree of conservation in aligned sequences of a family of protein homologues, they can be used as identifiers to determine if any polypeptide in question belongs to a previously identified polypeptide group. An “engineered” protein of the disclosure refers to a protein that has a sequence that is different at at least one amino acid position compared to at least one corresponding parent protein. An engineered protein can be a mutant protein that contains, e.g., one or more modifications such as deletions, additions, and / or substitutions of one or more amino acid positions relative to a parent protein. An engineered protein can be a chimeric protein and contain, e.g., one or more swapped or shuffled domains or fragments from at least two parent proteins. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0116]

[0051] An “engineered” protein of the disclosure refers to a protein that has a sequence that is different at least one amino acid position compared to at least one corresponding parent protein. An engineered protein can be a mutant protein that contains, e.g., one or more modifications such as deletions, additions, and / or substitutions of one or more amino acid positions relative to a parent protein. An engineered protein can be a chimeric protein and contain, e.g., one or more swapped or shuffled domains or fragments from at least two parent proteins.

[0117]

[0052] “Expression cassette” as used herein means a nucleic acid sequence capable of directing expression of a particular nucleotide sequence in an appropriate host cell, comprising a promoter operably linked to the nucleotide sequence of interest which is operably linked to termination signals. It also typically comprises sequences required for proper translation of the nucleotide sequence. The expression cassette comprising the nucleotide sequence of interest may have at least one of its components heterologous with respect to at least one of its other components. The expression cassette may also be one that is naturally occurring but has been obtained in a recombinant form useful for heterologous expression. Typically, however, the expression cassette is heterologous with respect to the host, i.e., the particular nucleic acid sequence of the expression cassette does not occur naturally in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation event. The expression of the nucleotide sequence in the expression cassette may be under the control of a constitutive promoter or of an inducible promoter that initiates transcription only when the host cell is exposed to some particular external stimulus. In the case of a multicellular organism, such as a plant, the promoter can also be specific to a particular tissue, or organ, or stage of development.

[0118]

[0053] “Effective insect-controlling amount” means that concentration of an insecticidal protein that inhibits, through a toxic effect, the ability of insects to survive, grow, feed and / or reproduce, or to limit insect-related damage or loss in crop plants. “Effective insect-controlling amount” may or may not mean killing the insects, although it preferably means killing the insects. A transgenic plant with “enhanced insecticidal properties” is a plant that is expresses a protein or proteins at effective insect-controlling amounts, so that, in some embodiments, the plant is insecticidal to an increased range of insect species, relative to a plant of the same kind Attorney Docket No. : PAT- 111602-WO-SEC- 1 which is not transformed. This increased range of insect species includes insect plant pests, such as lepidopteran insect pests, e.g., Spodoptera fiugiperda (Fall armyworm).

[0119]

[0054] The term “event” refers to the original transformant and / or progeny of the transformant that include the heterologous DNA. The term “event” also refers to progeny produced by a sexual outcross between the transformant and another maize line. Even after repeated backcrossing to a recurrent parent, the inserted DNA and the flanking DNA from the transformed parent is present in the progeny of the cross at the same chromosomal location. The term “event” also refers to DNA from the original transformant comprising the inserted DNA and flanking genomic sequence immediately adjacent to the inserted DNA that would be expected to be transferred to a progeny as the result of a sexual cross of one parental line that includes the inserted DNA (e.g., the original transformant and progeny resulting from selfing) and a parental line that does not contain the inserted DNA. Typically, transformation of plant tissue produces multiple events, each of which represent insertion of a DNA construct into a different location in the genome of a plant cell.

[0120]

[0055] "Expression cassette" as used herein means a nucleic acid sequence capable of directing expression of a particular nucleotide sequence in an appropriate host cell, comprising a promoter operably linked to the nucleotide sequence of interest which is operably linked to termination signals. It also typically comprises sequences required for proper translation of the nucleotide sequence. The expression cassette comprising the nucleotide sequence of interest may have at least one of its components heterologous with respect to at least one of its other components. The expression cassette may also be one that is naturally occurring but has been obtained in a recombinant form useful for heterologous expression. Typically, however, the expression cassette is heterologous with respect to the host, i.e., the particular nucleic acid sequence of the expression cassette does not occur naturally in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation event. The expression of the nucleotide sequence in the expression cassette may be under the control of a constitutive promoter or of an inducible promoter that initiates transcription only when the host cell is exposed to some particular external stimulus. In the case of a multicellular organism, such as a plant, the promoter can also be specific to a particular tissue, or organ, or stage of development. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0121]

[0056] An expression cassette comprising a nucleotide sequence of interest may be chimeric, meaning that at least one of its components is heterologous with respect to at least one of its other components. An expression cassette may also be one that comprises a native promoter driving its native gene; however, it has been obtained in a recombinant form useful for heterologous expression. Such usage of an expression cassette makes it so it is not naturally occurring in the cell into which it has been introduced.

[0122]

[0057] An expression cassette also can optionally include a transcriptional and / or translational termination region (i.e., termination region) that is functional in plants. A variety of transcriptional terminators are available for use in expression cassettes and are responsible for the termination of transcription beyond the heterologous nucleotide sequence of interest and correct mRNA polyadenylation. The termination region may be native to the transcriptional initiation region, may be native to the operably linked nucleotide sequence of interest, may be native to the plant host, or may be derived from another source (i.e., foreign or heterologous to the promoter, the nucleotide sequence of interest, the plant host, or any combination thereof). Appropriate transcriptional terminators include, but are not limited to, the CAMV 35S terminator, the tml terminator, the nopaline synthase terminator and / or the pea rbcs E9 terminator. These can be used in both monocotyledons and dicotyledons. In addition, a coding sequence's native transcription terminator can be used. Any available terminator known to function in plants can be used in the context of this disclosure.

[0123]

[0058] The term "expression" when used with reference to a polynucleotide, such as a gene, ORF or portion thereof, or a transgene in plants, refers to the process of converting genetic information encoded in a gene into RNA (e.g., mRNA, rRNA, tRNA, or snRNA) through "transcription" of the gene (i.e., via the enzymatic action of an RNA polymerase), and into protein where applicable (e.g. if a gene encodes a protein), through "translation" of mRNA. Gene expression can be regulated at many stages in the process. For example, in the case of antisense or dsRNA constructs, respectively, expression may refer to the transcription of the antisense RNA only or the dsRNA only. In some embodiments, “expression” refers to the transcription and stable accumulation of sense (mRNA) or functional RNA. “Expression” may also refer to the production of protein. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0124]

[0059] A “gene” is a defined region that is located within a genome and comprises a coding nucleic acid sequence and typically also comprises other, primarily regulatory, nucleic acids responsible for the control of the expression, that is to say the transcription and translation, of the coding portion. A gene may also comprise other 5' and 3' untranslated sequences and termination sequences. Further elements that may be present are, for example, introns. The regulatory nucleic acid sequence of the gene may not normally be operatively linked to the associated nucleic acid sequence as found in nature and thus would be a chimeric gene.

[0125]

[0060] “Gene of interest” refers to any nucleic acid molecule which, when transferred to a plant, confers upon the plant a desired trait such as antibiotic resistance, virus resistance, insect resistance, disease resistance, or resistance to other pests, herbicide tolerance, abiotic stress tolerance, male sterility, modified fatty acid metabolism, modified carbohydrate metabolism, improved nutritional value, improved performance in an industrial process or altered reproductive capability. The “gene of interest” may also be one that is transferred to plants for the production of commercially valuable enzymes or metabolites in the plant.

[0126]

[0061] The term “heterologous” when used in reference to a gene or a polynucleotide or a polypeptide refers to a gene or a polynucleotide or a polypeptide that is or contains a part thereof not in its natural environment (i.e., has been altered by the hand of man). For example, a heterologous gene may include a polynucleotide from one species introduced into another species. A heterologous gene may also include a polynucleotide native to an organism that has been altered in some way (e.g., mutated, added in multiple copies, linked to a non-native promoter or enhancer polynucleotide, etc.). Heterologous genes further may comprise plant gene polynucleotides that comprise cDNA forms of a plant gene; the cDNAs may be expressed in either a sense (to produce mRNA) or anti-sense orientation (to produce an anti-sense RNA transcript that is complementary to the mRNA transcript). In one aspect of the disclosure, heterologous genes are distinguished from endogenous plant genes in that the heterologous gene polynucleotide are typically joined to polynucleotides comprising regulatory elements such as promoters that are not found naturally associated with the gene for the protein encoded by the heterologous gene or with plant gene polynucleotide in the chromosome, or are associated with portions of the chromosome not found in nature (e.g., genes expressed in loci where the gene is not normally expressed). Further, a “heterologous” polynucleotide refers to a polynucleotide not Attorney Docket No. : PAT- 111602-WO-SEC- 1 naturally associated with a host cell into which it is introduced, including non-naturally occurring multiple copies of a naturally occurring polynucleotide. A heterologous nucleic acid sequence or nucleic acid molecule may comprise a chimeric sequence such as a chimeric expression cassette, where the promoter and the coding region are derived from multiple source organisms. The promoter sequence may be a constitutive promoter sequence, a tissue-specific promoter sequence, a chemically-inducible promoter sequence, a wound-inducible promoter sequence, a stress-inducible promoter sequence, or a developmental stage-specific promoter sequence.

[0127] [621 A "homologous" nucleic acid sequence is a nucleic acid sequence naturally associated with a host cell into which it is introduced.

[0128]

[0063] The terms “increase”, “increasing”, “increased”, “enhance”, “enhanced”, “enhancing”, and “enhancement” and similar terms, as used herein, describe an elevation in control of a plant pest, e.g., by contacting a plant with a polypeptide of the disclosure (such as, for example, by transgenic expression or by topical application methods). The increase in control can be in reference to the level of control of the plant pest in the absence of the polypeptide of the disclosure (e.g., a plant that is not transgenically expressing the polypeptide or is not topically treated with the polypeptide). Thus in some embodiments, the terms “increase”, “increasing”, “increased”, “enhance”, “enhanced”, “enhancing”, and “enhancement” and similar terms can indicate an elevation of at least about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 100%, 125%, 150%, 200%, 300%, 400%, 500% or more as compared to a suitable control (e.g., a plant, plant part, plant cell that is not contacted with the polypeptide of the disclosure.

[0129]

[0064] The term “identity” or “identical” in the context of two nucleic acid or amino acid sequences, refers to the percentage of identical nucleotides or amino acids in a linear polynucleotide or amino acid sequence of a reference (“query”) sequence (or its complementary strand) as compared to a test (“subject”) sequence when the two sequences are globally aligned. Unless otherwise stated, sequence identity as used herein refers to the value obtained using the Needleman and Wunsch algorithm ((1970) J. Mol. Biol. 48:443-453) implemented in the EMBOSS Needle alignment tool using default matrix fdes EBLOSUM62 for protein with default parameters (Gap Open = 10, Gap Extend =0.5, End Gap Penalty = False, End Gap Open = 10, End Gap Extend = 0.5) or DNAfull for nucleic acids with default parameters (Gap Open = 10, Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0130] Gap Extend =0.5, End Gap Penalty = False, End Gap Open = 10, End Gap Extend = 0.5); or any equivalent program thereof. EMBOSS Needle is available, e.g., from EMBL-EBI such as at the following website: ebi.ac.uk / Tools / psa / emboss_needle / and as described in the following publication: “The EMBL-EBI search and sequence analysis tools APIs in 2019.” Madeira et al. Nucleic Acids Research, June 2019, 47(W1):W636-W641. The term “equivalent program” as used herein refers to any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by EMBOSS Needle. In some embodiments, substantially identical nucleic acid or amino acid sequences may perform substantially the same function.

[0131] [651 ‘Insecticidal” as used herein is defined as a toxic biological activity capable of controlling an insect pest, optionally but preferably by killing them.

[0132]

[0066] In some embodiments, the polynucleotides or polypeptides of the disclosure are “isolated”. The term “isolated” polynucleotide or polypeptide is a polynucleotide or polypeptide that no longer exists in its natural environment. An isolated polynucleotide or polypeptide of the disclosure may exist in a purified form or may exist in a recombinant host such as in a transgenic bacteria or a transgenic plant. Therefore, for example, a claim to an “isolated” polynucleotide or polypeptide encompasses a nucleic acid molecule when the nucleic acid molecule is comprised within a transgenic plant genome.

[0133] [67J The term “isolated”, when used in the context of the nucleic acid molecules or polynucleotides of the present disclosure, refers to a polynucleotide that is identified within and isolated / separated from its chromosomal polynucleotide context within the respective source organism. An isolated nucleic acid or polynucleotide is not a nucleic acid as it occurs in its natural context if it indeed has a naturally occurring counterpart. In contrast, non-isolated nucleic acids are nucleic acids such as DNA and RNA, which are found in the state they exist in nature. For example, a given polynucleotide (e.g., a gene) is found on the host cell chromosome in proximity to neighboring genes. The isolated nucleic acid molecule may be present in singlestranded or double-stranded form. Alternatively, it may contain both the sense and antisense Attorney Docket No. : PAT- 111602-WO-SEC- 1 strands (i.e., the nucleic acid molecule may be double-stranded). In some embodiments, the nucleic acid molecules of the present disclosure are isolated.

[0134]

[0068] The term “motif’ or “consensus sequence” or “signature” refers to a short conserved region in the sequence of evolutionarily related proteins. Motifs are frequently highly conserved parts of domains, but may also include only part of the domain, or be located outside of conserved domain (if all of the amino acids of the motif fall outside of a defined domain).

[0135]

[0069] A “native” or “wild type” nucleic acid, polynucleotide, nucleotide sequence, polypeptide or amino acid sequence refers to a naturally occurring or endogenous nucleic acid, polynucleotide, nucleotide sequence, polypeptide or amino acid sequence.

[0136]

[0070] A “nucleic acid molecule” or “nucleic acid” is a segment of single- stranded, doublestranded or partially double-stranded DNA or RNA, or a hybrid thereof, that can be isolated or synthesized from any source. In the context of the present disclosure, the nucleic acid molecule is typically a segment of DNA. In some embodiments, the nucleic acid molecules of the disclosure are isolated nucleic acid molecules. In some embodiments, the nucleic acid molecules of the disclosure are comprised within a vector, a plant, a plant cell or a bacterial cell. The terms also include reference to a deoxyribopolynucleotide, ribopolynucleotide or analogs thereof that have the essential nature of a natural ribonucleotide in that they hybridize, under stringent hybridization conditions, to substantially the same nucleotide sequence as naturally occurring nucleotides and / or allow translation into the same amino acid(s) as the naturally occurring nucleotide(s). A nucleic acid molecule can be full-length or a subsequence of a native or heterologous structural or regulatory gene. Unless otherwise indicated, the term includes reference to the specified sequence as well as the complementary sequence thereof. Thus, DNAs or RNAs with backbones modified for stability or for other reasons are “polynucleotides” as that term is intended herein. Moreover, DNAs or RNAs comprising unusual bases, such as inosine or modified bases, such as tritylated bases, to name just two examples, are polynucleotides as the term is used herein. It will be appreciated that a great variety of modifications have been made to DNA and RNA that serve many useful purposes known to those of skill in the art. The term polynucleotide as it is employed herein embraces such chemically, enzymatically, or Attorney Docket No. : PAT- 111602-WO-SEC- 1 metabolically modified forms of polynucleotides, as well as the chemical forms of DNA and RNA characteristic of viruses and cells, including inter alia, simple, and complex cells.

[0137]

[0071] The terms “nucleic acid,” “nucleic acid molecule,” and “polynucleotide” are used interchangeably herein.

[0138]

[0072] “Operably linked” refers to the association of polynucleotides on a single nucleic acid molecule so that the function of one affects the function of the other. For example, a promoter is operably linked with a coding polynucleotide when it is capable of affecting the expression of that coding polynucleotide (i.e., that the coding polynucleotide is under the transcriptional control of the promoter). Coding polynucleotide in sense or antisense orientation can be operably linked to regulatory polynucleotides.

[0139]

[0073] As used herein “pesticidal,” insecticidal,” and the like, refer to the ability of proteins of the disclosure to control a pest organism or an amount of one or more proteins of the disclosure that can control a pest organism.

[0140]

[0074] The term “plant” includes reference to whole plants, plant organs, plant tissues (e.g., leaves, stems, roots, etc.), seeds and plant cells and progeny of same. Plant cell, as used herein includes, without limitation, seeds, suspension cultures, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, pollen, and microspores. The class of plants, which can be used in the methods of the disclosure, is generally as broad as the class of higher plants amenable to transformation techniques, including both monocotyledonous and dicotyledonous plants including species from the genera: Cucurbita, Rosa, Vitis, Juglans, Fragaria, Lotus, Medicago, Onobrychis, Trifolium, Trigonella, Vigna, Citrus, Linum, Geranium, Manihot, Daucus, Arabidopsis, Brassica, Raphanus, Sinapis, Atropa, Capsicum, Datura, Hyoscyamus, Lycopersicon, Nicotiana, Solanum, Petunia, Digitalis, Majorana, Ciahorium, Helianthus, Lactuca, Bromus, Asparagus, Antirrhinum, Heterocallis, Nemesis, Pelargonium, Panieum, Pennisetum, Ranunculus, Senecio, Salpiglossis, Cucumis, Browaalia, Glycine, Pisum, Phaseolus, Lolium, Oryza, Avena, Hordeum, Secale, Allium and Triticum. A particularly preferred plant is maize.

[0141]

[0075] A “plant cell” is a structural and physiological unit of a plant, comprising a protoplast and a cell wall. The plant cell may be in the form of an isolated single cell or a cultured cell, or Attorney Docket No. : PAT- 111602-WO-SEC- 1 as a part of a higher organized unit such as, for example, plant tissue, a plant organ, or a whole plant.

[0142]

[0076] “Plant cell culture” means cultures of plant units such as, for example, protoplasts, cell culture cells, cells in plant tissues, pollen, pollen tubes, ovules, embryo sacs, zygotes and embryos at various stages of development.

[0143]

[0077] “Plant material” refers to leaves, stems, roots, flowers or flower parts, fruits, pollen, egg cells, zygotes, seeds, cuttings, cell or tissue cultures, or any other part or product of a plant.

[0144]

[0078] A “plant organ” is a distinct and visibly structured and differentiated part of a plant such as a root, stem, leaf, flower bud, or embryo.

[0145]

[0079] As used herein, “plant material,” “plant part” or “plant tissue” means plant cells, plant protoplasts, plant cell tissue cultures from which plants can be regenerated, plant calli, plant clumps, and plant cells that are intact in plants or parts of plants such as embryos, pollen, ovules, seeds, leaves, flowers, branches, fruit, kernels, ears, cobs, husks, stalks, roots, root tips, anthers, tubers, rhizomes, and the like. Any tissue of a plant in planta or in culture is included in the term “plant tissue.”

[0146]

[0080] “Plant tissue” as used herein means a group of plant cells organized into a structural and functional unit. Any tissue of a plant in planta or in culture is included. This term includes, but is not limited to, whole plants, plant organs, plant seeds, tissue culture and any groups of plant cells organized into structural and / or functional units. The use of this term in conjunction with, or in the absence of, any specific type of plant tissue as listed above or otherwise embraced by this definition is not intended to be exclusive of any other type of plant tissue.

[0147]

[0081] As used herein “plant sample” or “biological sample” refers to either intact or nonintact (e.g. milled seed or plant tissue, chopped plant tissue, lyophilized tissue) plant tissue. It may also be an extract comprising intact or non-intact seed or plant tissue. The biological sample or extract may be selected from the group consisting of com flour, corn meal, corn syrup, corn oil, corn starch, and cereals manufactured in whole or in part to contain corn by-products.

[0148]

[0082] A “polynucleotide of interest” or “nucleic acid of interest” refers to any polynucleotide which, when transferred to an organism, e.g., a plant, confers upon the organism Attorney Docket No. : PAT- 111602-WO-SEC- 1 a desired characteristic such as insect resistance, disease resistance, herbicide tolerance, antibiotic resistance, improved nutritional value, improved performance in an industrial process, production of a commercially valuable enzyme or metabolite, an altered reproductive capability, and the like.

[0149]

[0083] A “portion” or a “fragment” of a polypeptide of the disclosure will be understood to mean an amino acid sequence or nucleic acid sequence of reduced length relative to a reference amino acid sequence or nucleic acid sequence of the disclosure. Such a portion or a fragment according to the disclosure may be, where appropriate, included in a larger polypeptide or nucleic acid of which it is a constituent (e.g., a tagged or fusion protein or an expression cassette). In some embodiments, the “portion” or “fragment” substantially retains the activity, such as insecticidal activity (e.g., at least 40%, 50%, 60%, 70%, 80%, 85%, 90%, 95% or even 100% of the activity) of the full-length protein or nucleic acid, or has even greater activity, e.g., insecticidal activity, than the full-length protein).

[0150]

[0084] The terms “protein,” “peptide,” and “polypeptide” are used interchangeably herein.

[0151]

[0085] The term “promoter,” as used herein, refers to a polynucleotide, usually upstream (51) of the translation start site of a coding sequence, which controls the expression of the coding sequence by providing the recognition for RNA polymerase and other factors required for proper transcription. For example, a promoter may contain a region containing basal promoter elements recognized by RNA polymerase, a region containing the 5' untranslated region (UTR) of a coding sequence, and optionally an intron.

[0152]

[0086] A “pollen-free promoter” is a promoter that drives low or no detectable gene expression in the pollen of the target plant species. Quantification of mRNA transcripts of a protein of interest in pollen could be measured by various methods including qRT-PCR / RNA- Seq; the protein can be measured by commonly used ELISA and Western blot methodology. A promoter is considered pollen-free in this disclosure if the promoter drives expression of a protein of the disclosure at <10 ng / mg TSP (total soluble protein) in pollen.

[0153]

[0087] As used herein, the term “recombinant” refers to a form of nucleic acid (e.g., DNA or RNA) or protein or an organism that would not normally be found in nature and as such was created by human intervention. As used herein, a “recombinant nucleic acid molecule” is a Attorney Docket No. : PAT- 111602-WO-SEC- 1 nucleic acid molecule comprising a combination of polynucleotides that would not naturally occur together and is the result of human intervention, e.g., a nucleic acid molecule that is comprised of a combination of at least two polynucleotides heterologous to each other, or a nucleic acid molecule that is artificially synthesized, for example, a polynucleotide synthesize using an assembled nucleotide sequence, and comprises a polynucleotide that deviates from the polynucleotide that would normally exist in nature, or a nucleic acid molecule that comprises a transgene artificially incorporated into a host cell's genomic DNA and the associated flanking DNA of the host cell's genome. Another example of a recombinant nucleic acid molecule is a DNA molecule resulting from the insertion of a transgene into a plants genomic DNA, which may ultimately result in the expression of a recombinant RNA or protein molecule in that organism. As used herein, a “recombinant plant” is a plant that would not normally exist in nature, is the result of human intervention, and contains a transgene or heterologous nucleic acid molecule which may be incorporated into its genome. As a result of such genomic alteration, the recombinant plant is distinctly different from the related wild-type plant. A “recombinant” bacteria is a bacteria not found in nature that comprises a heterologous nucleic acid molecule. Such a bacteria may be created by transforming the bacteria with the nucleic acid molecule or by the conjugation-like transfer of a plasmid from one bacteria strain to another, whereby the plasmid comprises the nucleic acid molecule.

[0154]

[0088] The terms “reduce,” “reduced,” “reducing,” “reduction,” “diminish,” and “suppress” (and grammatical variations thereof) and similar terms, as used herein, refer to a decrease in the survival, growth and / or reproduction of a plant pest, e.g., by contacting a plant with a polypeptide of the disclosure (such as, for example, by transgenic expression or by topical application methods). This decrease in survival, growth and / or reproduction can be in reference to the level observed in the absence of the polypeptide of the disclosure (e.g., a plant that is not transgenically expressing the polypeptide or is not topically treated with the polypeptide). Thus, in some embodiments, the terms “reduce,” “reduced,” “reducing,” “reduction,” “diminish,” and “suppress” (and grammatical variations thereof) and similar terms mean a decrease of at least about 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95% or more as compared with a plant that is not contacted with a polypeptide of the disclosure (e.g., a plant that is not transgenically expressing the polypeptide or is not Attorney Docket No. : PAT- 111602-WO-SEC- 1 topically treated with the polypeptide). In representative embodiments, the reduction results in no or essentially no (i.e., an insignificant amount, e g., less than about 10%, less than about 5% or even less than about 1%) detectable survival, growth and / or reproduction of the plant pest.

[0155]

[0089] “Regulatory elements” refer to nucleotide sequences located upstream (5’ non-coding sequences), within, or downstream (3’ non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences include enhancers, promoters, translational enhancer sequences, introns, terminators, and polyadenylation signal sequences. They include natural and synthetic sequences as well as sequences which may be a combination of synthetic and natural sequences. Regulatory sequences may determine expression level, the spatial and temporal pattern of expression and, for a subset of promoters, expression under inductive conditions (regulation by external factors such as light, temperature, chemicals and hormones).

[0156]

[0090] As used herein, “selectable marker” means a nucleotide sequence that when expressed imparts a distinct phenotype to the plant, plant part and / or plant cell expressing the marker and thus allows such transformed plants, plant parts and / or plant cells to be distinguished from those that do not have the marker. Such a nucleotide sequence may encode either a selectable or screenable marker, depending on whether the marker confers a trait that can be selected for by chemical means, such as by using a selective agent (e.g., an antibiotic, herbicide, or the like), or on whether the marker is simply a trait that one can identify through observation or testing, such as by screening (e g., the R-locus trait).

[0157]

[0091] “Stable transformation” or “stably transformed” as used herein means that a nucleic acid is introduced into a cell and integrates into the genome of the cell. As such, the integrated nucleic acid is capable of being inherited by the progeny thereof, more particularly, by the progeny of multiple successive generations. “Genome” as used herein also includes the nuclear and the plastid genome, and therefore includes integration of the nucleic acid into, for example, the chloroplast genome. Stable transformation as used herein can also refer to a transgene that is maintained extrachromosomally, for example, as a minichromosome.

[0158]

[0092] “Synthetic” refers to a nucleotide sequence comprising bases or a structural feature(s) that is not present in the natural sequence. For example, an artificial sequence encoding a protein Attorney Docket No. : PAT- 111602-WO-SEC- 1 of the disclosure that resembles more closely the G+C content and the normal codon distribution of dicot or monocot plant genes is said to be synthetic.

[0159]

[0093] As used herein, a protein of the disclosure that is “toxic” to an insect pest is meant that the protein functions as an orally active insect control agent to kill the insect pest, or the protein is able to disrupt or deter insect feeding, or causes growth inhibition to the insect pest, both of which may or may not cause death of the insect. When a toxic protein of the disclosure is delivered to an insect or an insect comes into oral contact with the toxic protein, the result is typically death of the insect, or the insect’s growth is slowed, or the insect stops feeding upon the source that makes the toxic protein available to the insect.

[0160]

[0094] The terms “toxin fragment” and “toxin portion” are used interchangeably herein to refer to a fragment or portion of a longer (e.g., full-length) insecticidal protein of the disclosure, where the “toxin fragment” or “toxin portion” retains insecticidal activity. For example, it is known in the art that native Cry proteins are expressed as protoxins that are processed at the N- terminal and C-terminal ends to produce a mature toxin. In some embodiments, the “toxin fragment” or “toxin portion” of a chimeric insecticidal protein of the disclosure is truncated at the N-terminus and / or C-terminus. In some embodiments, the “toxin fragment” or “toxin portion” is truncated at the N-terminus to remove part or all of the N-terminal peptidyl fragment, and optionally comprises at least about 400, 425, 450, 475, 500, 510, 520, 530, 540, 550, 560, 570, 580 or 590 contiguous amino acids of insecticidal protein specifically described herein or an amino acid sequence that is substantially identical thereto. Thus, in some embodiments, a “toxin fragment” or “toxin portion” of an insecticidal protein is truncated at the N-terminus (e.g., to omit part or all of the peptidyl fragment), for example, an N-terminal truncation of one amino acid or more than one amino acid, e.g., up to 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60 or more amino acids. In some embodiments, a “toxin fragment” or “toxin portion” of an insecticidal protein is truncated at the C-terminus (e.g., to omit part or all of the protoxin tail), for example, a C-terminal truncation of one amino acid or more than one amino acid, e.g., up to 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 70, 80, 90, 100, 125, Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0161] 150, 175, 200, 225, 250, 275, 300, 325, 350, 375, 400, 425, 450, 475, 500, 525, 550, 560 or more amino acids. In some embodiments, the “toxin fragment” or “toxin portion” comprises domains 1 and 11, and the core domain 111. In some embodiments, the “toxin fragment” or “toxin portion” is the mature (i.e., processed) toxin (e.g., Cry toxin).

[0162]

[0095] Transformation” is a process for introducing heterologous nucleic acid into a host cell or organism. In particular embodiments, “transformation” means the stable integration of a DNA molecule into the genome (nuclear or plastid) of an organism of interest. In some particular embodiments, the introduction into a plant, plant part and / or plant cell is via bacterial- mediated transformation, particle bombardment transformation, calcium-phosphate-mediated transformation, cyclodextrin-mediated transformation, electroporation, liposome-mediated transformation, nanoparticle-mediated transformation, polymer-mediated transformation, virus- mediated nucleic acid delivery, whisker-mediated nucleic acid delivery, microinjection, sonication, infiltration, polyethylene glycol-mediated transformation, protoplast transformation, or any other electrical, chemical, physical and / or biological mechanism that results in the introduction of nucleic acid into the plant, plant part and / or cell thereof, or a combination thereof. Procedures for transforming plants are well known and routine in the art and are described throughout the literature. Non-limiting examples of methods for transformation of plants include transformation via bacterial-mediated nucleic acid delivery (e.g., via bacteria from the genus Agrobacterium), viral-mediated nucleic acid delivery, silicon carbide or nucleic acid whisker-mediated nucleic acid delivery, liposome mediated nucleic acid delivery, microinjection, microparticle bombardment, calcium-phosphate-mediated transformation, cyclodextrin-mediated transformation, electroporation, nanoparticle-mediated transformation, sonication, infiltration, PEG-mediated nucleic acid uptake, as well as any other electrical, chemical, physical (mechanical) and / or biological mechanism that results in the introduction of nucleic acid into the plant cell, including any combination thereof. General guides to various plant transformation methods known in the art include Miki et al. (“Procedures for Introducing Foreign DNA into Plants” in Methods in Plant Molecular Biology and Biotechnology, Glick, B. R. and Thompson, J. E., Eds. (CRC Press, Inc., Boca Raton, 1993), pages 67-88) and Rakowoczy-Trojanowska (2002, Cell Mol Biol Lett 7:849-858 (2002)). Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0163]

[0096] “Transformed” and “transgenic” refer to a host organism such as a bacterium or a plant into which a heterologous nucleic acid molecule has been introduced. The nucleic acid molecule can be stably integrated into the genome of the host or the nucleic acid molecule can also be present as an extrachromosomal molecule. Such an extrachromosomal molecule can be auto-replicating. Transformed cells, tissues, or plants are understood to encompass not only the end product of a transformation process, but also transgenic progeny thereof. A “nontransformed”, “non-transgenic”, or “non- recombinant” host refers to a wild-type organism, e.g., a bacterium or plant, which does not contain the heterologous nucleic acid molecule.

[0164]

[0097] The term “transgenic plant” includes reference to a plant into which a heterologous nucleic acid molecule has been introduced. Generally, the heterologous nucleic acid sequence is stably integrated within the genome such that the nucleic acid sequence is passed on to successive generations. The heterologous nucleic acid sequence may be integrated into the genome alone or as part of a recombinant expression cassette. “Transgenic” is used herein to include any cell, cell line, callus, tissue, plant part or plant, the genotype of which has been altered by the presence of a heterologous nucleic acid sequence, including those transgenics initially so altered as well as those created by sexual crosses or asexual propagation from the initial transgenic.

[0165]

[0098] The term “vector” refers to a composition for transferring, delivering or introducing a nucleic acid (or nucleic acids) into a cell. A vector comprises a nucleic acid molecule comprising the nucleotide sequence(s) to be transferred, delivered or introduced. Example vectors include a plasmid, cosmid, phagemid, artificial chromosome, phage or viral vector.

[0166] Insecticidal Proteins and Polypeptides

[0167]

[0099] The present disclosure provides compositions and methods for controlling harmful plant pests. Particularly, the present disclosure provides engineered Cry proteins which have activity against Lepidopteran pests, for example Spodoplera frugiperda (Fall armyworm; FAW). The present disclosure also relates to nucleic acids whose expression results in insecticidal proteins of the disclosure, and to the making and using of the insecticidal proteins to control insect pests. In some embodiments, the expression of the nucleic acids results in insecticidal proteins that can be used to control Lepidopteran pests such as fall armyworm, particularly when Attorney Docket No. : PAT- 111602-WO-SEC- 1 expressed in a transgenic plant such as a transgenic corn plant. The disclosure further provides methods of making and using the proteins and polynucleotides of the disclosure to control insect pests.

[0168]

[0100] In some embodiments, the disclosure provides novel chimeric insecticidal proteins comprising an amino acid sequence of any one of SEQ ID NOs: 1, 2, 3, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 49, 50, 51, or 52. In some embodiments, the chimeric insecticidal protein comprises SEQ ID NO: 1. In some embodiments, the chimeric insecticidal protein comprises SEQ ID NO:4. In other embodiments, the chimeric insecticidal protein comprises SEQ ID NO:20.

[0169]

[0101] The present disclosure provides novel chimeric insecticidal proteins comprising at least one region from a first Cry protein (e. , a CrylA-like protein and substantially identical variants thereof). In some embodiments, a chimeric insecticidal protein is provided comprising a region from two or more different Cry proteins. In some embodiments, the N-terminal region of the first Cry protein is fused to a C-terminal region from a different Cry protein (e.g., a different Cryl protein) to form a chimeric insecticidal protein (e.g., a chimeric insecticidal Cry protein). In representative embodiments, the C-terminal region from a different Cry protein can be a C- terminal region from a different Cryl protein or a polypeptide comprising an amino acid sequence that is substantially identical to the C-terminal region from the different Cryl protein. In some embodiments, the different Cryl protein includes without limitation a Cryl A protein (e.g., a CrylAa or a CrylAb protein). In further embodiments, the disclosure provides a polypeptide comprising a) a domain I derived from a CrylA-like protein; b) a domain II derived from a CrylA-like protein; and c) a domain III derived from a CrylC protein. In further embodiments, the polypeptide comprises a domain III derived from a Cry IF protein. In further embodiments, the polypeptide comprises a C-terminus from a CrylA-like protein. In some embodiments, domains I and II of the chimeric protein comprise the first 490 residues. In some embodiments, domain III of the protein is comprised of residues 491 to 634 or 491 to 646. In further embodiments, the C-terminal tail comprises amino acid residues 635 to 1181 or 647 to 1193.

[0170]

[0102] Chimeric insecticidal proteins also encompass sequences derived from mutagenic and recombinogenic procedures such as DNA shuffling. With such a procedure, one or more Attorney Docket No. : PAT- 111602-WO-SEC- 1 different toxic protein coding regions can be used to create new toxic proteins possessing the desired properties. In this manner, libraries of recombinant polynucleotides are generated from a population of related sequence polynucleotides comprising sequence regions that have substantial sequence identity and can be homologously recombined in vitro or in vivo. For example, using this approach, sequence motifs encoding a domain of interest may be shuffled between a pesticidal gene of the disclosure and other known pesticidal genes to obtain a new gene coding for a protein with an improved property of interest, such as an increased insecticidal activity. Strategies for such DNA shuffling are known in the art. See, for example, Stemmer (1994) Proc. Natl. Acad. Sci. USA 91 : 10747-10751; Stemmer (1994) Nature 370:389-391; Crameri et al. (1997) Nature Biotech. 15:436-438; Moore et al. (1997) J. Mol. Biol. 272:336- 347; Zhang et al. (1997) Proc. Natl. Acad. Sci. USA 94:4504-4509; Crameri et al. (1998) Nature 391 :288-291; and U.S. Pat. Nos. 5,605,793 and 5,837,458.

[0171]

[0103] Domain swapping or shuffling is another mechanism for generating chimeric insecticidal proteins. Domains may be swapped between CrylA-like proteins, resulting in chimeric toxic proteins with improved pesticidal activity or target spectrum. Methods for generating recombinant proteins and testing them for pesticidal activity are well known in the art (see, for example, Naimov et al. (2001) Appl. Environ. Microbiol. 67:5328-5330; de Maagd et al. (1996) Appl. Environ. Microbiol. 62:1537-1543; Ge et al. (1991) J. Biol. Chem. 266: 17954- 17958; Schnepf et al. (1990) J. Biol. Chem. 265:20923-20930; Rang et al. 91999) Appl. Environ. Microbiol. 65:2918-2925).

[0172]

[0104] The term “three domain Cry protein” is a crystal protein of the delta-endotoxin type from B. thuringiensis in which the protein contains three domains, domain I, II and III, thought to be involved in pore formation and / or receptor recognition. Domain I is the N-terminal domain of the three domain Cry proteins containing seven alpha helices and is thought to be responsible for pore formation. Domain II is the central domain of the activated form of three domain Cry proteins containing three antiparallel beta sheets and is thought to be responsible for receptor recognition. Domain III is the C-terminal domain of the activated form of three domain Cry proteins containing an antiparallel beta sheet sandwich and whose function has been hypothesized to affect receptor recognition, pore formation, or how the protein interacts with the membrane. A three domain Cry protein can have a protoxin tail, which is a domain following Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0173] Domain III that is cleaved off during activation by insect proteases. A protoxin tail may vary in length or may not be present at all. The terms domain I, domain II, and domain III are used interchangeably with the terms domain 1, domain 2, and domain 3, respectively, herein.

[0174]

[0105] The terms “N-terminal region” and a “C-terminal region” do not necessarily indicate that the most N-terminal or C-terminal amino acids (e.g., the N-terminus or C-terminus), respectively, of the full-length protein are included within the region. For example, it is well- known by those skilled in the art that Cry protoxins are processed at both the N-terminus and C- terminus to produce a mature (i.e., processed) toxin. Thus, in some embodiments, the “N- terminal region” and / or the “C-terminal region” omit some or all of the processed out portions of the protoxin such that the chimeric insecticidal protein comprises the mature toxin protein (e.g., Cry protein Domains I, II and III), without some or all of the N-terminal peptidyl fragment and / or the C-terminal protoxin tail, or a polypeptide that is substantially identical to the mature toxin protein. In some embodiments, the chimeric insecticidal protein comprises the peptidyl fragment and / or protoxin tail. In some embodiments, the chimeric insecticidal protein does not comprise the peptidyl fragment or protoxin tail, i.e., corresponds to the mature processed toxin. In some embodiments, the chimeric insecticidal protein contains a truncated protoxin tail.

[0175]

[0106] In some embodiments, the disclosure provides novel chimeric insecticidal proteins wherein a portion of the C-terminal pro-toxin tail is absent. In some embodiments, the chimeric insecticidal protein is modified to be a certain length and retains biological activity. In some embodiments, the chimeric insecticidal protein is no more than 1200 amino acids, 1150 amino acids, 1100 amino acids, 1050 amino acids, 1025 amino acids, 1000 amino acids, 990 amino acids, 980 amino acids, 970 amino acids, 960 amino acids, 959 amino acids, 958 amino acids, 957 amino acids, 956 amino acids, 955 amino acids, 954 amino acids, 953 amino acids, 952 amino acids, 951 amino acids, 950 amino acids, 925 amino acids, 900 amino acids, 890 amino acids, 880 amino acids, 870 amino acids, 860 amino acids, 859 amino acids, 858 amino acids, 857 amino acids, 856 amino acids, 855 amino acids, 850 amino acids, 840 amino acids, 825 amino acids, 800 amino acids, 775 amino acids, 750 amino acids, 725 amino acids, 700 amino acids, 699 amino acid, 698 amino acids, 697 amino acids, 696 amino acids, 695 amino acids, 694 amino acids, 693 amino acids, 692 amino acids, 691 amino acids, 690 amino acids, 680 amino acids, 670 amino acids, 660 amino acids, 650 amino acids, 625 amino acids, or 600 amino acids Attorney Docket No. : PAT- 111602-WO-SEC- 1 in length. In some embodiments, the C-terminus is truncated by 524 amino acids. In some embodiments, the C-terminus is truncated by 535 amino acids. In some embodiments, the C- terminus is truncated by 536 amino acids. In some embodiments, the C-terminus is truncated by 547 amino acids.

[0176]

[0107] In some embodiments, the chimeric protein comprises any one of SEQ ID NOs: 14, 15, 16, or 17 or 19, 20, 21, or 22. In some embodiments, the chimeric protein comprises SEQ ID NOs: 14 or 16 and is no more than 634 amino acids in length. In some embodiments, the chimeric protein comprises SEQ ID NOs: 15 or 17 and is no more than 645 amino acids in length. In some embodiments, the chimeric protein comprises SEQ ID NOs: 19 or 21 and is no more than 646 amino acids in length. In some embodiments, the chimeric protein comprises SEQ ID NOs: 20 or 22 and is no more than 657 amino acids in length.

[0177]

[0108] In some embodiments, the disclosure provides a chimeric protein wherein a portion of the N-terminus is absent. In some embodiments, the chimeric protein comprises any one of SEQ ID NOs: 13, 14, or 15 or 18, 19, 20, or 21 and the N-terminus is truncated by 25 amino acids.

[0178]

[0109] In some embodiments, the disclosure provides a chimeric protein wherein a portion of the N-terminus as well as a portion of the protoxin tail is absent. In some embodiments, the chimeric protein comprises SEQ ID NOs 14 or 15. In some embodiments, the chimeric protein comprises SEQ ID NO: 19 or 20. In some embodiments, the chimeric protein comprises SEQ ID NO:20.

[0179] [HO] In some embodiments, the disclosure provides a chimeric protein that consists essentially of any one of SEQ ID NOs: 1, 2, 3, 4, or 13, 14, 15, 16, 17, 18, 19, 20, 21 or 22. In some embodiments, the chimeric protein consists essentially of SEQ ID NO: 1. In some embodiments, the chimeric protein consists essentially of SEQ ID NO: 4. In some embodiments, the chimeric protein consists essentially of SEQ ID NO: 20.

[0180] [Hl] In some embodiments, the polypeptide comprises one or more conserved protein domains based on Pfam data. The Pfam database is a database of protein families, which is described in Finn et al. (2014) Nucl. Acid Res. Database Issue 42:D222-D230 and is available online through InterPro at ebi.ac.uk / interpro / (see, e.g., Paysan-Lafosse T, Blum M, Chuguransky S, Grego T, Pinto BL, Salazar GA, Bileschi ML, Bork P, Bridge A, Colwell L, Gough J, Haft DH, Letunic I, Marchler-Bauer A, Mi H, Natale DA, Orengo CA, Pandurangan Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0181] AP, Rivoire C, Sign st CJA, Sillitoe I, Thanki N, Thomas PD, Tosatto SCE, Wu CH, Bateman A. InterPro in 2022. Nucleic Acids Research, Nov 2022). Both the Pfam domain and the positions of the Pfam domain within a given SEQ ID NO are provided in Table 1 below. The start position is the amino acid position in the applicable SEQ ID NO where the domain starts; the end position is the amino acid position in the applicable SEQ ID NO where the domain ends.

[0182] Table 1: PFAM Domains of Chimeric Proteins Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0183]

[0112] In some embodiments, insecticidal proteins which have been activated by means of proteolytic processing, for example, by proteases prepared from the gut of an insect, may be characterized and the N-terminal or C-terminal amino acids of the activated toxin fragment identified. A toxin fragment of an engineered insecticidal protein of the disclosure produced by introduction or elimination of protease processing sites at appropriate positions in the coding sequence to allow, or eliminate, proteolytic cleavage of a larger protein by insect, plant or microorganism proteases is also within scope of the disclosure. The result of such manipulation is understood to be the generation of toxin fragment molecules having the same or better activity as an intact insecticidal protein.

[0184]

[0113] Compositions are further provided that allow for a polypeptide of interest to be targeted to a cellular location of interest. Polynucleotides encoding a polypeptide of the disclosure may be fused to signal sequences which will direct the localization of the polypeptide to particular compartments of a prokaryotic or eukaryotic cell. Such localization signals can be positioned at the N terminus or the C terminus of the polypeptide of interest. For example, in E. coli, the expression of a protein of the disclosure can be directed to the periplasmic space. Examples of signal sequences or proteins (or fragments thereof) to which the polypeptides of the disclosure may be fused to direct the expression of the polypeptide to the periplasmic space of bacteria include, but are not limited to, the pelB signal sequence, the maltose binding protein (MBP) signal sequence, MBP, the ompA signal sequence, the signal sequence of the periplasmic E. coli heat-labile enterotoxin B-subunit and the signal sequence of alkaline phosphatase.

[0185]

[0114] For expression of a protein of the disclosure in eukaryotic cells, target peptides or transit peptides are provided that direct the transport of a protein to a specific region in the cell, including the nucleus, mitochondria, endoplasmic reticulum (ER), chloroplast, apoplast, peroxisome and plasma membrane. Such transit or target peptides can be positioned at the N Attorney Docket No. : PAT- 111602-WO-SEC- 1 terminus or the C terminus of the polypeptide of interest. For expression in plant cells, compositions are provided wherein the proteins of the disclosure can be expressed to reside in the cytosol or targeted to various organelles of the plant cell. For example, targeting a protein to the chloroplast may result in increased levels of expressed protein in a transgenic plant while preventing off-phenotypes from occurring. Targeting may also result in an increase in pest resistance efficacy in the transgenic event. Some target peptides are cleaved from the protein by signal peptidases after the proteins are transported. For targeting to the chloroplast, proteins contain transit peptides which are around 40-50 amino acids. For descriptions of the use of chloroplast transit peptides, see U.S. Patent Nos. 5, 188,642 and 5,728,925. Many chloroplast- localized proteins are expressed from nuclear genes as precursors and are targeted to the chloroplast by a chloroplast transit peptide (CTP). Examples of such isolated chloroplast proteins include, but are not limited to, those associated with the small subunit (SSU) of ribulose-1, 5,- bisphosphate carboxylase, ferredoxin, ferredoxin oxidoreductase, the light-harvesting complex protein I and protein II, thioredoxin F, enolpyruvyl shikimate phosphate synthase (EPSPS), and transit peptides described in U.S. Patent No. 7, 193,133. It has been demonstrated in vivo and in vitro that non-chloroplast proteins may be targeted to the chloroplast by use of protein fusions with a heterologous CTP and that the CTP is sufficient to target a protein to the chloroplast.

[0186]

[0115] Incorporation of a suitable chloroplast transit peptide such as the Arabidopsis thaliana EPSPS CTP (CTP2) (see, Klee et al., Mol. Gen. Genet. 210:437-442, 1987) or the Petunia hybrida EPSPS CTP (CTP4) (see, della-Cioppa et al., Proc. Natl. Acad. Sci. USA 83:6873-6877, 1986) has been shown to target heterologous EPSPS protein sequences to chloroplasts in 5 transgenic plants (see, U.S. Patent Nos. 5,627,061; 5,633,435; and 5,312,910; and EP 0218571; EP 189707; EP 508909; and EP 924299). Additional examples of CTPs include, but are not limited to Zea mays ssRUBISCO, Z. mays beta-glucosidase, Z. mays malate dehydrogenase, Z. mays thioredoxin M-type as described in US Patent Application Publication 2012 / 0304336. Additional CTPs of interest include those set forth in SEQ ID 18-25.

[0187]

[0116] For targeting the chloroplast, a sequence encoding a chloroplast transit peptide is placed 5' or 3’ in operable linkage and in frame to a polynucleotide encoding the disclosed proteins that has been designed for optimal expression in plant cells. Such compositions can include a CTP operably linked to any one of SEQ ID NOs: 1-4 or 13-22 or an active variant or fragment thereof. In one non-limiting embodiment, SEQ ID NO: 4 or SEQ ID NO: 20 or a Attorney Docket No. : PAT- 111602-WO-SEC- 1 polypeptide having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% to SEQ ID NO:4 or SEQ ID NO: 20 and retaining insecticidal activity and / or lepidopteran insecticidal activity is operably linked to any one of SEQ ID NO: 46 or 48.

[0188]

[0117] In some embodiments, the disclosed insecticidal proteins have insecticidal activity against lepidopteran pests. In some embodiments, the engineered insecticidal protein has activity against one or more of the following non-limiting examples of a lepidopteran pest: Spodoptera spp. such as S. frugiperda (fall armyworm), S. littoralis (Egyptian cotton leafworm), 5. ornithogalli (yellowstriped armyworm), S. praefica (western yellowstriped armyworm), S. eridcmia (southern armyworm), . litura (Common cutworm / Oriental leafworm), 5. cosmioides (black armyworm), S. exempta (African armyworm), 5. mauritia (lawn armyworm) and / or . exigua (beet armyworm), Ostrinia spp. such as O. nubilalis (European corn borer) and / or O. furnacalis (Asian com borer), Plutella spp. such as P. xylostella (diamondback moth), Agrotis spp. such as A. ipsilon (black cutworm), A. segetum (common cutworm), A. gladiaria (claybacked cutworm), and / or A. orthogonia (pale western cutworm), Striacosta spp. such as S. albicosta (western bean cutworm), Helicoverpa spp. such as H. zea (corn earworm / soybean podworm), H. punctigera (native budworm), and / or H. armigera (cotton bollworm), Pleliothis spp. such as PI. virescens (tobacco budworm), Diatraea spp. such as D. grandiosella (southwestern corn borer) and / or D. saccharalis (sugarcane borer), Trichophisia spp. such as T. ni (cabbage looper), Sesamia spp. such as S. nonagroides (Mediterranean com borer), S. inferens (Pink stem borer) and / or ,S'. calamistis (pink stem borer), Pectinophora spp. such as P. gossypiella (pink bollworm), Cochylis spp. such as C. hospes (banded sunflower moth), Manduca spp. such as M. sexta (tobacco horn worm) and / or M. quinquemaculata (tomato hornworm), Elasmopalpus spp. such as E. lignosellus (lesser cornstalk borer), Pseudoplusia spp. such as P. inchidens (soybean looper), Anticarsia spp. such as A. gemmatalis (velvetbean caterpillar), Plathypena spp. such as P. scabra (green cloverworm), Pieris spp. such as P. brassicae (cabbage butterfly), Papaipema spp. such as P. nebris (stalk borer), Pseudaletia spp. such as P. unipuncta (common armyworm), Peridroma spp. such as P. saucia (variegated cutworm), Keiferia spp. such as K. lycopersicella (tomato pinworm), Artogeia spp. such as A. rapae (imported cabbageworm), Phthorimaea spp. such as P. operculella (potato tuberworm), Chrysodeixis spp. such as C. includens (soybean looper), Feltia spp. such as F. ducens (dingy cutworm), Chilo spp. such as C. suppressalis (striped stem borer), C. Agamemnon (oriental corn Attorney Docket No. : PAT- 111602-WO-SEC- 1 borer), C. venosatus (spotted borer), and C. partellus (spotted stalk borer), Cnaphalocrocis spp. such as C. medinalis (rice leaffolder), Conogethes spp. such as C. piinctiferalis (Yellow peach moth), Mythimna spp. such as M. separata (Oriental armyworm), Athetis spp. such as A. lepigone (Two-spotted armyworm), Busseola spp. such as B.fiisca (maize stalk borer), Etiella spp. such as E. zinckenella (pulse pod borer), Leguminivora spp. such as L. glycinivorella (soybean pod borer), Matsnmuraeses spp. such as M. phaseoli (adzuki pod worm), Omiodes spp. such as (). indicata (Soybean leaffolder / Bean-leaf webworm), Rachiplusia spp. such as R. nu (sunflower Looper), Maruca spp. such as M. Testulalis Geyer (Bean pod borer), Monolepta spp. such as M. hieroglyphica (Double-spotted leaf beetle), or any combination of the foregoing.

[0189]

[0118] In some embodiments, the disclosed insecticidal proteins have insecticidal activity against S. frugiperda (fall army worm). In some embodiments, the disclosed insecticidal proteins have insecticidal activity against European corn borer (ECB; Ostrinia nubilalis), soybean looper (SBL; Pseudoplusia includens'), velvet bean caterpillar (VBC, Anticarsia gemmatalis), Southwestern corn borer (SWCB, Diatraea grandiosella), Southern armyworm (SAW, Spodoptera eridania), and Sugarcane borer (SCB, Diatraea saccharalis) .

[0190]

[0119] In some embodiments, the insecticidal proteins have insecticidal activity against an insect pest or colony that has resistance to another insecticidal agent, including another insecticidal protein (such as, e.g., a Bt protein). In some embodiments, the insecticidal proteins have insecticidal activity against a pest that is resistant to a Vip3A protein (e.g., Vip3Aal9 or Vip3Aa20, including without limitation maize event MIR162), a CrylF protein (e.g., CrylFa, including without limitation maize event TC1507 or DP-4114 or soy event DAS-81419), a CrylA protein (e.g., CrylAb, CrylAc or CrylA.105, including without limitation maize event Btl 1, MON810, or MON89034 or soy event MON87701 or DAS-81419), a Cry2A protein (e.g., Cry2Ab, including without limitation maize event MON89034 or soy event MON87751), a CrylD protein (e.g., CrylDa_7 or truncated Cry IDa, including without limitation maize event MON95379 or ME240913), a Cry IB protein (e.g., Cry IB.868, including without limitation maize event MON95379), and / or a CrylG protein (e.g., eCrylGb.Hg protein disclosed in PCT Patent Application Publication No. WO2022235606). Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0191]

[0120] The disclosed insecticidal proteins may also be active against Coleopteran, Hemipteran, Dipteran, Lygus spp., and / or other piercing and sucking insects, for example of the order Orthoptera or Thysanoptera. Coleopteran insect pests according to the present disclosure include Diabrotica spp. such as D. barberi (Northern corn rootworm), D. virgifera virgifera (Western corn rootworm), D. undecimpunctata howardii (Southern com rootworm), D. balteata (Banded cucumber beetle), D. undecimpunctata undecimpunctata (Western spotted cucumber beetle), D. significata (3-spotted leaf beetle), D. speciosa (cucurbit beetle), D. virgifera zeae (Mexican corn rootworm), D. beniensis, D. cristata, D. curviplustalata, D. dissimilis, D. elegantula, D. emorsitans, D. graminea, D. hispanloe, D. lemniscata, D. linsleyi, D. milleri, D. nummularis, D. occlusal, D. porrecea, D. scutellata, D. tibialis, D. trifasciata and / or D. viridula, Leptinotarsa spp. such as L. decemlineata (Colorado potato beetle), Chrysomela spp. such as C. scripta (cottonwood leaf beetle), Hypothenemus spp. such as / / , hampei (coffee berry borer), Sitophilus spp. such as . zeamais (maize weevil), Epitrix spp. such as E. hirtipennis (tobacco flea beetle) and / or E. cucumeris (potato flea beetle), Phyllotreta spp. such as P. cruciferae (crucifer flea beetle) and / or P. pusilia (western black flea beetle), Anthonomus spp. such as A. eugenii (pepper weevil), Hemicrepidus spp. such as H. memnonius (wireworms), Melanotus spp. such as M. communis (wireworm), Ceutorhychus spp. such as C. assimilis (cabbage seedpod weevil), Phyllotreta spp. such as P. cruciferae (crucifer flea beetle), Aeolus spp. such as A. mellillus (wireworm), Aeolus spp. such as A. mancus (wheat wireworm), Horistonotus spp. such as H. uhlerii (sand wireworm), Sphenophorus spp. such as S. maidis (maize billbug), S. zeae (timothy billbug), S. parvulus (bluegrass billbug), and S. callosus (southern corn billbug), Phyllophaga spp. (White grubs), Chaetocnema spp. such as C. pulicaria (corn flea beetle), Popillia spp. such as P.japonica (Japanese beetle), Epilachna spp. such as E. varivestis (Mexican bean beetle), Cerotoma spp. such as C. trifurcate (Bean leaf beetle), Epicauta spp. such as E. pestifera and E. lemniscata (Blister beetles), Holotrichia spp. such as H. diomphalia Bates (Northeast larger black chafer), or any combination of the foregoing. In some embodiments, the insecticidal protein(s) has / have activity against one or more of the following Hemiptera pests: Chinavia hilaris (green stink bug), Anasa tristis De Geer (squash bug), Blissus leucopterus (chinch bug), Corythuca gossypii Fabricius (cotton lace bug), Cyrtopeltis modesta Distant (tomato bug), Dysdercus suturellus Hernch-Schaffer (cotton Stainer), Euschistus servus Say (brown stink bug), E. variolarius Palisot de Beauvois (one-spotted stink bug), Graptostethus Attorney Docket No. : PAT- 111602-WO-SEC- 1 spp. (complex of seed bugs), Leptoglossus corculus Say (leaf-footed pine seed bug), Lygus lineolaris Palisot de Beauvois (tarnished plant bug), L. Hesperus Knight (Western tarnished plant bug), L. pratensis Linnaeus (common meadow bug), L. rugulipennis Poppius (European tarnished plant bug), Lygocoris pabulinus Linnaeus (common green capsid), Nezara viridula Linnaeus (southern green stink bug), Oebalus pugnax Fabricius (rice stink bug), Oncopeltus fasciatus Dallas (large milkweed bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper), Calocoris norvegicus Gmelin (strawberry bug), Orthops canipestris Linnaeus, Plesiocoris rugicollis Fallen (apple capsid), Cyrtopeltis modestus Distant (tomato bug), Cyrtopeltis notatus Distant (suckfly), Spanagonicus albofasciatus Reuter (whitemarked fleahopper), Diaphnocoris chlorionis Say (honeylocust plant bug), Labopidicola allii Knight (onion plant bug), Pseudatomoscelis seriatus Reuter (cotton fleahopper), Adelphocoris rapidus Say (rapid plant bug), Poecilocapsus lineatus Fabricius (four-lined plant bug), Nysius ericae Schilling (false chinch bug), Nysius raphanus Howard (false chinch bug), Nezara viridula Linnaeus (Southern green stink bug), Eurygaster spp., Coreidae spp., Pyrrhocoridae spp., Tinidae spp., Blostomatidae spp., Reduviidae spp. and Cimicidae spp., or any combination of the foregoing. In some embodiments, the insecticidal protein(s) has / have activity against one or more of the following Diptera pests: Liriomyza spp. such as L. trifolii (leafminer) and L. sativae (vegetable leafminer), Scrobipalpula spp. such as S. absoluta (tomato leafminer), Delia spp. such as D. platura (seedcorn maggot), D. brassicae (cabbage maggot) and D. radicum (cabbage root fly), Psilia spp. such as P. rosae (carrot rust fly), Tetanops spp. such as T. myopaeformis (sugarbeet root maggot), or any combination of the foregoing. In some embodiments, the insecticidal protein(s) has / have activity against one or more of the following Orthoptera pests: Melanoplus spp. such as M. differentialis (Differential grasshopper), M. femurrubrum (Redlegged grasshopper), M. bivittatus (Two striped grasshopper), or any combination of the foregoing. In some embodiments, the insecticidal protein(s) has / have activity against one or more of the following Thysanoptera pests: Frankliniella spp. such as F. occidentalis (western flower thrips) and F. fusca (tobacco thrips), and Thrips spp. such as T. tabaci (onion thrips), T. palmi (melon thrips), or any combination of the foregoing.

[0192]

[0121] The disclosed insecticidal proteins may also have insecticidal activity against any one or more of the following: Phyllophaga spp., Rhopalosiphum maidis, Pratylenchus penetrans, Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0193] Melanotus cribulosus, Cyclocephala lurida, Limonius californicus, Tetranychus urticae, Haplothrips aculeatus, Tetranychus truncates, Anomala corpulenta, Oedaleus infernalis, Frankliniella tenuicornis, Tetranychus cinnabarinus, Aiolopus thalassinus tamulus, Trachea tokionis, Laodelphax striatellus, Holotrichia oblita, Dichelops furcatus, Diloboderus abderu, Dalbulus maidis, Astylus variegathus, Scaptocoris castanea, Locusta migratoria manilensis, Agriotes lineatus, Peregrinus maidis, Oscinellafrit, Frankliniella williamsi, Zyginidia manaliensis, Atherigona soccata, Nicentrites testaceipes, Myllocerus undecimpustulatus, Atherigona naquii, Amsecta albistriga, Plodia interpuctella, Melanotus caudex, Microtermes spp., Atherigona oryzae, Tanymecus dilaticollis, Delphacodes kuschelli, Lepidiota stigma, Phyllophaga hellery, Tribolium castaneum, Pelopidas mathias, Oxya chinensis (Thunberg), Stenocranus pacificus, Scutigerella immaculata, Chrysodeixis chalcites, Euproctis spp. (Lymantriidae), Phyllotreata spp.(undulata), Reptalus panzer, Cyrtacanthacris tartarica Linnaeus, Orgyia postica, Dactylispa lameyi, Patanga succincta Johanson, Tetranychus spp., Calomycterus spp., Adoretus compressus Weber, and Paratetranychus Stickney.

[0194]

[0122] Optionally, the engineered insecticidal proteins of the disclosure have increased activity against one or more lepidopteran pests as compared with one or more of the related molecules (e.g., the first Cry protein and the different Cry protein). In some embodiments, the engineered insecticidal protein has enhanced insecticidal activity against fall armyworm (Spodoptera frugiperda) as compared with one or more related molecules (e.g., the first Cry protein and the different Cry protein). According to the foregoing embodiments, the engineered insecticidal protein can optionally have insecticidal activity against a fall armyworm insect pest or colony that has resistance to another insecticidal agent, including another insecticidal protein (such as, e.g., a Bt protein). In some embodiments, the engineered insecticidal protein has insecticidal activity against a fall armyworm colony that is resistant to a Vip3A protein (e.g., a Vip3Aa, including without limitation maize event MIR162) or a CrylF protein (e.g., CrylFa, including without limitation maize event TCI 507).

[0195]

[0123] The disclosed insecticidal proteins may also be active against nematodes. The term “nematode” as used herein encompasses any organism that is now known or later identified that is classified in the animal kingdom, phylum Nematoda, including without limitation nematodes within class Adenophorea (including for example, orders Enoplida, Isolaimida, Mononchida, Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0196] Dorylaimida, Trichocephalida, Mermithida, Muspiceida, Araeolaimida, Chromadorida, Desmoscolecida, Desmodorida and Monhysterida) and / or class Secementea (including, for example, orders Rhabdita, Strongylida, Ascaridida, Spirurida, Camallanida, Diplogasterida, Tylenchida and Aphelenchida).

[0197]

[0124] Nematodes include but are not limited to parasitic nematodes such as root-knot nematodes, cyst nematodes and / or lesion nematodes. Exemplary genera of nematodes according to the present disclosure include but are not limited to, Meloidogyne (root-knot nematodes), Heterodera (cyst nematodes), Globodera (cyst nematodes), Radopholus (burrowing nematodes), Rotylenchulus (reniform nematodes), Pratylenchus (lesion nematodes), Aphelenchoides (foliar nematodes), Helicotylenchus (spiral nematodes), Hoplolaimus (lance nematodes), Paratrichodorus (stubby-root nematodes), Longidorus, Nacobbus (false root-knot nematodes), Subanguina, Belonlaimus (sting nematodes), Criconemella, Criconemoides (ring nematodes), Ditylenchus, Dolichodorus, Hemicriconemoides, Hemicycliophora, Hirschmaniella, Hypsoperine, Macroposthonia, Melinius, Punctodera, Quinisulcius, Scutellonema, Xiphinema (dagger nematodes), Tylenchorhynchus (stunt nematodes), Tylenchulus, Bursaphelenchus (round worms), and any combination thereof.

[0198]

[0125] Exemplary plant parasitic nematodes according to the present disclosure include, but are not limited to, Belonolaimus gracilis, Belonolaimus longicaudatus, Bursaphelenchus xylophilus (pine wood nematode), Criconemoides ornata, Ditylenchus destructor (potato rot nematode), Ditylenchus dipsaci (stem and bulb nematode), Globodera pallida (potato cyst nematode), Globodera rostochiensis (golden nematode), Heterodera glycines (soybean cyst nematode), Heterodera schachtii (sugar beet cyst nematode); Heterodera zeae (corn cyst nematode), Heterodera avenae (cereal cyst nematode), Heterodera carotae, Heterodera trifolii, Hoplolaimus columbus, Hoplolaimus galeatus, Hoplolaimus magnistylus, Longidorus breviannulatus, Meloidogyne arenaria, Meloidogyne chitwoodi, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Mesocriconema xenoplax, Nacobbus aberrans, Naccobus dorsalis, Paratrichodorus christiei, Paratrichodorus minor, Pratylenchus brachyurus, Pratylenchus crenatus, Pratylenchus hexincisus, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus projectus, Pratylenchusscribneri, Pratylenchus tenuicaudatus, Pratylenchus thornei, Pratylenchus zeae, Punctodera chaccoensis, Quinisulcius acutus, Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0199] Radopholus similis, Rotylenchuhis reniformis, Tylenchorhynchus dnbius, Tylenchulus semipenetrans (citrus nematode), Siphinema americanum, X. Mediterranean!, and any combination of the foregoing.

[0200]

[0126] The disclosure also encompasses antibodies that specifically bind to the engineered insecticidal proteins of the disclosure. The antibody can optionally be a monoclonal antibody or a polyclonal antisera. Such antibodies may be produced using standard immunological techniques for production of polyclonal antisera and, if desired, immortalizing the antibodyproducing cells of the immunized host for sources of monoclonal antibody production.

[0201] Techniques for producing antibodies to any substance of interest are well known, e.g., as described in Harlow and Lane (1988. Antibodies a laboratory manual, pp. 726. Cold Spring Harbor Laboratory) and as in Goding (Monoclonal Antibodies: Principles & practice.1986. Academic Press, Inc., Orlando, FL). The present disclosure also encompasses an insecticidal protein that cross-reacts with an antibody, particularly a monoclonal antibody, raised against one or more of the chimeric insecticidal proteins of the present disclosure.

[0202]

[0127] The antibodies according to the disclosure are useful, e.g., in immunoassays for determining the amount or presence of a chimeric insecticidal protein of the disclosure or an antigenically related polypeptide, e.g., in a biological sample. Such assays are also useful in quality-controlled production of compositions containing one or more of the chimeric insecticidal proteins of the disclosure or an antigenically related polypeptide. In addition, the antibodies can be used to assess the efficacy of recombinant production of one or more of the chimeric proteins of the disclosure or an antigenically related polypeptide, as well as for screening expression libraries for the presence of a nucleotide sequence encoding one or more of the chimeric proteins of the disclosure or an antigenically related polypeptide. Antibodies further find use as affinity ligands for purifying or isolating any one or more of the proteins of the disclosure or an antigenically related polypeptide.

[0203] Nucleic acids. Expression cassettes, and Vectors

[0204]

[0128] In some aspects, the disclosure provides nucleic acids, expression cassettes, and vectors that encode the insecticidal proteins of the disclosure. In some embodiments, coding Attorney Docket No. : PAT- 111602-WO-SEC- 1 sequences comprising synthetic nucleotide sequences that are codon optimized for expression in a plant (for example, a transgenic monocot plant host or a transgenic dicot plant host, such as a corn or soy plant). In some embodiments, the nucleotide coding sequence is partially or completely synthetic. In representative embodiments, for expression in transgenic plants, such as com or soy, the nucleotide sequences of the disclosure are modified and / or optimized. For example, although in many cases genes from microbial organisms can be expressed in plants at high levels without modification, low expression in transgenic plants may result from microbial nucleotide sequences having codons that are not preferred in plants. It is known in the art that living organisms have specific preferences for codon usage, and the codons of the nucleotide sequences described in this disclosure can be changed to conform with plant preferences, while maintaining the amino acids encoded thereby. A table of codon usage for maize and soy is provided below. In some embodiments, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, at least 95% or at least 99% of the codons in the nucleotide coding sequence correspond to those with the highest frequency according to the below table. It is understood that it might not be possible to use all of the highest frequency codons to encode a desired amino acid sequence as it could introduce, e.g., unintended splice sites or out-of-frame open reading frames.

[0205] Table 2A: Preferred codon usage in Maize Attorney Docket No. : PAT- 111602-WO-SEC- 1 Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0206] Table 2B: Preferred codon usage in Soy Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0207]

[0129] Furthermore, it is known in the art that high expression in plants, for example com plants, can be achieved from coding sequences that have at least about 35% GC content, or at least about 45%, or at least about 50%, or at least about 60%. Accordingly, in some embodiments, a nucleic acid sequence of the disclosure is codon-optimized for expression in plants by reducing the AT content of the nucleic acid relative to the wild-type sequence (e.g., SEQ ID NOs: 5-8 and 23-32), such as to achieve at least 35%, at least 45%, at least 50% or at Attorney Docket No. : PAT- 111602-WO-SEC- 1 least 60% GC content. Microbial nucleotide sequences that have low GC contents may express poorly in plants. Although certain nucleotide sequences can be adequately expressed in both monocotyledonous and dicotyledonous plant species, sequences can be modified to account for the specific codon preferences and GC content preferences of monocotyledons or dicotyledons as these preferences have been shown to differ (Murray et al. Nucl. Acids Res. 17:477-498 (1989)). In addition, in some embodiments, the nucleotide sequence is modified to remove illegitimate splice sites that may cause message truncation. Such modifications to the nucleotide sequences can be made using well known techniques of site directed mutagenesis, PCR, and synthetic gene construction using the methods described, for example, in US Patent Nos. 5,625,136; 5,500,365 and 6,013,523.

[0208] [1301 In some embodiments, the disclosure provides synthetic coding sequences or polynucleotides made according to the procedure disclosed in U.S. Pat. No. 5,625,136. In this procedure, maize preferred codons, i.e., the single codon that most frequently encodes that amino acid in maize, are used. The maize preferred codon for a particular amino acid can be derived, for example, from known gene sequences from maize. For example, maize codon usage for 28 genes from maize plants is found in Murray et al., Nucleic Acids Research 17:477-498 (1989). It is recognized that codons optimized for expression in one plant species will also function in other plant species but possibly not at the same level as the plant species for which the codons were optimized. In this manner, the nucleotide sequences can be optimized for expression in any plant. It is recognized that all or any part of a nucleotide sequence may be optimized or synthetic. That is, a polynucleotide may comprise a nucleotide sequence that is part native sequence and part codon optimized sequence.

[0209]

[0131] In representative embodiments, a polynucleotide of the disclosure is an isolated polynucleotide. In some embodiments, a polynucleotide of the disclosure is a recombinant polynucleotide.

[0210]

[0132] In some embodiments, the disclosure provides a nucleic acid comprising a coding sequence which encodes the chimeric polypeptides of any one of SEQ ID NOs: 1, 2, 3, or 4, or 13, 14, 15, 16, 17, 18, 19, 20, 21, or 22, or 49, 50, 51, or 52. In some embodiments, the coding Attorney Docket No. : PAT- 111602-WO-SEC- 1 sequence comprises any one of SEQ ID NOs: 5, 6, 7, 8, 9, 10, 11, or 12 or 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, or 44.

[0211] [133J In some embodiments, a heterologous promoter is operably linked to a nucleic acid comprising, consisting essentially of or consisting of a coding sequence that encodes an engineered protein of the disclosure that is toxic to a lepidopteran pest. Promoters can include, for example, constitutive, inducible, temporally regulated, developmentally regulated, chemically regulated, tissue-preferred and / or tissue-specific promoters. In particular aspects, a promoter useful with the disclosure is a promoter capable of initiating transcription of a nucleotide sequence in a plant cell, e.g., in a cell of a monocot (e.g., maize or rice) or dicot (e.g., soybean, cotton) plant.

[0212] [1341 In some embodiments, the heterologous promoter is a plant-expressible promoter (e.g., monocot expressible or dicto expressible). For example, without limitation, the plant- expressible promoter can be selected from the group of promoters consisting of ubiquitin, cestrum yellow virus, corn TrpA, OsMADS 6, maize H3 histone, bacteriophage T3 gene 9 5' UTR, corn sucrose synthetase 1, corn alcohol dehydrogenase 1, corn light harvesting complex, corn heat shock protein, maize mtl, pea small subunit RuBP carboxylase, rice actin, rice cyclophilin, Ti plasmid mannopine synthase, Ti plasmid nopaline synthase, petunia chaicone isomerase, bean glycine rich protein 1, potato patatin, lectin, CaMV 35S and S-E9 small subunit RuBP carboxylase promoter.

[0213]

[0135] Although many promoters from dicotyledons have been shown to be operational in monocotyledons and vice versa, in some embodiments, dicotyledonous promoters are selected for expression in dicotyledons, and monocotyledonous promoters for expression in monocotyledons. However, there is no restriction to the provenance of selected promoters; it is sufficient that they are operational in driving the expression of the nucleotide sequences in the desired cell.

[0214]

[0136] The choice of promoter can vary depending on the temporal and spatial requirements for expression, and also depending on the host cell to be transformed. Thus, for example, expression of the nucleotide sequences of the disclosure can be in any plant and / or plant part, (e.g., in leaves, in stalks or stems, in ears, in inflorescences (e.g., spikes, panicles, cobs, etc.), in Attorney Docket No. : PAT- 111602-WO-SEC- 1 roots, seeds and / or seedlings, and the like). For example, where expression in a specific tissue or organ is desired, a tissue-specific or tissue-preferred promoter can be used (e g., a root specific / preferred promoter). For example, where expression is not desired in a specific tissue or organ, a tissue-free promoter can be used. In some embodiments, a “pollen-free” promoter is provided which results in low or no detectable gene expression in the pollen of the target plant species. In contrast, where expression in response to a stimulus is desired a promoter inducible by stimuli or chemicals can be used. Where continuous expression at a relatively constant level is desired throughout the cells of a plant a constitutive promoter can be chosen.

[0215]

[0137] Promoters useful with the disclosure include, but are not limited to, those that drive expression of a nucleotide sequence constitutively, those that drive expression when induced, and those that drive expression in a tissue- or developmentally-specific manner. These various types of promoters are known in the art.

[0216]

[0138] Suitable constitutive promoters include, for example, CaMV 35S promoter (Odell et al., Nature 313:810-812, 1985); Arabidopsis At6669 promoter (see PCT Publication No.

[0217] W004081173A2); maize Ubi 1 (Christensen et al., Plant Mol. Biol. 18:675-689, 1992); rice actin (McElroy et al., Plant Cell 2: 163-171, 1990); pEMU (Last et al., Theor. Appl. Genet. 81:581- 588, 1991); CaMV 19S (Nilsson et al., Physiol. Plant 100:456-462, 1997); GOS2 (de Pater et al., Plant I November; 2(6):837-44, 1992); ubiquitin (Christensen et al., Plant Mol. Biol. 18: 675- 689, 1992); Rice cyclophilin (Bucholz et al., Plant Mol Biol. 25(5):837-43, 1994); Maize H3 histone (Lepetit et al., Mol. Gen. Genet. 231 : 276-285, 1992); Actin 2 (An et al., Plant I.

[0218] 10( 1); 107- 121 , 1996), constitutive root tip CT2 promoter (see PCT application No. IL / 2005 / 000627) and Synthetic Super MAS (Ni et al., The Plant Journal 7: 661-76, 1995). Other constitutive promoters include those in U.S. Pat. Nos. 5,659,026, 5,608,149; 5,608,144;

[0219] 5,604,121; 5,569,597: 5,466,785; 5,399,680; 5,268,463; and 5,608,142.

[0220]

[0139] Tissue-specific or tissue-preferential promoters useful for the expression of the polypeptides of the disclosure in plants, optionally maize, include those that direct expression in root, pith, leaf or pollen. Suitable tissue-specific promoters include, but not limited to, leafspecific promoters (such as described, for example, by Yamamoto et al., Plant J. 12:255-265, 1997; Kwon et al., Plant Physiol. 105:357-67, 1994; Yamamoto et al., Plant Cell Physiol. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0221] 35:773-778, 1994; Gotor et al., Plant J. 3:509-18, 1993; Orozco et al., Plant Mol. Biol. 23: 1129- 1138, 1993; and Matsuoka et al., Proc. Natl. Acad. Sci. USA 90:9586-9590, 1993), seedpreferred promoters (e.g., from seed specific genes; Simon, et al., Plant Mol. Biol. 5. 191, 1985; Scofield, et al., J. Biol. Chem. 262: 12202, 1987; Baszczynski, et al., Plant Mol. Biol. 14: 633, 1990), Brazil Nut albumin (Pearson et al., Plant Mol. Biol. 18: 235-245, 1992), legumin (Ellis, et al. Plant Mol. Biol. 10: 203-214, 1988), Glutelin (Takaiwa, et al., Mol. Gen. Genet. 208: 15-22, 1986; Takaiwa, et al., FEBS Letts. 221 : 43-47, 1987), Zein (Matzke et al., Plant Mol Biol, 143).323-32 1990), napA (Stalberg, et al., Planta 199: 515-519, 1996), Wheat SPA (Albanietal, Plant Cell, 9: 171-184, 1997), sunflower oleosin (Cummins, et al., Plant Mol. Biol. 19: 873-876, 1992)], endosperm specific promoters (e.g., wheat LMW and HMW, glutenin- 1 (Mol Gen Genet 216:81-90, 1989; NAR 17:461-2), wheat a, b and g gliadins (EMB03: 1409-15, 1984), Barley Itrl promoter, barley Bl, C, D hordein (Theor Appl Gen 98: 1253-62, 1999; Plant J 4:343-55, 1993; Mol Gen Genet 250:750-60, 1996), Barley DOF (Mena et al., The Plant Journal, 116(1): 53-62, 1998), Biz2 (EP99106056.7), Synthetic promoter (Vicente-Carbajosa et al., Plant J. 13: 629-640, 1998), rice prolamin NRP33, rice -globulin Glb-1 (Wu et al., Plant Cell Physiology 39(8) 885- 889, 1998), rice alpha-globulin REB / OHP-1 (Nakase et al. Plant Mol. Biol. 33: 513-S22, 1997), rice ADP-glucose PP (Trans Res 6:157-68, 1997), maize ESR gene family (Plant J 12:235-46,

[0222] 1997), sorgum gamma-kafirin (Plant Mol. Biol 32: 1029-35, 1996)], embryo specific promoters (e.g., rice OSHI; Sato et al., Proc. Nati. Acad. Sci. USA, 93: 8117-8122), KNOX (Postma- Haarsma of al, Plant Mol. Biol. 39:257-71, 1999), rice oleosin (Wu et at, J. Biochem., 123:386,

[0223] 1998)] flower-specific promoters, for example, AtPRP4, chalene synthase (chsA) (Van der Meer, et al., Plant Mol. Biol. 15, 95-109, 1990), LAT52 (Twell et al., Mol. Gen Genet. 217:240-245; 1989), apetala-3, and promoters specific for plant reproductive tissues (e.g., OsMADS promoters; U.S. Patent Publication 2007 / 0006344).

[0224]

[0140] Examples of promoters suitable for preferential expression in green tissue include many that regulate genes involved in photosynthesis and many of these have been cloned from both monocotyledons and dicotyledons. One such promoter is the maize PEPC promoter from the phosphoenol carboxylase gene (Hudspeth & Grula, Plant Molec. Biol. 12:579-589 (1989)). Another promoter for root specific expression is that described by de Framond (FEBS 290: 103- 106 (1991) or US Patent No. 5,466,785). Another promoter useful in the disclosure is the stem Attorney Docket No. : PAT- 111602-WO-SEC- 1 specific promoter described in U.S. Pat. No. 5,625,136, which naturally drives expression of a maize trpA gene.

[0225]

[0141] In addition, promoters functional in plastids can be used. Non-limiting examples of such promoters include the bacteriophage T3 gene 9 5' UTR and other promoters disclosed in U.S. Patent No. 7,579,516. Other promoters useful with the disclosure include but are not limited to the S-E9 small subunit RuBP carboxylase promoter and the Kunitz trypsin inhibitor gene promoter (Kti3).

[0226]

[0142] In some embodiments, inducible promoters can be used. Thus, for example, chemical-regulated promoters can be used to modulate the expression of a gene in a plant through the application of an exogenous chemical regulator. Regulation of the expression of nucleotide sequences of the disclosure via promoters that are chemically regulated enables the polypeptides of the disclosure to be synthesized only when the crop plants are treated with the inducing chemicals. Depending upon the objective, the promoter may be a chemical-inducible promoter, where application of a chemical induces gene expression, or a chemical-repressible promoter, where application of the chemical represses gene expression. Examples of such technology for chemical induction of gene expression is detailed in published application EP 0 332 104 and US Patent No. 5,614,395.

[0227]

[0143] Chemical inducible promoters are known in the art and include, but are not limited to, the maize In2-2 promoter, which is activated by benzene sulfonamide herbicide safeners, the maize GST promoter, which is activated by hydrophobic electrophilic compounds that are used as pre-emergent herbicides, the tobacco PR-1 a promoter, which is activated by salicylic acid (e.g., the PRla system), steroid steroid-responsive promoters (see, e.g., the glucocorticoidinducible promoter in Schena et al. (1991) Proc. Natl. Acad. Sci. USA 88, 10421-10425 and McNellis et al. (1998) Plant J. 14, 247-257), tetracycline-inducible and tetracycline-repressible promoters (see, e.g., Gatz et al. (1991) Mol. Gen. Genet. 227, 229-237, and U.S. Patent Numbers 5,814,618 and 5,789,156), Lac repressor system promoters, copper-inducible system promoters, salicylate-inducible system promoters (e.g., the PRla system), glucocorticoid-inducible promoters (Aoyama et al. (1997) Plant J. 11 :605-612), and ecdysone-inducible system promoters. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0228]

[0144] Other non-limiting examples of inducible promoters include ABA- and turgorinducible promoters, the auxin-binding protein gene promoter (Schwob et al. (1993) Plant J. 4:423-432), the UDP glucose flavonoid glycosyl-transferase promoter (Ralston et al. (1988) Genetics 119: 185-197), the MPI proteinase inhibitor promoter (Cordero et al. (1994) Plant J. 6: 141-150), and the glyceraldehyde-3 -phosphate dehydrogenase promoter (Kohler et al. (1995) Plant Mol. Biol. 29: 1293-1298; Martinez et al. (1989) J. Mol. Biol. 208:551-565; and Quigley et al. (1989) J. Mol. Evol. 29:412-421). Also included are the benzene sulphonamide-inducible (US Patent No. 5,364,780) and alcohol-inducible (Int'l Patent Application Publication Nos. WO 97 / 06269 and WO 97 / 06268) systems and glutathione S-transferase promoters. Likewise, one can use any of the inducible promoters described in Gatz (1996) Current Opinion Biotechnol. 7: 168-172 and Gatz (1997) Annu. Rev. Plant Physiol. Plant Mol. Biol. 48:89-108. Other chemically inducible promoters useful for directing the expression of the nucleotide sequences of this disclosure in plants are disclosed in US Patent 5,614,395. Chemical induction of gene expression is also detailed in EP 0 332 104 (to Ciba- Geigy) and U.S. Patent 5,614,395.

[0229]

[0145] Another category of promoters useful in the disclosure are wound inducible promoters. Examples of promoters of this kind include those described by Stanford et al. Mol. Gen. Genet. 215:200-208 (1989), Xu et al. Plant Molec. Biol. 22:573-588 (1993), Logemann et al. Plant Cell 1: 151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22:783-792 (1993), Firek et al. Plant Molec. Biol. 22: 129-142 (1993), and Warner et al. Plant J. 3: 191-201 (1993).

[0230]

[0146] In some embodiments, a recombinant vector is provided which comprises a polynucleotide, an assembled polynucleotide, a nucleic acid molecule, or an expression cassette of the disclosure. Certain vectors for use in transformation of plants and other organisms are known in the art. In other embodiments, non-limiting examples of a vector include a plasmid, cosmid, phagemid, artificial chromosome, phage or viral vector. In some embodiments, the vector is plant vector, e.g., for use in transformation of plants. In some embodiments, the vector is a bacterial vector, e.g., for use in transformation of bacteria. Suitable vectors for plants, bacteria and other organisms are known in the art.

[0231]

[0147] Thus, some embodiments are directed to expression cassettes designed to express the polynucleotides and nucleic acid molecules of the disclosure. In some embodiments, an Attorney Docket No. : PAT- 111602-WO-SEC- 1 expression cassette comprises a nucleic acid molecule having at least a control sequence operatively linked to a nucleotide sequence of interest, e.g. a nucleotide sequence encoding an insecticidal protein of the disclosure. In this manner, for example, plant promoters operably linked to the nucleotide sequences to be expressed are provided in expression cassettes for expression in a plant, plant part or plant cell.

[0232]

[0148] An expression cassette comprising a polynucleotide of interest may be chimeric, meaning that at least one of its components is heterologous with respect to at least one other of its other components. An expression cassette may also be one that is naturally occurring but has been obtained in a recombinant form useful for heterologous expression. Typically, however, the expression cassette is heterologous with respect to the host, i.e., the particular nucleic acid sequence of the expression cassette does not occur naturally in the host cell and must have been introduced into the host cell or an ancestor of the host cell by a transformation event.

[0233]

[0149] In addition to the promoters operatively linked to the nucleotide sequences of the disclosure, an expression cassette of this disclosure also can include other regulatory sequences. Regulatory sequences include, but are not limited to, enhancers, introns, translation leader sequences, termination signals, and polyadenylation signal sequences.

[0234]

[0150] In some embodiments, one or more heterologous introns can be inserted into the nucleotide sequences of the disclosure. In some embodiments, insertion of one or more heterologous introns results in increased mRNA stability during translation or expression of the insecticidal proteins disclosed. As such, any one of SEQ ID NOs; 1, 2, 3, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 49, 50, 51, or 52 can further comprise at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or more heterologous introns.

[0235]

[0151] In some embodiments, an expression cassette can also include polynucleotides that encode other desired traits in addition to the disclosed engineered proteins. Such expression cassettes comprising the stacked traits may be used to create plants, plant parts or plant cells having a desired phenotype with the stacked traits (i.e., molecular stacking). Such stacked combinations in plants can also be created by other methods including, but not limited to, cross breeding plants by any conventional methodology. If stacked by genetically transforming the plants, the nucleotide sequences of interest can be combined at any time and in any order. For example, a transgenic plant comprising one or more desired traits can be used as the target to Attorney Docket No. : PAT- 111602-WO-SEC- 1 introduce further traits by subsequent transformation. The additional nucleotide sequences can be introduced simultaneously in a co-transformation protocol with a nucleotide sequence, nucleic acid molecule, nucleic acid construct, or composition of this disclosure, provided by any combination of expression cassettes. For example, if two nucleotide sequences will be introduced, they can be incorporated in separate cassettes (trans) or can be incorporated on the same cassette (cis). Expression of polynucleotides can be driven by the same promoter or by different promoters. It is further recognized that polynucleotides can be stacked at a desired genomic location using a site-specific nuclease or recombination system (e.g., FRT / Flp, Cre / Lox, TALE-endonucleases, zinc finger nucleases, CRISPR / Cas and related technologies). See US Patent Nos. US7214536, US8921332, US8765448, US5527695, US5744336, US5910415, US6110736, US6175058, US6720475, US6455315, US6458594 and US Patent Publication Nos. US2019093090, US2019264218, US2018327785, US2017240911, US2016208272, US2019062765.

[0236] Transgenic Cells, Plants, Plant parts. Seed

[0237]

[0152] In some aspects, the disclosure further provides transgenic cells, plants, plant parts, and seed comprising the insecticidal proteins or nucleic acids of the disclosure. In some embodiments, the disclosure provides a non-human host cell comprising a polynucleotide, a nucleic acid molecule, an expression cassette, a vector, or a polypeptide of the disclosure. The transgenic non-human host cell can include, but is not limited to, a plant cell (including a monocot cell and / or a dicot cell), a yeast cell, a bacterial cell or an insect cell. Accordingly, in some embodiments, a bacterial cell is provided which is selected from the genera Bacillus, Brevibacillus, Clostridium, Xenorhabdus, Photorhabdus, Pasteuria, Escherichia, Pseudomonas, Erwinia, Serratia, Klebsiella, Salmonella, Pasteurella, Xanthomonas, Streptomyces, Rhizobhim, Rhodopseudomonas, Methylophilius, Agrobacterium, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, or Alcaligenes. Thus, for example, as biological insect control agents, the disclosed engineered insecticidal proteins can be produced by expression of a polynucleotide encoding the same in a bacterial cell. For example, in some embodiments, a Bacillus thuringiensis cell comprising a polynucleotide encoding an insecticidal protein of the disclosure is provided. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0238]

[0153] In some embodiments, the transgenic plant cell is a dicot plant cell or a monocot plant cell. In additional embodiments, the dicot plant cell is a bush bean cell, soybean cell, sunflower cell, tomato cell, cole crop cell, cotton cell, sugar beet cell or a tobacco cell. In further embodiments, the monocot cell is a barley cell, maize cell, oat cell, rice cell, sorghum cell, sugar cane cell or wheat cell. In some embodiments, the disclosure provides a plurality of dicot cells or monocot cells comprising a polynucleotide expressing a disclosed insecticidal protein. In some embodiments, the plurality of cells are juxtaposed to form an apoplast and are grown in natural sunlight. In some embodiments, the transgenic plant cell cannot regenerate a whole plant.

[0239]

[0154] In other embodiments of the disclosure, an insecticidal engineered protein of the disclosure is expressed in a higher organism, for example, a plant. Such transgenic plants expressing effective amounts of the insecticidal protein to control plant pests such as insect pests. When an insect starts feeding on such a transgenic plant, it ingests the expressed insecticidal protein. This can deter the insect from further biting into the plant tissue or may even harm or kill the insect. In some embodiments, a disclosed polynucleotide is inserted into an expression cassette, which is then stably integrated in the genome of the plant. In other embodiments, the polynucleotide is included in a non-pathogenic self-replicating virus.

[0240]

[0155] In some embodiments of the disclosure, a transgenic plant cell comprising a nucleic acid molecule or polypeptide of the disclosure is a cell of a plant part, a plant organ or a plant culture (each as described herein) including, but not limited to, a root, a leaf, a seed, a flower, a fruit, a pollen cell, organ or plant culture, and the like, or a callus cell or culture.

[0241]

[0156] A transgenic plant or plant cell transformed in accordance with the disclosure may be a monocot or dicot plant or plant cell and includes, but is not limited to, com (maize), soybean, rice, wheat, barley, rye, oats, sorghum, millet, sunflower, safflower, sugar beet, cotton, sugarcane, oilseed rape, alfalfa, tobacco, peanuts, vegetables, including, sweet potato, bean, pea, chicory, lettuce, cabbage, cauliflower, broccoli, turnip, carrot, eggplant, cucumber, radish, spinach, potato, tomato, asparagus, onion, garlic, melons, pepper, celery, squash, pumpkin, zucchini, fruits, including, apple, pear, quince, plum, cherry, peach, nectarine, apricot, strawberry, grape, raspberry, blackberry, pineapple, avocado, papaya, mango, banana, and Attorney Docket No. : PAT- 111602-WO-SEC- 1 specialty plants, such as Arabidopsis, and woody plants such as coniferous and deciduous trees. Preferably, plants of the of the disclosure are crop plants such as maize, sorghum, wheat, sunflower, tomato, crucifers, peppers, potato, cotton, rice, soybean, sugar beet, sugarcane, tobacco, barley, oilseed rape, and the like.

[0242]

[0157] Once a desired polynucleotide has been transformed into a particular plant species, it may be propagated in that species or moved into other varieties of the same species, particularly including commercial varieties, using any appropriate technique including traditional breeding techniques.

[0243]

[0158] The disclosed insecticidal proteins can function in the plant part, plant cell, plant organ, seed, harvested product, processed product or extract, and the like, as an insect control agent. In other words, the insecticidal proteins can continue to perform the insecticidal function it had in the transgenic plant. The nucleic acid can function to express the insecticidal protein. As an alternative to encoding the insecticidal protein of the disclosure, the nucleic acid can function to identify a transgenic plant part, plant cell, plant organ, seed, harvested product, processed product or extract of the disclosure.

[0244]

[0159] In some embodiments, a transgenic plant, plant part, plant cell, plant organ, or seed of the disclosure is hemizygous for a polynucleotide or expression cassette of the disclosure. In some embodiments, a transgenic plant, plant part, plant cell, plant organ, or seed of the disclosure is homozygous for a polynucleotide or expression cassette of the disclosure.

[0245]

[0160] Additional embodiments of the disclosure include harvested products produced from the transgenic plants or parts thereof of the disclosure, as well as a processed product produced from the harvested products. A harvested product can be a whole plant or any plant part, as described herein. Thus, in some embodiments, non-limiting examples of a harvested product include a seed, a fruit, a flower or part thereof (e.g., an anther, a stigma, and the like), a leaf, a stem, and the like. In other embodiments, a processed product includes, but is not limited to, a flour, meal, oil, starch, cereal, and the like produced from a harvested seed or other plant part of the disclosure, wherein said seed or other plant part comprises a nucleic acid molecule / polynucleotide / nucleotide sequence of this disclosure. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0246]

[0161] In other embodiments, the disclosure provides an extract from a transgenic seed or a transgenic plant of the disclosure, wherein the extract comprises a nucleic acid molecule, a polynucleotide, a nucleotide sequence or an insecticidal protein of the disclosure. Extracts from plants or plant parts can be made according to procedures well known in the art (See, de la Torre et al., Food, Agric. Environ. 2(l):84-89 (2004); Guidet, Nucleic Acids Res. 22(9): 1772-1773 (1994); Lipton et al., Food Agric. Immun. 12: 153-164 (2000)). Such extracts may be used, e.g., in methods to detect the presence of an insecticidal protein or a polynucleotide of the disclosure.

[0247]

[0162] In some embodiments, a transgenic plant, plant part, plant cell, plant organ, seed, harvested product, processed product or extract has increased insecticidal activity to one or more insect pests (e.g., a lepidopteran pest, such as fall armyworm) as compared with a suitable control that does not comprise a nucleic acid encoding an insecticidal protein of the disclosure.

[0248] Plant Transformation

[0249]

[0163] Procedures for transforming plants are well known and routine in the art and are described throughout the literature. Non-limiting examples of methods for transformation of plants include transformation via bacterial-mediated nucleic acid delivery (e.g., via Agrobacterium). viral-mediated nucleic acid delivery, silicon carbide or nucleic acid whisker- mediated nucleic acid delivery, liposome mediated nucleic acid delivery, microinjection, microparticle bombardment, calcium-phosphate-mediated transformation, cyclodextrin-mediated transformation, electroporation, nanoparticle-mediated transformation, sonication, infiltration, PEG-mediated nucleic acid uptake, as well as any other electrical, chemical, physical (mechanical) or biological mechanism that results in the introduction of nucleic acid into the plant cell, including any combination thereof. General guides to various plant transformation methods known in the art include Miki et al. (“Procedures for Introducing Foreign DNA into Plants” in Methods in Plant Molecular Biology and Biotechnology, Glick, B. R. and Thompson, J. E., Eds. (CRC Press, Inc., Boca Raton, 1993), pages 67-88) and Rakowoczy-Trojanowska (Cell. Mol. Biol. Lett. 7:849-858 (2002)).

[0250]

[0164] For Agrobacterium-vae^ QA transformation, binary vectors or vectors carrying at least one T-DNA border sequence are generally suitable, whereas for direct gene transfer (e.g., Attorney Docket No. : PAT- 111602-WO-SEC- 1 particle bombardment and the like) any vector is suitable and linear DNA containing only the construction of interest can be used. In the case of direct gene transfer, transformation with a single DNA species or co-transformation can be used (Schocher et al., Biotechnology 4: 1093- 1096 (1986)). For both direct gene transfer and Agrobacterium-mediated transfer, transformation is usually (but not necessarily) undertaken with a selectable marker that may be a positive selection (e.g., Phosphomannose Isomerase), provide resistance to an antibiotic (e.g., kanamycin, hygromycin or methotrexate) or a herbicide (e.g., glyphosate or glufosinate). However, the choice of selectable marker is not critical to the disclosure.

[0251]

[0165] Agrobacterium-mediated transformation is a commonly used method for transforming plants because of its high efficiency of transformation and because of its broad utility with many different species. Agrobacterium-mediated transformation typically involves transfer of the binary vector carrying the foreign DNA of interest to an appropriate Agrobacterium strain that may depend on the complement of vir genes carried by the host Agrobacterium strain either on a co-resident Ti plasmid or chromosomally (Uknes et al. (1993) Plant Cell 5: 159-169). The transfer of the recombinant binary vector to Agrobacterium can be accomplished by a triparental mating procedure using Escherichia coli carrying the recombinant binary vector, a helper E. coli strain that carries a plasmid that is able to mobilize the recombinant binary vector to the target Agrobacterium strain. Alternatively, the recombinant binary vector can be transferred to Agrobacterium by nucleic acid transformation (Hofgen & Willmitzer (1988) Nucleic Acids Res. 16:9877).

[0252]

[0166] Dicots as well as monocots may be transformed using Agrobacterium. Methods for Agrobacterium-medaated transformation of rice include well known methods for rice transformation, such as those described in any of the following: European patent application EP 1198985 Al, Aldemita and Hodges (Planta 199: 612-617, 1996); Chan et al. (Plant Mol Biol 22 (3): 491-506, 1993), Hiei et al. (Plant J 6 (2): 271-282, 1994), which disclosures are incorporated by reference herein as if fully set forth. In the case of com transformation, the preferred method is as described in either Ishida et al. (Nat. Biotechnol 14(6): 745-50, 1996) or Frame et al. (Plant Physiol 129(1): 13-22, 2002), which disclosures are incorporated by reference herein as if fully set forth. Said methods are further described by way of example in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0253] Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225). The nucleic acids or the construct to be expressed is preferably cloned into a vector, which is suitable for transforming Agrobacterium tumefaciens, for example pBinl9 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711). Agrobacteria transformed by such a vector can then be used in known manner for the transformation of plants, such as plants used as a model, like Arabidopsis or crop plants such as, by way of example, tobacco plants, for example by immersing bruised leaves or chopped leaves in an Agrobacterial solution and then culturing them in suitable media. The transformation of plants by means of Agrobacterium tumefaciens is described, for example, by Hagen and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 or is known inter alia from F. F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S. D. Kung and R. Wu, Academic Press, 1993, pp. 15-38.

[0254]

[0167] Soybean plant material can be suitably transformed, and fertile plants regenerated by many methods which are well known to one of skill in the art. For example, fertile morphologically normal transgenic soybean plants may be obtained by: 1) production of somatic embryogenic tissue from, e.g., immature cotyledon, hypocotyl or other suitable tissue; 2) transformation by particle bombardment or infection with Agrobacteriunr, and 3) regeneration of plants. In one example, as described in U.S. Pat. No. 5,024,944, cotyledon tissue is excised from immature embryos of soybean, preferably with the embryonic axis removed, and cultured on hormone-containing medium to form somatic embryogenic plant material. This material is transformed using, for example, direct DNA methods, DNA coated microprojectile bombardment or infection with Agrobacterium, cultured on a suitable selection medium and regenerated, optionally also in the continued presence of selecting agent, into fertile transgenic soybean plants. Selection agents may be antibiotics such as kanamycin, hygromycin, or herbicides such as phosphinothricin or glyphosate or, alternatively, selection may be based upon expression of a visualizable marker gene such as GUS. Alternatively, target tissues for transformation comprise meristematic rather than somaclonal embryogenic tissue or, optionally, is flower or flower-forming tissue. Other examples of soybean transformations can be found, e.g. by physical DNA delivery method, such as particle bombardment (Finer and McMullen (1991) In Vitro Cell Dev. Biol. 27P: 175-182; McCabe et al. (1988) Bio / technology 6:923-926), whisker Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0255] (Khalafalla et al. (2006) African J. of Biotechnology 5:1594-1599), aerosol bean injection (U.S. Pat. No. 7,001,754), or by Agrobacterium-mediated delivery methods (Hinchee et al. (1988) Bio / Technology 6:915-922; U.S. Pat. No. 7,002,058; U.S. Patent Application Publication No. 20040034889; U.S. Patent Application Publication No. 20080229447; Paz et al. (2006) Plant Cell Report 25:206-213).

[0256]

[0168] Soybean transgenic plants can be generated with the heretofore described binary vectors containing selectable marker genes with different transformation methods. For example, a vector is used to transform immature seed targets as described (see e.g., U.S. Patent Application Publication No. 20080229447) to generate transgenic HPPD soybean plants directly using HPPD inhibitor, such as mesotrione, as selection agent. Optionally, other herbicide tolerance genes can be present in the polynucleotide alongside other sequences which provide additional means of selection / identification of transformed tissue including, for example, the known genes which provide resistance to kanamycin, hygromycin, phosphinothricin, butafenacil, or glyphosate. For example, different binary vectors containing PAT or EPSPS selectable marker genes are transformed into immature soybean seed target to generate pesticidal and herbicide tolerant plants using Agrobacterium-mediated transformation and glufosinate or glyphosate selection as described (see e.g., U.S. Patent Application Publication No. 20080229447).

[0257]

[0169] Transformation of a plant by recombinant Agrobacterium usually involves cocultivation of the Agrobacterium with explants from the plant and follows methods well known in the art. Transformed tissue is regenerated on selection medium carrying an antibiotic or herbicide resistance marker between the binary plasmid T-DNA borders.

[0258]

[0170] As discussed previously, another method for transforming plants, plant parts and plant cells involves propelling inert or biologically active particles at plant tissues and cells. See, e.g., US Patent Nos. 4,945,050; 5,036,006 and 5,100,792. Generally, this method involves propelling inert or biologically active particles at the plant cells under conditions effective to penetrate the outer surface of the cell and afford incorporation within the interior thereof. When inert particles are utilized, the vector can be introduced into the cell by coating the particles with the vector containing the nucleic acid of interest. Alternatively, a cell or cells can be surrounded by the vector so that the vector is carried into the cell by the wake of the particle. Biologically Attorney Docket No. : PAT- 111602-WO-SEC- 1 active particles (e.g., a dried yeast cell, a dried bacterium or a bacteriophage, each containing one or more nucleic acids sought to be introduced) also can be propelled into plant tissue.

[0259]

[0171] In other embodiments, a polynucleotide of the disclosure can be directly transformed into the plastid genome. Plastid transformation technology is extensively described in U.S. Patent Nos. 5,451,513, 5,545,817, and 5,545,818, in PCT application no. WO 95 / 16783, and in McBride et al. (1994) Proc. Nati. Acad. Sci. USA 91, 7301-7305.

[0260]

[0172] Methods of selecting for transformed, transgenic plants, plant cells or plant tissue culture are routine in the art and can be employed in the methods of the disclosure provided herein. For example, a recombinant vector of the disclosure also can include an expression cassette comprising a nucleotide sequence for a selectable marker, which can be used to select a transformed plant, plant part or plant cell.

[0261]

[0173] Examples of selectable markers include, but are not limited to, a nucleotide sequence encoding neo or nptll, which confers resistance to kanamycin, G418, and the like (Potrykus et al. (1985) Mol. Gen. Genet. 199: 183-188); a nucleotide sequence encoding bar, which confers resistance to phosphinothricin; a nucleotide sequence encoding an altered 5- enolpyruvylshikimate-3-phosphate (EPSP) synthase, which confers resistance to glyphosate (Hinchee et al. (1988) Biotech. 6:915-922); a nucleotide sequence encoding a nitrilase such as bxn from Klebsiella ozaenae that confers resistance to bromoxynil (Stalker et al. (1988) Science 242:419-423); a nucleotide sequence encoding an altered acetolactate synthase (ALS) that confers resistance to imidazolinone, sulfonylurea or other ALS-inhibiting chemicals (EP Patent Application No. 154204); a nucleotide sequence encoding a methotrexate-resistant dihydrofolate reductase (DHFR) (Thillet et al. (1988) J. Biol. Chem. 263: 12500-12508); a nucleotide sequence encoding a dalapon dehalogenase that confers resistance to dalapon; a nucleotide sequence encoding a mannose-6-phosphate isomerase (also referred to as phosphomannose isomerase (PMI)) that confers an ability to metabolize mannose (US Patent Nos. 5,767,378 and 5,994,629); a nucleotide sequence encoding an altered anthranilate synthase that confers resistance to 5- methyl tryptophan; or a nucleotide sequence encoding hph that confers resistance to hygromycin. One of skill in the art is capable of choosing a suitable selectable marker for use in an expression cassette of this disclosure. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0262]

[0174] Additional selectable markers include, but are not limited to, a nucleotide sequence encoding P-glucuronidase or uidA (GUS) that encodes an enzyme for which various chromogenic substrates are known; an R-locus nucleotide sequence that encodes a product that regulates the production of anthocyanin pigments (red color) in plant tissues (Dellaporta et al., “Molecular cloning of the maize R-nj allele by transposon-tagging with Ac” 263-282 In: Chromosome Structure and Function: Impact of New Concepts, 18th Stadler Genetics Symposium (Gustafson & Appels eds., Plenum Press 1988)); a nucleotide sequence encoding P- lactamase, an enzyme for which various chromogenic substrates are known (e.g., PAD AC, a chromogenic cephalosporin) (Sutcliffe (1978) Proc. Natl. Acad. Sci. USA 75:3737-3741); a nucleotide sequence encoding xylE that encodes a catechol dioxygenase (Zukowsky et al. (1983) Proc. Natl. Acad. Sci. USA 80: 1101-1105); a nucleotide sequence encoding tyrosinase, an enzyme capable of oxidizing tyrosine to DOPA and dopaquinone, which in turn condenses to form melanin (Katz et al. (1983) J. Gen. Microbiol. 129:2703-2714); a nucleotide sequence encoding P-galactosidase, an enzyme for which there are chromogenic substrates; a nucleotide sequence encoding luciferase (lux) that allows for bioluminescence detection (Ow et al. (1986) Science 234:856-859); a nucleotide sequence encoding aequorin which may be employed in calcium-sensitive bioluminescence detection (Prasher et al. (1985) Biochem. Biophys. Res. Comm. 126: 1259-1268); or a nucleotide sequence encoding green fluorescent protein (Niedz et al. (1995) Plant Cell Reports 14:403-406) or other fluorescent protein such as dsRed or mCherry. One of skill in the art is capable of choosing a suitable selectable marker for use in an expression cassette of this disclosure.

[0263]

[0175] Further, as is well known in the art, intact transgenic plants can be regenerated from transformed plant cells, plant tissue culture or cultured protoplasts using any of a variety of known techniques. Plant regeneration from plant cells, plant tissue culture or cultured protoplasts is described, for example, in Evans et al. (Handbook of Plant Cell Cultures, Vol. 1, MacMilan Publishing Co. New York (1983)); and Vasil I. R. (ed.) (Cell Culture and Somatic Cell Genetics of Plants, Acad. Press, Orlando, Vol. I (1984), and Vol. II (1986)).

[0264]

[0176] Additionally, the genetic properties engineered into the transgenic seeds and plants, plant parts, or plant cells of the disclosure described above can be passed on by sexual reproduction or vegetative growth and therefore can be maintained and propagated in progeny Attorney Docket No. : PAT- 111602-WO-SEC- 1 plants. Generally, maintenance and propagation make use of known agricultural methods developed to fit specific purposes such as harvesting, sowing or tilling.

[0265]

[0177] A polynucleotide therefore can be introduced into the plant, plant part or plant cell in any number of ways that are well known in the art, as described above. Therefore, no particular method for introducing one or more polynucleotides into a plant is relied upon, rather any method that allows the one or more polynucleotides to be stably integrated into the genome of the plant can be used. Where more than one polynucleotide is to be introduced, the respective polynucleotides can be assembled as part of a single nucleic acid molecule, or as separate nucleic acid molecules, and can be located on the same or different nucleic acid molecules.

[0266] Accordingly, the polynucleotides can be introduced into the cell of interest in a single transformation event, in separate transformation events, or, for example, in plants, as part of a breeding protocol.

[0267]

[0178] Once a desired polynucleotide has been transformed into a particular plant species, it may be propagated in that species or moved into other varieties of the same species, particularly including commercial varieties, using traditional breeding techniques.

[0268]

[0179] The polynucleotides encoding the polypeptide of SEQ ID NO: 1, 2, 3, 4, 13, 14, 15, 16, 17, 18, 19, 20, 21, or 22, and active variants and fragments thereof provided herein can be stacked with one or more polynucleotides encoding a desirable trait such as a polynucleotide that confers, for example, insect, disease or herbicide resistance or other desirable agronomic traits of interest including, but not limited to, traits associated with high oil content; traits associated with increased protein content, increased digestibility; balanced amino acid content; improved drought resistance, modified maturity and / or flowering time, and high energy content. Such traits may refer to properties of both seed and non-seed plant tissues, or to food or feed prepared from plants or seeds having such traits.

[0269]

[0180] As used herein, gene or trait “stacking” comprises combining desired genes or traits into one transgenic plant line. Stacking can include the introduction of transgenic traits of interest, genome edited traits of interest or native traits of interests. The additional polynucleotide can be introduced by a variety of approaches including by transgenic means, by breeding, or by genome editing. As one approach, plant breeders stack transgenic traits by Attorney Docket No. : PAT- 111602-WO-SEC- 1 making crosses between parents that each have a desired trait and then identifying offspring that have both of these desired traits (so-called “breeding stacks”). Another way to stack genes is by transferring two or more genes into the cell nucleus of a plant at the same time during transformation. In embodiments, the two or more genes may be transferred via distinct expression cassettes or via a common expression cassette. Another way to stack genes is by retransforming a transgenic plant comprising a desired trait with another gene of interest conferring another desired trait to thereby provide a progeny transgenic plant comprising the combination of traits. Such methods can include, for example, random integration techniques or targeted integration via a gene editing system such as Crispr or meganucleases. For example, gene stacking can be used to combine two different insect resistance traits, two different herbicide resistance traits, two different agronomic performance traits, an insect resistance trait with a disease resistance trait, an herbicide resistance trait (such as, for example, Btl 1), or an agronomic performance trait, etc. The use of a selectable marker in addition to a gene of interest would also be considered gene stacking. In embodiments, the offspring or progeny plant having the desired combination of traits is identified through the use of genetic markers or molecular markers including but not limited to SNPs, QTLs, primers or probes directed to desired trait- associated genes or transgenes, promoters, microRNAs, siRNAs, mRNAs, ds RNAs, transcriptional profiles, and methylation patterns.

[0270]

[0181] In some embodiments, a polypeptide, a nucleic acid molecule or vector provided herein can include an additional coding sequence for one omore polypeptides or double stranded RNA molecules (dsRNA) of interest for agronomic traits that primarily are of benefit to a seed company, grower or grain processor. A polypeptide of interest can be any polypeptide encoded by a nucleotide sequence of interest. Non-limiting examples of polypeptides of interest that are suitable for production in plants include those resulting in agronomically important traits such as herbicide resistance (also sometimes referred to as "herbicide tolerance"), disease resistance, virus resistance, bacterial pathogen resistance, insect resistance, nematode resistance, or fungal resistance. See, e.g., U.S. Patent Nos. 5,569,823; 5,304,730; 5,495,071; 6,329,504; and 6,337,431. The polypeptide also can be one that increases plant vigor or yield (including traits that allow a plant to grow at different temperatures, soil conditions and levels of sunlight and precipitation), or one that allows identification of a plant exhibiting a trait of interest (e.g., a selectable marker, seed coat color, relative maturity group, etc.). Various polypeptides of Attorney Docket No. : PAT- 111602-WO-SEC- 1 interest, as well as methods for introducing these polypeptides into a plant, are described, for example, in US Patent Nos. 4,761,373; 4,769,061; 4,810,648; 4,940,835; 4,975,374; 5,013,659; 5,162,602; 5,276,268; 5,304,730; 5,495,071; 5,554,798; 5,561,236; 5,569,823; 5,767,366; 5,879,903, 5,928,937; 6,084,155; 6,329,504 and 6,337,431; as well as US Patent Publication No. 2001 / 0016956.

[0271]

[0182] Non-limiting examples of polynucleotides that can be stacked with the sequences provided herein, include, polynucleotides conferring resistance / tolerance to an herbicide that inhibits the growing point or meristem, such as an imidazalinone or a sulfonylurea can also be suitable in some embodiments. Exemplary polynucleotides in this category code for mutant ALS and AHAS enzymes as described, e.g., in U.S. Patent Nos. 5,767,366 and 5,928,937. U.S. Patent Nos. 4,761,373 and 5,013,659 are directed to plants resistant to various imidazalinone or sulfonamide herbicides. U.S. Patent No. 4,975,374 relates to plant cells and plants containing a nucleic acid encoding a mutant glutamine synthetase (GS) resistant to inhibition by herbicides that are known to inhibit GS, e.g., phosphinothricin and methionine sulfoximine. U.S. Patent No. 5,162,602 discloses plants resistant to inhibition by cyclohexanedione and aryloxyphenoxypropanoic acid herbicides. The resistance is conferred by an altered acetyl coenzyme A carboxylase (ACCase).

[0272]

[0183] Non-limiting examples of polynucleotides that can be stacked with the sequences provided herein, include, polypeptides encoded by nucleotides sequences conferring resistance to glyphosate are also suitable for the disclosure. See, e.g., U.S. Patent No. 4,940,835 and U.S. Patent No. 4,769,061. U.S. Patent No. 5,554,798 discloses transgenic glyphosate resistant maize plants, which resistance is conferred by an altered 5-enolpyruvyl-3-phosphoshikimate (EPSP) synthase gene.

[0273]

[0184] Non-limiting examples of polynucleotides that can be stacked with the sequences provided herein, include, polynucleotides coding for resistance to phosphono compounds such as glufosinate ammonium or phosphinothricin, and pyridinoxy or phenoxy propionic acids and cyclohexones are also suitable. See, European Patent Application No. 0 242 246. See also, U.S. Patent Nos. 5,879,903, 5,276,268 and 5,561,236.

[0274]

[0185] Other suitable polynucleotides include those coding for resistance to herbicides that inhibit photosynthesis, such as a triazine and a benzonitrile (nitrilase) See, U.S. Patent No. 4,810,648. Additional suitable polynucleotides coding for herbicide resistance include those Attorney Docket No. : PAT- 111602-WO-SEC- 1 coding for resistance to 2,2-dichloropropionic acid, sethoxydim, haloxyfop, imidazolinone herbicides, sulfonylurea herbicides, triazolopyrimidine herbicides, s-triazine herbicides and bromoxynil. Also suitable are polynucleotides conferring resistance to a protox enzyme, or that provide enhanced resistance to plant diseases; enhanced tolerance of adverse environmental conditions (abiotic stresses) including but not limited to drought, excessive cold, excessive heat, or excessive soil salinity or extreme acidity or alkalinity; and alterations in plant architecture or development, including changes in developmental timing. See, e.g., U.S. Patent Publication No. 2001 / 0016956 and U.S. Patent No. 6,084, 155. Additional herbicide tolerant traits include, PPO tolerant traits including, for example, one or more PPO trait set forth in US20190062777, US10370677, US11124803, WO2017217793, WO2020251313, US10392630, US10378023, WO2016099153, WO2019117579, WO2019117578, and US10100329, each of which is herein incorporated by reference in their entirety. HPPD tolerant traits include, for example, W02009144079, US8642748, EP2453012, W02013026740, US9078446, US10793872, US10508089, US10400249, US10597674, WO2018119364, WO2018119361, US11180770, US20200157086, US20210147866, US11279944, US202000331866, WO2019227036, WO2019227028, WO2022115296, and WO2011068567, each of which is herein incorporated by reference in their entirety. ACCase tolerant traits include, for example, US20120284812, US20120284853, US20160108423, US20160244780, US20160264990, US20170275645, US20210153448, US10696975B2, US10370678, CN109082416, US10694694,

[0275] US20170265469, US20170231225, each of which is herein incorporated by reference. Dicamba tolerant traits include, for example, RE45048 or US7884262. Various traits the confer tolerance to AOPP herbicides, phenoxy acid herbicides and / or pyridinyloxy acid herbicides include, for example, US10174337, US8278505, W005107437, WO11022469, US10023874, and US2019241903 (and other traits therein), each of which is herein incorporated by reference.

[0276]

[0186] Additional herbicides tolerant traits of interest for stacking include glucosyl transferase polypeptides as set forth in 2018213022 or solanesyl diphosphate synthase polypeptides as set forth in W02020236790, each of which is herein incorporated by reference in their entirety.

[0277]

[0187] Disease resistance proteins that increase resistance to various plant disease including rust, include, but are not limited to, one or more of the various resistance genes set forth in: W02019103918; W0202100878; W02021022022; WO2021260673; WO2022173659; Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0278] WO2022159341; WO2021154632A1, W02021022026, W02021022101, US20220135997; US10842097; or WO2022140257; each of which is incorporated by reference in their entirety. In other embodiments, the nucleic acid sequence encoding the Mquad_45 or MQuad_9 proteins or active variant or fragments thereof is stacked with a native trait that confers disease resistance. For example, the various intervals, locus or resistance genes as set forth in W02009079729, US9091681, WO2010009404, WO2017222827, WO2021000878, WO2021022026, W02021022101, WO2021154632, WO2022173659, (each of which is incorporated by reference in their entirety) can used to introduce a trait of interest. Disease resistance proteins and / or native traits that increase resistance to various plant diseases including NCLB include, for example, US8921646, US2021000059, US10858668, US20200199610, WO2022 / 013268, WO2022 / 013268, US9040772, US10897862, EP3839073, each of which is herein incorporated by reference.

[0279]

[0188] Additional suitable polynucleotides include those coding for pesticidal (e.g., insecticidal) polypeptides. These polypeptides may be produced in amounts sufficient to control, for example, insect pests (i.e., insect controlling amounts). It is recognized that the amount of production of a pesticidal polypeptide in a plant necessary to control insects or other pests may vary depending upon the cultivar, type of pest, environmental factors and the like. Polynucleotides useful for additional insect or pest resistance include, for example, those that encode toxins identified in Bacillus organisms. Polynucleotides comprising nucleotide sequences encoding Bacillus thuringiensis (Bt) Cry proteins from several subspecies have been cloned and recombinant clones have been found to be toxic to lepidopteran, dipteran and / or coleopteran insect larvae. Examples of such Bt insecticidal proteins include the Cry proteins such as Cryl Aa, CrylAb, CrylAc, CrylB, CrylC, CrylD, CrylEa, CrylFa, Cry3A, Cry9A, Cry9B, Cry9C, and the like, as well as vegetative insecticidal proteins such as Vipl, Vip2, Vip3, and the like. A full list of Bt-derived proteins can be found on the worldwide web at Bacillus thuringiensis Toxin Nomenclature Database maintained by the University of Sussex (see also, Crickmore et al. (1998) Microbiol. Mol. Biol. Rev. 62:807-813).

[0280]

[0189] In some embodiments, an additional polypeptide is an insecticidal polypeptide derived from a non-Bt source, including without limitation, an alpha-amylase, a peroxidase, a cholesterol oxidase, a patatin, a protease, a protease inhibitor, a urease, an alpha-amylase inhibitor, a pore-forming protein, a chitinase, a lectin, an engineered antibody or antibody Attorney Docket No. : PAT- 111602-WO-SEC- 1 fragment, a Bacillus cereus insecticidal protein, a Xenorhabdus spp. (such as X. nematophila or X. bovienii) insecticidal protein, a Photorhabdus spp. (such as P. luminescens or P. asymobiotica) insecticidal protein, a Brevibacillus spp. (such as B. laterosporous) insecticidal protein, a Lysinibacillus spp. (such as L. sphearicus) insecticidal protein, a Chromobacterium spp. (such as C. subtsugae or C. piscinae) insecticidal protein, a Yersinia spp. (such as Y. entomophaga) insecticidal protein, a Paenibacillus spp. (such as P. propylaea) insecticidal protein, a Clostridium spp. (such as C. bifermentans) insecticidal protein, a Pseudomonas spp. (such as P. fluorescens) and a lignin.

[0281]

[0190] In certain embodiments, the additional polypeptide is a resistance protein conferring enhanced pathogen resistance, such as enhanced resistance to any one of the following pathogens: soy cyst nematode, bacterial pustule, root knot nematode, frog eye leaf spot, phytopthora, brown stem rot, nematode, Asian Soybean Rust, smut, Golovinomyces cichoracearum, Erysiphe cichoracearum, Blumeria graminis, Podosphaera xanthii, Sphaerotheca fuliginea, Pythium ultimum, Uncinula necator, Mycosphaerella pinodes, Magnaporthe grisea, Bipolaris oryzae, Magnaporthe grisea, Rhizoctonia solani, Phytophthora sojae, Schizaphis graminum, Bemisia tabaci, Rhopalosiphum maidis, Deroceras reticulatum, Diatraea saccharalis, Schizaphis graminum, Myzus persicae, Sclerotinia sclerotiorum, Macrophomina phaseolina, or Fusarium virguliforme. Exemplary polynucleotides encoding proteins that confer increased pathogen resistance that may be stacked with polynucleotides of the invention include polynucleotides encoding proteins that confer increased ASR resistance as described in US Patent publication Nos. US 20200354739 and PCT Publications Nos. W02019103918, WO2021154632A1, W02021022022, W02021022026, W02021022101, WO2021260673, and WO2021263249, each of which is incorporated by reference in its entirety.

[0282]

[0191] Polypeptides that are suitable for production in plants further include those that improve or otherwise facilitate the conversion of harvested plants or plant parts into a commercially useful product, including, for example, increased or altered carbohydrate content or distribution, improved fermentation properties, increased oil content, increased protein content, improved digestibility, and increased nutraceutical content, e.g., increased phytosterol content, increased tocopherol content, increased stanol content or increased vitamin content. Polypeptides of interest also include, for example, those resulting in or contributing to a reduced content of an unwanted component in a harvested crop, e.g., phytic acid, or sugar degrading Attorney Docket No. : PAT- 111602-WO-SEC- 1 enzymes. By "resulting in" or "contributing to" is intended that the polypeptide of interest can directly or indirectly contribute to the existence of a trait of interest (e.g., increasing cellulose degradation by the use of a heterologous cellulase enzyme).

[0283]

[0192] In some embodiments, the polypeptide contributes to improved digestibility for food or feed. Xylanases are hemicellulolytic enzymes that improve the breakdown of plant cell walls, which leads to better utilization of the plant nutrients by an animal. This leads to improved growth rate and feed conversion. Also, the viscosity of the feeds containing xylan can be reduced. Heterologous production of xylanases in plant cells also can facilitate lignocellulosic conversion to fermentable sugars in industrial processing.

[0284]

[0193] Numerous xylanases from fungal and bacterial microorganisms have been identified and characterized (see, e.g., U.S. Patent No. 5,437,992; Coughlin et al. (1993) "Proceedings of the Second TRICEL Symposium on Trichoderma reesei Cellulases and Other Hydrolases" Espoo; Souminen and Reinikainen, eds. (1993) Foundation for Biotechnical and Industrial Fermentation Research 8: 125-135; U.S. Patent Publication No. 2005 / 0208178; and PCT Publication No. WO 03 / 16654). In particular, three specific xylanases (XYL-I, XYL-II, and XYL-III) have been identified in T. reesei (Tenkanen et al. (1992) Enzyme Microb. Technol. 14:566; Torronen et al. (1992) Bio / Technology 10: 1461; and Xu et al. (1998) Appl. Microbiol. Biotechnol. 49:718).

[0285]

[0194] In other embodiments, a polypeptide useful for the disclosure can be a polysaccharide degrading enzyme. Plants of this disclosure producing such an enzyme may be useful for generating, for example, fermentation feedstocks for bioprocessing. In some embodiments, enzymes useful for a fermentation process include alpha amylases, proteases, pullulanases, isoamylases, cellulases, hemicellulases, xylanases, cyclodextrin glycotransferases, lipases, phytases, laccases, oxidases, esterases, cutinases, granular starch hydrolyzing enzyme and other glucoamylases.

[0286]

[0195] Polysaccharide-degrading enzymes include: starch degrading enzymes such as a- amylases (EC 3.2.1.1), glucuronidases (E.C. 3.2.1.131); exo-l,4-a-D glucanases such as amyloglucosidases and glucoamylase (EC 3.2.1.3), P-amylases (EC 3.2.1.2), a-glucosidases (EC 3.2.1.20), and other exo-amylases; starch debranching enzymes, such as a) isoamylase (EC 3.2.1.68), pullulanase (EC 3.2.1.41), and the like; b) cellulases such as exo-1,4-3- cellobiohydrolase (EC 3.2.1.91), exo-l,3-P-D-glucanase (EC 3.2.1.39), P-glucosidase (EC Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0287] 3.2.1.21); c) L-arabinases, such as endo-l,5-a-L-arabinase (EC 3.2.1.99), a-arabinosidases (EC 3.2.1.55) and the like; d) galactanases such as endo-l,4-|3-D-galactanase (EC 3.2.1.89), endo-1,3- P-D-galactanase (EC 3.2.1.90), a-galactosidase (EC 3.2.1.22), P-galactosidase (EC 3.2.1.23) and the like; e) mannanases, such as endo-l,4-P-D-mannanase (EC 3.2.1.78), P-mannosidase (EC 3.2.1.25), ot-mannosidase (EC 3.2.1.24) and the like; f) xylanases, such as endo-l,4-P-xylanase (EC 3.2.1.8), P-D-xylosidase (EC 3.2.1.37), 1 ,3-P-D-xylanase, and the like; and g) other enzymes such as a-L-fucosidase (EC 3.2.1.51), a-L-rhamnosidase (EC 3.2.1.40), levanase (EC 3.2.1.65), inulanase (EC 3.2.1.7), and the like. In one embodiment, the a-amylase is the synthetic a-amylase, Amy797E, described is US Patent No. 8,093,453, herein incorporated by reference in its entirety.

[0288]

[0196] Further enzymes which may be used with the disclosure include proteases, such as fungal and bacterial proteases. Fungal proteases include, but are not limited to, those obtained from Aspergillus, Trichoderma, Mucor and Rhizopus, such as A. niger, A. awamori, A. oryzae and M. miehei. In some embodiments, the polypeptides of this disclosure can be cellobiohydrolase (CBH) enzymes (EC 3.2.1.91). In one embodiment, the cellobiohydrolase enzyme can be CBH1 or CBH2.

[0289]

[0197] Other enzymes useful with the disclosure include, but are not limited to, hemicellulases, such as mannases and arabinofuranosidases (EC 3.2.1.55); ligninases; lipases (e.g., E.C. 3.1.1.3), glucose oxidases, pectinases, xylanases, transglucosidases, alpha 1,6 glucosidases (e.g., E.C. 3.2.1.20); esterases such as ferulic acid esterase (EC 3.1.1.73) and acetyl xylan esterases (EC 3.1.1.72); and cutinases (e.g. E C. 3.1.1.74).

[0290]

[0198] In additional embodiments, the nucleic acid encoding the polypeptide provided herein, or an active variant or fragment thereof, can be stacked with one or more of any number of Bacillus thuringiensis insecticidal proteins including but not limited to a Cry protein, a vegetative insecticidal protein (VIP) and insecticidal chimeras of any of the preceding insecticidal proteins. In other embodiments, the second pest control agent is a Cry protein selected from: CrylAa, Cry 1 Ab, Cry 1 Ac, Cry 1 Ad, CrylAe, CrylAf, CrylAg, Cry 1 Ah, CrylAi, CrylAj, CrylBa, CrylBb, CrylBc, CrylBd, CrylBe, CrylBf, CrylBg, CrylBh, CrylBi, CrylCa, CrylCb, CrylDa, CrylDb, CrylDc, CrylDd, CrylEa, CrylEb, CrylFa, CrylFb, CrylGa, CrylGb, CrylGc, CrylHa, CrylHb, CrylHc, Crylla, Cryllb, Cryllc, Crylld, Crylle, Cryllf, Cryllg, CrylJa, Cryllb, CrylJc, CrylJd, CrylKa, CrylLa, CrylMa, CrylNa, CrylNb, Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0291] Cry2Aa, Cry2Ab, Cry2Ac, Cry2Ad, Cry2Ae, Cry2Af, Cry2Ag, Cry2Ah, Cry2Ai, Cry2Aj, Cry2Ak,Cry2Al, Cry2Ba, Cry3Aa, Cry3Ba, Cry3Bb, Cry3Ca, Cry4Aa, Cry4Ba, Cry4Ca, Cry4Cb, Cry4Cc, Cry5Aa, Cry5Ab, Cry5Ac, Cry5Ad, Cry5Ba, Cry5Ca, Cry5Da, Cry5Ea, Cry6Aa, Cry6Ba, Cry7Aa, Cry7Ab, Cry7Ac, Cry7Ba, Cry7Bb, Cry7Ca, Cry7Cb, Cry7Da, Cry7Ea, Cry7Fa, Cry7Fb, Cry7Ga, Cry7Gb, Cry7Gc, Cry7Gd, Cry7Ha, Cry7Ia, Cry7Ja, Cry7Ka, Cry 7Kb, Cry7La, Cry8Aa, Cry8Ab, Cry8Ac, Cry8Ad, Cry8Ba, Cry8Bb, Cry8Bc, Cry8Ca, Cry8Da, Cry8Db, Cry8Ea, Cry8Fa, Cry8Ga, Cry8Ha, Cry8Ia, Cry8Ib, Cry8Ja, Cry8Ka, Cry8Kb, Cry8La, Cry8Ma, Cry8Na, Cry8Pa, Cry8Qa, Cry8Ra, Cry8Sa, Cry8Ta, Cry9Aa, Cry9Ba, Cry9Bb, Cry9Ca, Cry9Da, Cry9Db, Cry9Dc, Cry9Ea, Cry9Eb, Cry9Ec, Cry9Ed, Cry9Ee, Cry9Fa, Cry9Ga, CrylOAa, Cryl lAa, Cryl lBa, Cryl lBb, Cryl2Aa,Cryl3Aa, Cryl4Aa, Cryl4Ab, Cryl5Aa, Cryl6Aa, Cryl7Aa, Cryl8Aa, Cryl8Ba, Cryl8Ca, Cryl9Aa, Cryl9Ba, Cryl9Ca, Cry20Aa, Cry20Ba, Cry21Aa, Cry21Ba, Cry21Ca, Cry21Da, Cry21Ea, Cry21Fa, Cry21Ga, Cry21Ha, Cry22Aa, Cry22Ab, Cry22Ba, Cry22Bb, Cry23Aa, Cry24Aa, Cry24Ba, Cry24Ca, Cry25Aa, Cry26Aa, Cry27Aa, Cry28Aa, Cry29Aa, Cry29Ba, Cry3OAa, Cry3OBa, Cry3OCa, Cry3ODa, Cry3ODb, Cry3OEa, Cry3OFa, Cry3OGa,Cry31Aa, Cry31Ab, Cry31Ac, Cry31Ad, Cry32Aa, Cry32Ab, Cry32Ba, Cry32Ca, Cry32Cb, Cry32Da, Cry32Ea, Cry32Eb, Cry32Fa, Cry32Ga, Cry32Ha, Cry32Hb, Ciy32Ia, Cry32Ja, Cry32Ka, Cry32La, Cry32Ma, Cry32Mb, Cry32Na, Cry320a, Cry32Pa, Cry32Qa, Cry32Ra, Cry32Sa, Cry32Ta, Cry32Ua, Cry33Aa, Cry34Aa, Cry34Ab, Cry34Ac, Cry34Ba, Cry35Aa, Cry35Ab, Cry35Ac, Cry35Ba, Cry36Aa, Cry37Aa, Cry38Aa, Cry39Aa, Cry40Aa, Cry40Ba, Cry40Ca, Cry40Da, Cry41Aa, Cry41Ab, Cry41Ba, Cry42Aa, Cry43Aa, Cry43Ba, Cry43Ca, Cry43Cb, Cry43Cc, Cry44Aa, Cry45Aa, Cry46Aa Cry46Ab, Cry47Aa, Cry48Aa, Cry48Ab, Cry49Aa, Cry49Ab, Cry5OAa, Cry5OBa, Cry51Aa, Cry52Aa, Cry52Ba, Cry53Aa, Cry53Ab, Cry54Aa, Cry54Ab, Cry54Ba, Cry55Aa, Cry56Aa, Cry57Aa, Cry57Ab, Cry58Aa, Cry59Aa, Cry59Ba, Cry60Aa, Cry60Ba, Cry61Aa, Cry62Aa, Cry63Aa, Cry64Aa, Cry65Aa, Cry66Aa, Cry67Aa, Cry68Aa, Cry69Aa, Cry69Ab, Cry70Aa, Cry70Ba, Cry70Bb, Cry71Aa, Cry72Aa, Cry73Aa, or any combination of the foregoing. In some embodiments, the second pest control agent comprises the CrylAb protein in the Btl 1 event (see US Patent No. US6,114,608), the Cry3A055 protein in the MIR604 event (see US Patent No. US8884102), the eCry3.1Ab protein in the 5307 event (see US Patent No. US10428393) and / or the mCry3A protein in the MZIR098 event (see US Patent Application No. US20200190533). In some embodiments, the second pest control agent Attorney Docket No. : PAT- 111602-WO-SEC- 1 comprises the Btl 1 event (see US Patent No. US6,114,608), the MIR604 event (see US Patent No. US8884102), the 5307 event (see US Patent No. US10428393) and / or the MZIR098 event (see US Patent Application No. US20200190533).

[0292]

[0199] In additional embodiments, the nucleic acid encoding the polypeptide provided herein, or an active variant or fragment thereof, can be stacked with one or more Vip3 vegetative insecticidal proteins. Some structural features that identify a protein as being in the Vip3 class of proteins includes: 1) a size of about 80-88 kDa that is proteolytically processed by insects or trypsin to about a 62-66 kDa toxic core (Lee et al. 2003. Appl. Environ. Microbiol. 69:4648- 4657); and 2) a highly conserved N-terminal secretion signal which is not naturally processed during secretion in B. thuringiensis. Non-limiting examples of members of the Vip3 class and their respective GenBank accession numbers, U.S. Patent or patent publication number are Vip3Aal (AAC37036), Vip3Aa2 (AAC37037), Vip3Aa3 (U.S. Pat. No. 6,137,033), Vip3Aa4 (AAR81079), Vip3Aa5 (AAR81080), Vip3Aa6 (AAR81081), Vip3Aa7 (AAK95326), Vip3Aa8 (AAK97481), Vip3Aa9 (CAA76665), Vip3Aal0 (AAN60738), Vip3Aal l (AAR36859), Vip3Aal2 (AAM22456), Vip3Aal3 (AAL69542), Vip3Aal4 (AAQ12340), Vip3Aal5 (AAP51131), Vip3Aal6 (AAW65132), Vip3Aal7 (U.S. Pat. No. 6,603,063), Vip3Aal8 (AAX49395), Vip3Aal9 (DQ241674), Vip3Aal9 (DQ539887), Vip3Aa20 (DQ539888), Vip3Aa21 (ABD84410), Vip3Aa22 (AAY41427), Vip3Aa23 (AAY41428), Vip3Aa24 (BI 880913), Vip3Aa25 (EF608501), Vip3Aa26 (EU294496), Vip3Aa27 (EU332167), Vip3Aa28 (FJ494817), Vip3Aa29 (FJ626674), Vip3Aa30 (FJ626675), Vip3Aa31 (FJ626676), Vip3Aa32 (FJ626677), Vip3Aa33 (GU073128), Vip3Aa34 (GU073129), Vip3Aa35 (GU733921), Vip3Aa36 (GU951510), Vip3Aa37 (HM132041), Vip3Aa38 (HM117632), Vip3Aa39 (HM117631), Vip3Aa40 (HM132042), Vip3Aa41 (HM132043), Vip3Aa42 (HQ587048), Vip3Aa43 (HQ594534), Vip3Aa44 (HQ650163), Vip3Abl (AAR40284), Vip3Ab2 (AAY88247), Vip3Acl (U.S. Patent Application Publication 20040128716), Vip3Adl (U.S. Patent Application Publication 20040128716), Vip3Ad2 (CAI43276), Vip3Ael (CAI43277), Vip3Afl (US Pat. No. 7,378,493), Vip3Af2 (ADN08753), Vip3Afi (HM117634), Vip3Agl (ADN08758), Vip3Ag2 (FJ556803),Vip3Ag3 (HM117633), Vip3Ag4 (HQ414237), Vip3Ag5 (HQ542193), Vip3Ahl (DQ832323), Vip3Bal (AAV70653), Vip3Ba2 (HM117635), Vip3Bbl (US Pat. No. 7,378,493), Vip3Bb2 (AB030520) and Vip3Bb3 (ADI48120). In some embodiments, the Vip3 protein is Vip3Aa (US Patent No. 6,137,033), for example, as Attorney Docket No. : PAT- 111602-WO-SEC- 1 represented by com event MIR162 (US Patent No. 8,232,456; US Patent No. 8,455,720; and US Patent No. 8,618,272). In some embodiments, the second pest control agent comprises the event M1R162 (US Patent No. 8,232,456; US Patent No. 8,455,720; and US Patent No. 8,618,272).

[0200] In additional embodiments, the nucleic acid encoding the polypeptide provided herein, or an active variant or fragment thereof, can be stacked with any one or more of the insecticidal proteins or dsRNAs present in any of the following events: the Btl 1 event (see US Patent No. US6114608), the MIR604 event (see US Patent No. US8884102), the MIR162 event (see US Patent No. 8232456), the 5307 event (see US Patent No. US10428393), the MZIR098 event (see US Patent Application No. US20200190533), the TC1507 event (see US Patent No. US7288643), the DAS-59122-7 event (see US Patent No. US7323556), the MON810 event (see US6713259), the MON863 event (see US Patent No. US7705216), the MON89034 event (see US Patent No. US8062840), the NK603 event (see US Patent No. US6825400), the MON88017 event (see US Patent No. US9556492), the DP-4114 event (see US Patent No. US9725772), the MON87411 event (see US Patent No. US9441240), the DAS40278 event (see PCT publication No. WO11 / 022469), the T25 event, the DP-032218-9 event (see US Patent Application No. US2015361447), the DP-033121-3 event (see US Patent Application No. US2015361446), the DP-023211-2 event (see PCT Publication No. WO2019209700), the DP-202216-6 event (see PCT Publication No. WO19 / 204253), the DP-051292-2 event (see PCT

[0293] PublicationWO24 / l 12634), the MON95379 event (see US Patent Application No. US2020032289 and PCT Publication No. WO25 / 122655), the MON87429 event (see PCT Publication No. WO19 / 152316), the ZM CSM36715 event (see PCT Publication No. WO2024 / 137408), the DBN9936 event (see PCT Publication No. WO2016173361), the DBN9501 event (see PCT Publication No. W020207125), the DBN9858 event (see PCT Publication No. WO16 / 173508) the Origin GH5112E-117C event (see PCT Publication No. W017 / 088480), the LP007-1 event (see Chinese Patent Application No. CN112852801), the UP007-2 event (see Chinese Patent Application No. CN112831584), the LP007-3 event (see Chinese Patent Application No. CN112877454), the LP007-4 event (see Chinese Patent Application No. CN112831585), the UP007-5 event (see Chinese Patent Application No. CN113151534), the UP007-6 event (see Chinese Patent Application No. CN113151533), the UP007-7 event (see Chinese Patent Application No. CN112852991), the LP007-8 event (see CN113980958), Ruifeng8, ND207, or the Ruifengl25 event (see Chinese Patent Application No. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0294] CN105017391), the KJ1172 event (see Chinese Patent Application No. CN1164109774), the LD02 event (see Chinese Patent Application No. CN115820630A), the LD05 event (See Chinese Patent Application No. CN 116287384), the LG11 event (see Chinese Patent Application Nos. CN116200529A and CN115725571A), the DBN9235 event (see Chinese Patent Application No. CN116219063), the DBN9508 event (see Chinese Patent No. CN109971880), the DBN9888 event (see PCT Publication No. WO16 / 173540), the DBN9978 event (see PCT Publication No. WO16 / 173362), the DBN9953 event (see Chinese Patent No. CN104878092), the DBN9927 event (see PCT Publication No. WO16 / 173360), the LP026-1 event (see Chinese Application No. CN116144672A), the LP026-2 event (see Chinese Application No. CN116144818A), the LP026-3 event (see Chinese Application No. CN116144671 A), the LP026-4 event (see Chinese Application No. CN116144817A), the LP026-5 event (see Chinese Application No.

[0295] CN116200519A), the 2A-7 event (see Chinese Patent Application No. CN112280743 A), the CA09328 event (see Chinese Patent Application No. CN112126707A), the ZM8-143 event (see Chinese Patent Application No. CN108018286), the ZM 1-027 event (see Chinese Patent Application No. CN108018368A), the DP-915635-4 event (see PCT Publication No.

[0296] WO2 1 / 247204), the DP-910521-2 event (see PCT Publication No. WO23 / 091888), the DAS- 01131-3 event (see PCT Publication No. WO23 / 091884), the MON95275event (see PCT Publication Nos. WO21 / 216571 and WO25 / 122657),the ME240913 event (see PCT Publication No. WO21 / 087586), the MZIR260 event (see PCT Publication No. WO25 / 188947) the EH913 event (see PCT Publication No. WO21 / 087586), the GTS 40-3-2 event, the MON87701 event (see PCT Publication No. WO09 / 64652), the MON87708 event (see PCT Publication No.

[0297] WO1 1 / 034704), the MON87751 event (see PCT Publication No. WO14 / 201235), the MON98788 event (see PCT Publication No. W006 / 128095), the A5547-127 / A2704-12 event (see PCT Publications Nos. 006 / 108674 and WO06 / 108675), the FG072-03 event (see PCT Publication No. WO 11 / 063411), the DAS-44406 event (see PCT Publication No.

[0298] WO 12 / 075426), the DAS-81419 event (see PCT Publication No. WO 13 / 016527), the COR- 23134 event (see PCT Publication No. WO 25 / 165829), the GM CSM63714 event (see PCT Publication No. WO23 / 212564), the GM_CSM63717 event (see PCT Publication No. WO2025 / 128414), the GM_CSM63770 event (see PCT Publication No. WO24 / 006698), the GMB151 event (see PCT Publication Nos. WO18 / 119364 and WO19 / 227036), the SHZD32 event (see PCT Publication No. WO 17 / 059795) , the DBN8002 event (see PCT Publication No. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0299] W02 1 / 026688), the DBN9004-6 event (see PCT Publication No. WO 17 / 215328), and the Verdeca HB4 (IND-00410) event (see PCT Publication No. WO20 / 197558) and MZIR260 (WO188947).

[0300]

[0201] In additional embodiments, the nucleic acid encoding the polypeptide provided herein, or an active variant or fragment thereof, can be stacked with a second pest control agent that is derived from sources other than B. thuringiensis. For example, the second pest control agent can be an alpha-amylase, a peroxidase, a cholesterol oxidase, a patatin, a protease, a protease inhibitor, a urease, an alpha-amylase inhibitor, a pore-forming protein, a chitinase, a lectin, an engineered antibody or antibody fragment, a Bacillus cereus insecticidal protein, a Xenorhabdus spp. (such as X. nematophila or X. bovienii) insecticidal protein, a Photorhabdus spp. (such as P. luminescens or P. asymobiotica) insecticidal protein, a Brevibacillus spp. (such as B. laterosporous) insecticidal protein, a Lysinibacillus spp. (such as L. sphearicus) insecticidal protein, a Chromobacterium spp. (such as C. subtsugae or C. piscinae) insecticidal protein, a Yersinia spp. (such as Y. entomophaga) insecticidal protein, a Paenibacillus spp. (such as P. propylaea) insecticidal protein, a Clostridium spp. (such as C. bifermentans) insecticidal protein, a Pseudomonas spp. (such as P. fluorescens) and a lignin. In other embodiments, the second agent may be at least one insecticidal protein derived from an insecticidal toxin complex (Tc) from Photorhabdus, Xenorhabus, Serratia, or Yersinia. In other embodiments, the insecticidal protein may be an ADP-ribosyltransferase derived from an insecticidal bacteria, such as Photorhabdus ssp. In other embodiments, the insecticidal protein may be a VIP protein, such as VIP1 and / or VIP2 from B. cereus. In still other embodiments, the insecticidal protein may be a binary toxin derived from an insecticidal bacteria, such as 1SP1A and 1SP2A from B. laterosporous or BinA and BinB from L. sphaericus. In still other embodiments, the insecticidal protein may be engineered or may be a hybrid or chimera of any of the preceding insecticidal proteins.

[0301]

[0202] Other example second pest controls agents that can be stacked with the nucleic acid encoding the polypeptide provided herein, or an active variant or fragment thereof, can be stacked with one or more of any number of Bacillus include DIG-657 (US Patent Publication 2015366211); PtIP-96 (US Patent Publication 2017233440); PIP-72 (US Patent Publication US2016366891); PIP-83 (US Patent Publication 2016347799); PIP-50 (US Patent Publication 2017166921); IPD73 (US Patent Publication 2019119334); IPD090 (US Patent Publication Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0302] 2019136258); IPD80 (US Patent Publication 2019256563); IPD078, IPD084, IPD086, IPD087, IPD089 (US Patent Publication 2020055906); IPD079 (International Application Publication WO2017023486); 1PD093 (International Application Publication WO2018111551); 1PD059 (International Application Publication WO2018232072); IPD113 (International Application Publication WO2019178042); IPD121 (International Application Publication WO2018208882); IPD110 (International Application Publication WO2019178038); IPD103 (International Application Publication WO2019125717); IPD092; IPD095; IPD097; IPD099; IPD100, IPD105; IPD106; IPD107; IPD111; IPD112 (International Application Publication W02020055885); IPD102 (International Application Publication W02020076958) CrylB.868 and CrylDa_7 (US Patent Publication 2020-032289); TIC107 (US Patent 8049071); Cry2Ab and CrylA.105 (US Patent 10584391); CrylF, Cry34Abl, Cry35Abl (US Patent 10407688); TIC6757, TIC7472, TIC7473, TIC6757 (US Patent Publication 2017058294); TIC3668, TIC3669, TIC3670, TIC4076, TIC4078, TIC4260, TIC4346, TIC4826, TIC4861, TIC4862, TIC4863, TIC-3668 (US Patent Publication 2016319302); TIC7040, TIC7042, TIC7381, TIC7382, TIC7383, TIC7386, TIC7388, TIC7389 (US Patent Publication 2018291395); TIC7941 (US Patent Publication 2020229445) TIC836, TIC860, TIC867, TIC868, TIC869, and TIC1100 (International Application Publication W02016061391), TIC2160 (International Application Publication WO2016061392), ET66, TIC400, TIC800, TIC834, TIC1415, AXMI-001, AXMI-002, AXMI- 030, AXMI-035, AND AXMI-045 (US Patent Publication 20130117884), AXMI-52, AXMI-58, AXMI-88, AXMI-97, AXMI-102, AXMI-112, AXMI-117, AXMI-100 (US Patent Publication 201-0310543), AXMI-115, AXMI-113, AXMI-005 (US Patent Publication 20130104259), AXM1-134 (US Patent Publication 20130167264), AXM1-150 (US Patent Publication 20100160231), AXMI-184 (US Patent Publication 20100004176), AXMI-196, AXMI-204, AXMI-207, AXMI-209 (US Patent Publication 2011-0030096), AXMI-218, AXMI-220 (US Patent Publication 20140245491), AXMI-221z, AXMI-222z, AXMI-223z, AXMI-224z, AXMI- 225z (US Patent Publication 20140196175), AXMI-238 (US Patent Publication 20140033363), AXMI-270 (US Patent Publication 20140223598), AXMI-345 (US Patent Publication 20140373195), AXMI-335 (International Application Publication WO2013134523), DIG-3 (US Patent Publication 20130219570), DIG-5 (US Patent Publication 20100317569), DIG-11 (US Patent Publication 20100319093), AflP-lA (US Patent Publication 20140033361), AflP-lB (US Patent Publication 20140033361), PIP-1APIP-1B (US Patent Publication 20140007292), Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0303] PSEEN3174 (US Patent Publication 20140007292), AECFG-592740 (US Patent Publication 20140007292), Pput_1063 (US Patent Publication 20140007292), DIG-657 (International Application Publication WO2015195594), Pput_1064 (US Patent Publication 20140007292), GS-135 (US Patent Publication 20120233726), GS153 (US Patent Publication 20120192310), GS154 (US Patent Publication 20120192310), GS155 (US Patent Publication 20120192310), DIG-91 1 and DIG-180 (US Patent Publication No. 20150264940); and the like.

[0304]

[0203] In some embodiments, the second pesticidal agent can be non-proteinaceous, for example, an interfering RNA molecule such as a dsRNA, which can be expressed transgenically or applied as part of a composition (e.g., using topical methods). An interfering RNA typically comprises at least a RNA fragment against a target gene, a spacer sequence, and a second RNA fragment which is complementary to the first, so that a double-stranded RNA structure can be formed. RNA interference (RNAi) occurs when an organism recognizes double-stranded RNA (dsRNA) molecules and hydrolyzes them. The resulting hydrolysis products are small RNA fragments of about 19-24 nucleotides in length, called small interfering RNAs (siRNAs). The siRNAs then diffuse or are carried throughout the organism, including across cellular membranes, where they hybridize to mRNAs (or other RNAs) and cause hydrolysis of the RNA. Interfering RNAs are recognized by the RNA interference silencing complex (RISC) into which an effector strand (or “guide strand”) of the RNA is loaded. This guide strand acts as a template for the recognition and destruction of the duplex sequences. This process is repeated each time the siRNA hybridizes to its complementary-RNA target, effectively preventing those mRNAs from being translated, and thus “silencing” the expression of specific genes from which the mRNAs were transcribed. Interfering RNAs are known in the art to be useful for insect control (see, for example, publication WO2013 / 192256, incorporated by reference herein). An interfering RNA designed for use in insect control produces a non-naturally occurring doublestranded RNA, which takes advantage of the native RNAi pathways in the insect to trigger down-regulation of target genes that may lead to the cessation of feeding and / or growth and may result in the death of the insect pest. The interfering RNA molecule may confer insect resistance against the same target pest as the disclosed proteins or may target a different pest. The targeted insect plant pest may feed by chewing, sucking, or piercing. Interfering RNAs are known in the art to be useful for insect control. In some embodiments, the dsRNA useful for insect control is described in US Patent Publications 20190185526, 2018020028 or 20190177736. In some Attorney Docket No. : PAT- 111602-WO-SEC- 1 embodiments, the dsRNA useful for insect control is described in U.S. Patent Nos. 9,238,8223, 9,340, 797, or 8,946,510. In some embodiments, the dsRNA useful for insect control is described in U.S. Patent Publications 20200172922, 20110054007, 20140275208, 20160230185, or 20160230186. In other embodiments, the interfering RNA may confer resistance against a non-insect plant pest, such as a nematode pest or a virus pest.

[0305] Insecticidal Compositions

[0306]

[0204] In some embodiments, an insecticidal composition is provided comprising an insecticidal protein of the disclosure in an agriculturally acceptable carrier. As used herein an “agriculturally-acceptable carrier” can include natural or synthetic, organic or inorganic material which is combined with the active protein to facilitate its application to or in the plant, or part thereof. Examples of agriculturally acceptable carriers include, without limitation, powders, dusts, pellets, granules, sprays, emulsions, colloids, and solutions. Agriculturally-acceptable carriers further include, but are not limited to, inert components, dispersants, surfactants, adjuvants, tackifiers, stickers, binders, or combinations thereof, that can be used in agricultural formulations. Such compositions can be applied in any manner that brings the pesticidal proteins or other pest control agents in contact with the pests. Accordingly, the compositions can be applied to the surfaces of plants or plant parts, including seeds, leaves, flowers, stems, tubers, roots, and the like. In other embodiments, a plant producing an insecticidal engineered protein of the disclosure in planta is an agriculturally-acceptable carrier of the expressed insecticidal protein, the combination of plant and the protein is an insecticidal composition.

[0307]

[0205] In further embodiments, the insecticidal composition comprises a bacterial cell or a transgenic bacterial cell of the disclosure, wherein the bacterial cell or transgenic bacterial cell produces an engineered insecticidal protein of the disclosure. Such an insecticidal composition can be prepared by desiccation, lyophilization, homogenization, extraction, filtration, centrifugation, sedimentation, or concentration of a culture of Bacillus thuringiensis (Bt), including a transgenic Bt culture. In some embodiments, a composition of the disclosure may comprise at least about 1%, at least about 5%, at least about 10%, at least about 20%, at least about 25%, at least about 30%, at least about 35%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, at least about 95%, Attorney Docket No. : PAT- 111602-WO-SEC- 1 at least about 97%, or at least 99% by weight a polypeptide of the disclosure. In additional embodiments, the composition comprises from about 1% to about 99% by weight of the insecticidal protein of the disclosure.

[0308]

[0206] Disclosed engineered proteins can be used in combination with other pest control agents to increase pest target spectrum and / or for the prevention or management of insect resistance. Furthermore, the use of the disclosed insecticidal proteins in combination with an insecticidal agent which has a different mode of action or target a different receptor in the insect gut has particular utility for the prevention and / or management of insect resistance.

[0309]

[0207] Therefore, in some embodiments, a composition is provided that controls one or more plant pests (e.g., an insect pest such as a lepidopteran insect pest, a coleopteran insect pest, a hemipteran insect pest and / or a dipteran insect pest), wherein the composition comprises a first pest control agent, which is a disclosed insecticidal protein and at least a second pest control agent that is different from the first pest control agent. In other embodiments, the composition is a formulation for topical application to a plant. In still other embodiments, the composition is a transgenic plant. In further embodiments, the composition is a combination of a formulation topically applied to a transgenic plant. In some embodiments, the formulation comprises the first pest control agent, which is a disclosed insecticidal protein when the transgenic plant comprises the second pest control agent. In other embodiments, the formulation comprises the second pest control agent when the transgenic plant comprises the first pest control agent, which is an engineered insecticidal protein of the disclosure.

[0310]

[0208] In some embodiments, the second pest control agent can be one or more of a chemical pesticide, such as an insecticide, . Bacillus thuringiensis (Bt) insecticidal protein, and / or a non- Bt pesticidal agent including without limitation a Xenorhabdus insecticidal protein, a Photorhabdus insecticidal protein, a Brevibacillus laterosporus insecticidal protein, a Bacillus sphaericus insecticidal protein, a protease inhibitor (both serine and cysteine types), a lectin, an alpha-amylase, a peroxidase, a cholesterol oxidase, or a double stranded RNA (dsRNA) molecule.

[0311]

[0209] In other embodiments, the second pest control agent is one or more chemical pesticides, which is optionally a seed coating. Non-limiting examples of chemical pesticides Attorney Docket No. : PAT- 111602-WO-SEC- 1 include pyrethroids, carbamates, neonicotinoids, neuronal sodium channel blockers, insecticidal macrocyclic lactones, gamma-aminobutyric acid (GABA) antagonists, insecticidal ureas and juvenile hormone mimics. In other embodiments, the chemical pesticide is one or more of abamectin, acephate, acetamiprid, amidoflumet (S-1955), avermectin, azadirachtin, azinphos- methyl, bifenthrin, binfenazate, buprofezin, carbofuran, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl, chromafenozide, clothianidin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, diflubenzuron, dimethoate, diofenolan, emamectin, endosulfan, esfenvalerate, ethiprole, fenothicarb, fenoxycarb, fenpropathrin, fenproximate, fenvalerate, fipronil, flonicamid, flucythrinate, tau-fluvalinate, flufenerim (UR-50701), flufenoxuron, fonophos, halofenozide, hexaflumuron, imidacloprid, indoxacarb, isofenphos, lufenuron, malathion, metaldehyde, methamidophos, methidathion, methomyl, methoprene, methoxychlor, monocrotophos, methoxyfenozide, nithiazin, novaluron, noviflumuron (XDE-007), oxamyl, parathion, parathion- methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, profenofos, pymetrozine, pyridalyl, pyriproxyfen, rotenone, spinosad, spiromesifin (BSN 2060), sulprofos, tebufenozide, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tralomethrin, trichlorfon and triflumuron, aldicarb, oxamyl, fenamiphos, amitraz, chinomethionat, chlorobenzilate, cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpropathrin, fenpyroximate, hexythiazox, propargite, pyridaben and tebufenpyrad. In still other embodiments, the chemical pesticide is selected from one or more of cypermethrin, cyhalothrin, cyfluthrin and beta-cyfluthrin, esfenvalerate, fenvalerate, tralomethrin, fenothicarb, methomyl, oxamyl, thiodicarb, clothianidin, imidacloprid, thiacloprid, indoxacarb, spinosad, abamectin, avermectin, emamectin, endosulfan, ethiprole, fipronil, flufenoxuron, triflumuron, diofenolan, pyriproxyfen, pymetrozine and amitraz.

[0312]

[0210] In additional embodiments, the second pest control agent can be one or more of any of the insecticidal proteins set forth above for use as a stacking partner. As noted above, such insecticidal compositions can occur in planta as a molecular stack or a breeding stack or as a composition applied to the exterior of the plant, plant part or seed. In still further embodiments, the first insect control agent, which is a disclosed engineered insecticidal protein Attorney Docket No. : PAT- 111602-WO-SEC- 1 and the second pest control agent are co-expressed in a transgenic plant. This co-expression of more than one pesticidal principle in the same transgenic plant can be achieved by genetically engineering a plant to contain and express the nucleic acid sequences encoding the insect control agents. For example, the co-expression of more than one pesticidal agent in the same transgenic plant can be achieved by making a single recombinant vector comprising coding sequences of more than one pesticidal agent in a “molecular stack” and genetically engineering a plant to contain and express all the pesticidal agents in the transgenic plant. Such molecular stacks may be also be made by using mini-chromosomes as described, for example in US Patent 7,235,716. Alternatively, a plant, Parent 1, can be genetically engineered for the expression of the disclosed insecticidal proteins. A second plant, Parent 2, can be genetically engineered for the expression of a second pest control agent. By crossing Parent 1 with Parent 2, progeny plants are obtained which express both insect control agents from Parents 1 and 2.

[0313]

[0211] In other embodiments, the disclosure provides a stacked transgenic plant resistant to plant pest infestation comprising a nucleic acid (e.g., DNA) sequence encoding a dsRNA for suppression of an essential gene in a target pest and a nucleic acid e.g., (DNA) sequence encoding a disclosed insecticidal protein exhibiting insecticidal activity against the target pest. It has been reported that dsRNAs are ineffective against certain lepidopteran pests (Rajagopol et al. 2002. J. Biol. Chem. 277:468-494), likely due to the high pH of the midgut which destabilizes the dsRNA. Therefore, in some embodiments where the target pest is a lepidopteran pest, a disclosed insecticidal protein acts to transiently reduce the midgut pH which serves to stabilize the co-ingested dsRNA rendering the dsRNA effective in silencing the target genes.

[0314]

[0212] Transgenic plants or seed comprising and / or expressing a disclosed engineered protein can also be treated with an insecticide or insecticidal seed coating as described in U. S. Patent Nos. 5,849,320 and 5,876,739. In some embodiments, where both the insecticide or insecticidal seed coating and the transgenic plant or seed of the disclosure are active against the same target insect, for example a lepidopteran pest (e.g., fall armyworm), the combination is useful (i) in a method for further enhancing activity of the composition of the disclosure against the target insect, and / or (ii) in a method for preventing development of resistance to the composition of the disclosure by providing yet another mechanism of action against the target insect. Thus, in some embodiments, a method is provided of enhancing control of a lepidopteran Attorney Docket No. : PAT- 111602-WO-SEC- 1 insect population comprising providing a transgenic plant or seed of the disclosure and applying to the plant or the seed an insecticide or insecticidal seed coating to a transgenic plant or seed of the disclosure.

[0315]

[0213] Even where the insecticide or insecticidal seed coating is active against a different insect, the insecticide or insecticidal seed coating is useful to expand the range of insect control, for example by adding an insecticide or insecticidal seed coating that has activity against coleopteran insects to a transgenic seed of the disclosure, which, in some embodiments, has activity against lepidopteran insects, the coated transgenic seed produced controls both lepidopteran and coleopteran insect pests.

[0316] Methods of Making and Using the Chimeric Insecticidal Proteins, Nucleic Acids, and Transgenic Plants

[0317]

[0214] In addition to providing compositions, the disclosure also provides methods of producing and using an engineered insecticidal protein of the disclosure. In some embodiments, the method of producing comprises culturing a transgenic non-human host cell that comprises a polynucleotide, expression cassette or vector that expresses a described engineered insecticidal protein under conditions in which the host cell produces the insecticidal protein that is toxic to the lepidopteran pest. In some embodiments, the transgenic non-human host cell is a plant cell. In some other embodiments, the plant cell is a maize cell. In some other embodiments, the plant cell is a soybean cell. In other embodiments, the conditions under which the plant cell are grown include natural sunlight. In other embodiments, the transgenic non-human host cell is a bacterial cell. In still other embodiments, the transgenic non-human host cell is a yeast cell.

[0318]

[0215] In some embodiments, the methods of the disclosure provide control of at least one lepidopteran insect pest, including without limitation, one or more of the following: Spodoptera spp. such as S. frugiperda (fall armyworm), S. littoralis (Egyptian cotton leafworm), 5. ornithogcdli (yellowstriped armyworm), S. praeflca (western yellowstriped armyworm), S. eridania (southern armyworm), S. litura (Common cutworm / Oriental leafworm), S. cosmioides (black armyworm), S. exempta (African armyworm), S. mauritia (lawn armyworm) and / or . exigua (beet armyworm), Ostrinia spp. such as O. nubilalis (European corn borer) and / or O. furnacalis (Asian com borer), Plutella spp. such as P. xylostella (diamondback moth), Agrotis Attorney Docket No. : PAT- 111602-WO-SEC- 1 spp. such as A. ipsilon (black cutworm), A. segetum (common cutworm), A. gladiaria (claybacked cutworm), and / or A. orthogonia (pale western cutworm), Striacosta spp. such as 5. albicosta (western bean cutworm), Helicoverpa spp. such as H. zea (corn earworm / soybean podworm), H. punctigera (native budworm), and / or H. armigera (cotton bollworm), Heliothis spp. such as H. virescens (tobacco budworm), Diatraea spp. such as D. giandiosella (southwestern corn borer) and / or I). saccharalis (sugarcane borer), Trichoplusia spp. such as T. ni (cabbage looper), Sesamia spp. such as S. nonagroides (Mediterranean corn borer), S. inferens (Pink stem borer) and / or S. calamistis (pink stem borer), Pectinophora spp. such as P. gossypiella (pink bollworm), Cochylis spp. such as C. hospes (banded sunflower moth), Manduca spp. such as M. sexta (tobacco hornworm) and / or M. quinquemaculata (tomato hornworm), Elasmopalpus spp. such as E. lignosellus (lesser cornstalk borer), Pseudoplusia spp. such as / / includens (soybean looper), Anti car si a spp. such as A. gemmatalis (velvetbean caterpillar), Plathypena spp. such as P. scabra (green cloverworm), Pieris spp. such as P. brassicae (cabbage butterfly), Papaipema spp. such as P. nebris (stalk borer), Pseudaletia spp. such as P. unipuncta (common armyworm), Peridroma spp. such as P. saucia (variegated cutworm), Keiferia spp. such as K. lycopersicella (tomato pinworm), Artogeia spp. such as A. rapae (imported cabbageworm), Phthorimaea spp. such as P. operculella (potato tuberworm), Chrysodeixis spp. such as C. includens (soybean looper), Feltia spp. such as F. ducens (dingy cutworm), Chilo spp. such as C. suppressalis (striped stem borer), C. Agamemnon (oriental corn borer), C. venosatus (spotted borer), and C. partellus (spotted stalk borer), Cnaphalocrocis spp. such as C. medinalis (rice leaffolder), Conogethes spp. such as C. punctiferalis (Yellow peach moth), Mythimna spp. such as M. separata (Oriental armyworm), Athetis spp. such as A. lepigone (Two-spotted armyworm), Busseola spp. such as B.fusca (maize stalk borer), Etiella spp. such as E. zinckenella (pulse pod borer), Leguminivora spp. such as L. glycinivorella (soybean pod borer), Matsumuraeses spp. such as M. phaseoli (adzuki pod worm), Omiodes spp. such as (). indicata (Soybean leaffolder / Bean-leaf webworm), Rachiplusia spp. such as R. nu (sunflower Looper), Maruca spp. such as M. Testulalis Geyer (Bean pod borer), Monolepta spp. such as hieroglyphica (Double-spotted leaf beetle), or any combination of the foregoing. In some embodiments, the methods provide control of a pest that is resistant to a Vip3A protein (e.g., Vip3Aal9 or Vip3Aa20, including without limitation maize event MIR162), a Cry IF protein (e.g., CrylFa, including without limitation maize event TC1507 or DP -4114 or soy event Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0319] DAS-81419), a CrylA protein (e.g., CrylAb, CrylAc or CrylA.105, including without limitation maize event Btl 1, MON810, or MON89034 or soy event MON87701 or DAS-81419), a Cry2A protein (e.g., Cry2Ab, including without limitation maize event MON89034 or soy event MON87751), a CrylD protein (e.g., CrylDa_7 or truncated CrylDa, including without limitation maize event MON95379 or ME240913), a Cry IB protein (e.g., Cry IB.868, including without limitation maize event MON95379), and / or a CrylG protein (e.g., eCrylGb.Hg protein disclosed in PCT Patent Application Publication No. WO2022235606).

[0320]

[0216] Also encompassed are methods of producing an insect-resistant (e.g., a lepidopteran insect-resistant) transgenic plant. In representative embodiments, the method comprises: introducing into a plant a polynucleotide, expression cassette or vector comprising a nucleotide sequence that encodes a disclosed engineered insecticidal protein (including toxin fragments and modified forms that are substantially identical to the polypeptides specifically disclosed herein), wherein the nucleotide sequence is expressed in the plant to produce the disclosed insecticidal protein, thereby conferring to the plant resistance to the insect pest, and producing an insectresistant transgenic plant (e.g., as compared with a suitable control plant, such as a plant that does not comprise the disclosed polynucleotide, expression cassette or vector and / or does not express a disclosed insecticidal polypeptide).

[0321]

[0217] In some embodiments, a pest-resistant transgenic plant is resistant to an insect pest selected from the group consisting of Ostrinia nubilalis (European com borer; ECB), Spodoptera frugiperda (Fall armyworm, FAW), Diatraea saccharalis (sugar cane borer; SCB), Chrysodeixis inchidens (soybean looper; SBL), Anticarsia gemmatalis (velvetbean caterpillar; VBC), Southwestern corn borer (SWCB, Diatraea grandiosella), and Southern armyworm (SAW, Spodoptera eridania).

[0322]

[0218] In some embodiments, the method of introducing the disclosed polynucleotide, expression cassette or vector into the plant comprises first transforming a plant cell with the polynucleotide, expression cassette or vector and regenerating a transgenic plant therefrom, where the transgenic plant comprises the polynucleotide, expression cassette or vector and expresses the disclosed chimeric insecticidal protein of the disclosure. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0323]

[0219] Alternatively, or additionally, the introducing step can comprise crossing a first plant comprising the polynucleotide, expression cassette or vector with a second plant (e.g., a different plant from the first plant, for example, a plant that does not comprise the polynucleotide, expression cassette or vector) and, optionally, producing a progeny plant that comprises the polynucleotide, expression cassette or vector and expresses a disclosed insecticidal protein, thereby resulting in increased resistance to at least one insect pest. Thus, a transgenic plant encompasses a plant that is the direct result of a transformation event and the progeny thereof (of any generation) that comprise the polynucleotide, expression cassette or vector and optionally expresses the chimeric insecticidal protein resulting in increased resistance to at least one insect pest.

[0324]

[0220] The disclosure further provides a method of identifying a transgenic plant of the disclosure, the method comprising detecting the presence of a polynucleotide, expression cassette, vector or engineered insecticidal protein of the disclosure in a plant (or a plant cell, plant part, and the like derived therefrom), and thereby identifying the plant as a transgenic plant of the disclosure based on the presence of the polynucleotide, expression cassette, vector or engineered insecticidal protein of the disclosure.

[0325]

[0221] Embodiments further provide a method of producing a transgenic plant with increased resistance to at least one insect pest (e.g., a least one lepidopteran pest), the method comprising: planting a seed comprising a polynucleotide, expression cassette or vector of the disclosure, and growing a transgenic plant from the seed, where the transgenic plant comprises the polynucleotide, expression cassette or vector and produces the engineered insecticidal protein.

[0326]

[0222] In some embodiments, transgenic plants produced by the methods of the disclosure comprise a polynucleotide, expression cassette or vector of the disclosure. In some embodiments, a transgenic plant produced by the methods of the disclosure comprise an engineered insecticidal protein of the disclosure and, optionally have increased resistance to at least one insect pest.

[0327]

[0223] The methods of producing a transgenic plant described herein optionally comprise a further step of harvesting a seed from the transgenic plant, where the seed comprises the Attorney Docket No. : PAT- 111602-WO-SEC- 1 polynucleotide, expression cassette or vector and produces the engineered insecticidal protein. Optionally, the seed produces a further transgenic plant that comprises the polynucleotide, expression cassette or vector and produces the engineered insecticidal protein, and thereby has increased resistance to at least one insect pest.

[0328]

[0224] The disclosure further provides plant parts, plant cells, plant organs, plant cultures, seed, plant extracts, harvested products and processed products of the transgenic plants produced by the methods of the disclosure.

[0329]

[0225] As a further aspect, the disclosure also provides a method of producing seed, the method comprising: providing a transgenic plant that comprises a disclosed polynucleotide, expression cassette or vector, and harvesting a seed from the transgenic plant, wherein the seed comprises the polynucleotide, expression cassette, vector and produces the engineered insecticidal protein. Optionally, the seed produces a further transgenic plant that comprises the polynucleotide, expression cassette or vector and produces the engineered insecticidal protein, and thereby has increased resistance to at least one insect pest. In representative embodiments, the step of providing the transgenic plant comprises planting a seed that produces the transgenic plant.

[0330]

[0226] Further provided is a method of producing a hybrid plant seed, the method comprising: crossing a first inbred plant, which is a transgenic plant comprising a polynucleotide, expression cassette or vector of the disclosure, and optionally expressing an engineered insecticidal protein of the disclosure with a different inbred plant (e.g., an inbred plant that does not comprise a polynucleotide, expression cassette or vector of the disclosure) and allowing hybrid seed to form. Optionally, the method further comprises harvesting a hybrid seed. In some embodiments, the hybrid seed comprises the polynucleotide, expression cassette or vector of the disclosure, and in some embodiments may further comprise an engineered insecticidal protein of the disclosure and have increased resistance to an insect pest. In some embodiments, the hybrid seed produces a transgenic plant that comprises the polynucleotide, expression cassette or vector of the disclosure, expresses the engineered insecticidal protein of the disclosure, and has increased resistance to at least one insect pest. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0331]

[0227] In further embodiments, a method of controlling a lepidopteran pest is provided, the method comprising delivering to the insects an effective amount of a disclosed insecticidal engineered protein. To be effective, the insecticidal protein is first orally ingested by the insect. However, the insecticidal protein can be delivered to the insect in many recognized ways. The ways to deliver a protein orally to an insect include, but are not limited to, providing the protein (1) in a transgenic plant, wherein the insect eats (ingests) one or more parts of the transgenic plant, thereby ingesting the polypeptide that is expressed in the transgenic plant; (2) in a formulated protein composition(s) that can be applied to or incorporated into, for example, insect growth media; (3) in a protein composition(s) that can be applied to the surface, for example, sprayed, onto the surface of a plant part, which is then ingested by the insect as the insect eats one or more of the sprayed plant parts; (4) a bait matrix; or (5) any other art-recognized protein delivery system. Thus, any method of oral delivery to an insect can be used to deliver the disclosed insecticidal proteins of the disclosure. In some particular embodiments, the engineered protein is delivered orally to an insect, wherein the insect ingests one or more parts of a transgenic plant.

[0332]

[0228] In other embodiments, the disclosed insecticidal protein is delivered orally to an insect, wherein the insect ingests one or more parts of a plant covered or partially covered with a composition comprising the insecticidal proteins. Delivering the compositions of the disclosure to a plant surface can be done using any method known to those of skill in the art for applying compounds, compositions, formulations and the like to plant surfaces. Some non-limiting examples of delivering to or contacting a plant or part thereof include spraying, dusting, sprinkling, scattering, misting, atomizing, broadcasting, soaking, soil injection, soil incorporation, drenching (e.g., root, soil treatment), dipping, pouring, coating, leaf or stem infiltration, seed dressing or seed treatment, and the like, and combinations thereof. These and other procedures for contacting a plant or part thereof with compound(s), composition(s) or formulation(s) are well-known to those of skill in the art.

[0333]

[0229] In some embodiments, the disclosed nucleotide and polypeptide sequences can be used in a bioinformatic analysis to identify additional insecticidal toxins, both the nucleotide sequences and the proteins encoded by the nucleic acids. In some embodiments, this identification of additional toxins can be based on percent identity (e.g., using a BLAST or Attorney Docket No. : PAT- 111602-WO-SEC- 1 similar algorithm). In other embodiments, the identification of additional toxins could be accomplished using conserved protein domains or epitopes (e.g., Hmmer, psi-BLAST, or hhsuite). In some embodiments, the bioinformatic assay comprises running a sequence identity comparison and selecting one or more candidate insecticidal toxins that has a sequence identity above a certain threshold (e.g., at least 30%, at least 40%, at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or more identical) relative to a disclosed nucleotide or polypeptide sequence of the disclosure. In some embodiments, the bioinformatic assay comprises running a domain or epitope conservation analysis and selecting one or more candidate insecticidal toxins that has at least one conserved domain or epitope relative to a disclosed nucleotide or polypeptide sequence of the disclosure.

[0334] [2301 Insome embodiments, the bioinformatic identification of the additional toxins could be accomplished using computational methods (e.g., machine learning models and optimization algorithms) to select candidate insecticidal toxins. For example, such a method may involve an iterative process of generating candidate toxin sequences, evaluating their structural, sequence, and physical properties using machine learning models, deep learning models, statistical physics-based models, and / or sequence analysis protocols, and selectively modifying the sequences to optimize toward desired characteristics such as insecticidal properties.

[0335]

[0231] In some embodiments, a starting sequence of a polypeptide of the disclosure is provided as input to a generative model, a statistical physics-based model, or other model. The models produce a set of candidate protein toxin sequences that diverge from the starting sequence while maintaining key structural motifs and / or functional regions. These candidate toxin sequences can be generated by techniques such as (a) mutating residues at selected positions in the starting sequence, guided by evolutionary conservation data, structural constraints, and physics and knowledge-based potentials, (b) recombining fragments from diverse protein families to graft new structural elements onto the starting sequence backbone, or (c) using generative adversarial networks (GANs), protein language models (pLMs), or other deep learning models to generate entirely novel sequences optimized for desired properties such as insecticidal activity. The resulting candidate toxin sequences may then be evaluated by a series of models, such as AlphaFold2, RoseTTAFold, Rosetta, or Attorney Docket No. : PAT- 111602-WO-SEC- 1 language models, to evaluate desired characteristics such as insecticidal activity. This process may involve the identification of key domains or regions within the protein structure that are important for the desired function or property and the evaluation of these regions’ properties in the candidate sequences. Such identification can be done using activity data (e.g., insecticidal activity based on bioassays) and / or using conserved domain identification through sequence analysis with homologues, such as orthologs. Candidate toxin sequence selection may be accomplished through evaluation and scoring of the generated candidate protein sequences based on various criteria, including structural quality, energy minimization, and predicted functional properties. Examples of such methods are described, e.g., in patent application publications CN116768990 and WO2024095126, as well as in Sumida et al. Improving Protein Expression, Stability, and Function with ProteinMPNN. Journal of the American Chemical Society. 2024, 146(3): 2054-2061 and Murphy et al. Increasing Sequence Diversity with Flexible Backbone Protein Design: The Complete Redesign of a Protein Hydrophobic Core. Structure. 2012, 20(6): 1086-1096. In some embodiments, a method of identifying a candidate insecticidal toxin using computational methods comprises: a) providing a three-dimensional structure of a polypeptide of the disclosure (e.g.; computationally such as with Alphafold2 or by crystallography); b) identifying active regions or positions within the polypeptide amino acid sequence that contribute to insecticidal activity (e.g., using the bioassay activity data such as the data disclosed herein and / or conserved regions or positions through sequence analysis with homologues, such as orthologs); c) computationally generating a plurality of putative toxin amino acid sequences, wherein the active regions or positions are maintained (e.g., at at least 90%, at least 95%, at least 95%, at least 95%, at least 95%, at least 95%, at least 95%, at least 95%, at least 95%, at least 95%, or 100% identity relative to the regions and / or positions in the polypeptide amino acid sequence) and at least one other portion of the polypeptide amino acid sequence is modified (e.g., through one or more amino acid substitution, deletion, or addition) to include at least one difference relative to the unmodified polypeptide amino acid sequence (e.g., modified so that it is less than 95%, less than 90%, less than 80%, less than 70%, less than 60%, less than 50%, less than 40%, less than 30%, less than 20% or less than 10%, or between 10% to 90%, 20% to 90%, 30% to 90%, 40% to 90%, 50% to 90%, 60% to 90%, 70% to 90%, 80% to 90%, 10% to 80%, 20% Attorney Docket No. : PAT- 111602-WO-SEC- 1 to 80%, 30% to 80%, 40% to 80%, 50% to 80%, 60% to 80%, 70% to 80%, 10% to 70%, 20% to 70%, 30% to 70%, 40% to 70%, 50% to 70%, or 60% to 70% identical to the corresponding unmodified portion of the polypeptide amino acid sequence); d) predicting three-dimensional structures for the plurality of putative toxin sequences; e) evaluating whether the three-dimensional structures of the plurality of putative toxin sequences are similar to the three-dimensional structure of the polypeptide amino acid sequence (e g., using criteria such as structural quality, energy minimization, and predicted insecticidal properties); and f) selecting candidate insecticidal toxins based on the evaluation in step e). In some embodiments, the method comprises repeating step c) based on the results of step e) to develop further candidate insecticidal toxins.

[0336]

[0232] In some embodiments, any of the above-mentioned methods may further comprise determining the insecticidal activity of one or more candidate insecticidal toxins identified using the bioinformatic analysis.

[0337]

[0233] In some embodiments, determination of insecticidal activity of disclosed engineered proteins can be accomplished through an insect bioassay. Insect bioassay methods are well known in the art and can be “in vitro ” or “in planta" . In in vitro bioassays, the disclosed proteins are delivered to the desired insect species following production in recombinant bacterial strains (e.g., E. coli, Bacillus thuringiensis Cry-). Clarified lysates containing the disclosed engineered proteins produced in these recombinant bacterial strains can be fed orally to the insects. Alternatively, purified engineered proteins can be prepared and fed orally to the insects. In some embodiments, the clarified lysate or purified protein is overlaid on artificial diet prior to infestation with the insects. In other embodiments, the clarified lysate or purified protein is mixed into or incorporated into the artificial diet prior infestation with insects. In in planta bioassays, transgenic plants expressing the disclosed proteins are utilized to deliver the toxin to the desired insect species. In some embodiments, sampled tissue is fed orally to the insects. Nonlimiting examples of sampled tissue include leaf, root, pollen, silk, and stem. In some embodiments the plant tissue is mixed into or incorporated into artificial diet prior to infestation with the insects. In some embodiments, the evaluated insects are LI instars or neonates. In other embodiments, the evaluated insects are of later larval stages, namely L2, L3, L4, or L5 instars. Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0338] EXAMPLES

[0339]

[0234] Embodiments of the invention can be better understood by reference to the following examples. The foregoing and following description of embodiments of the invention and the various embodiments are not intended to limit the claims but are rather illustrative thereof.

[0340] Therefore, it will be understood that the claims are not limited to the specific details of these examples. It will be appreciated by those skilled in the art that other embodiments of the invention may be practiced without departing from the spirit and the scope of the disclosure, the scope of which is defined by the appended claims.

[0341] Example 1. Engineering of Chimeric Proteins with Insecticidal Activity against Fall Armyworm

[0342]

[0235] Using a CrylA-like protein as a template, engineered proteins IC3009, IC3011, 1C3012 and 1C3013 were designed using domain swapping. Table 3 indicates the domains for the four engineered proteins. The cDNAs encoding the engineered proteins were synthesized by Genscript Inc. (Piscataway, NJ) and cloned into the expression vectors for Bacillus.

[0343]

[0236] Engineered candidates were expressed in a crystal minus Bacillus thuringiensis (Bt) strain having no observable background insecticidal activity via a shuttle vector designated 23378, designed for expression in both E. coli and Bt. Vector 23378 comprises a Cry3-promoter that drives expression of the cloned Bt Cry gene and an erythromycin resistance marker.

[0344] Expression cassettes comprising the Cry coding sequence of interest were transformed into the host Bt strain via electroporation and transgenic Bt strains were selected for on erythromycin containing agar plates. Selected transgenic Bt strains were grown to the sporulation phase in T3 or ZYP-5052 media at 28°C for 4-5 days. Cell pellets were harvested and washed iteratively before solubilization in high pH sodium carbonate buffer (50mM) containing salt and 5 mM DTT. Protein solution was subsequently checked for purity and concentration via in gel densitometry and confirmed via mass spectrometry.

[0345]

[0237] An equal amount of protein in 30 pL buffer solution was applied to the surface of 500 uL artificial insect diet (Multiple species Lepidoptera diet, Southland, AK) in 48 well plates. After the diet surface dried, one larvae of the desired insect species being tested was added to Attorney Docket No. : PAT- 111602-WO-SEC- 1 each well. The plates were sealed (Viewseal sealer, Greiner Bio-One, NC) and maintained at ambient laboratory conditions regarding temperature, lighting and relative humidity. Small air holes were poked in the seals with insect pins (size and number of holes depends on insect species tested but ranged from size 000 to size 2). Negative control groups consisted of larvae exposed to insect diet treated with the buffer solution and insect diet treated with water.

[0346] Mortality and effective mortality was assessed at 168 (+ / - 4) hours. After the assay passed QC (<16% background mortality), results were analyzed using a Pairwise Fisher’s Exact Test.

[0347] Results are shown in Table 4, where a means 0-16% mortality, a “+” means 17-50% mortality, a “++” means 51-75% mortality, and a “+++” means 76-100% mortality. Samples with an indicate that there was stunting of the surviving larvae at the LI instar.

[0348] Table 3: Engineered Proteins via domain swapping

[0349] Table 4: Lepidopteran spectrum bioassay with engineered IC3009 and IC3013 proteins

[0350] NT=Not Tested

[0351] Example 2. Engineered Chimeric Proteins IC3009, IC3011, and IC3O13 Display Concentration Dependent Insecticidal Activity against Lepidopteran Pests

[0352]

[0238] Engineered proteins IC3009, IC3011, and IC3O13 were prepared as described in

[0353] Example 1. Protein concentrations were determined by gel densitometry (using a BSA standard Attorney Docket No. : PAT- 111602-WO-SEC- 1 curve). The protein samples were tested against 48 larvae over a range of concentrations in the surface treatment method described above. The positive control, Co756 is a broad-spectrum Bacillus strain; the negative controls consisted of high pH sodium carbonate buffer (50mM) containing salt and 5 mM DTT, the storage buffer for the tested proteins and water. Additional replicates of the protein samples were prepared and tested in bioassay and yielded similar results. As shown in Table 5, the proteins display concentration dependent bioactivity to soybean looper and a Cry 1 Fa-resistant strain of fall armyworm. Minimal activity was observed against velvet bean caterpillar confirming the results from the single dose bioassay disclosed in Table 4. Samples with an indicate that there was stunting of the surviving larvae at the LI instar.

[0354] Table 5: Dose Response Assay for IC3009, IC3011, and IC3013 against VBC, SBL, and CrylFa- resistant FAW Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0355] Example 3: IC3009 and IC3O13 Possess Insecticidal Activity against Resistant Fall Armyworm colonies

[0356]

[0239] To determine if the insecticidal activity of IC3009 and IC3O13 (SEQ ID NOs: 1 and 4, respectively) is through a mode-of-action different from CrylFa, CrylA.105 / Cry2Ab2 (MON89), Vip3A, and eCrylGb.Hg (IC3002), the proteins were prepared as described above and tested against resistant FAW colonies. In addition, the proteins were tested against the founder population used to develop the Vip3A-R colony, as well as a susceptible FAW colony. Surface treatment assays were performed essentially as described in Example 2. Additional replicates of the protein samples were prepared and tested in the bioassay and yielded similar results. As shown in Table 6, both IC3009 and IC3013 have insecticidal activity against all 4 of the resistant FAW colonies indicating that they have a unique mode-of -action compared to CrylFa, CrylA.105 / Cry2Ab2, Vip3A, and eCrylGb.Hg (IC3002).

[0357] Table 6: Insecticidal Activity of IC3009 and IC3013 against Resistant FAW colonies

[0358] Example 4: Expression and Insect Bioassay of Chimeric Proteins in Transient Bush Bean Assay

[0359]

[0240] In addition to full length versions of IC3009 and IC3013, truncated versions of the proteins were designed. Truncations were designed at both the C-terminus and N-terminus. Synthetic polynucleotides comprising maize codon optimized nucleotide sequences encoding IC3009, IC3013, as well as the truncated chimeras were synthesized on an automated gene Attorney Docket No. : PAT- 111602-WO-SEC- 1 synthesis platform (Genscript, Inc. Piscataway, NJ). Expression cassettes were made comprising a plant expressible promoter operably linked to the engineered protein coding sequence which is operably linked to a terminator sequence. Agrobacterium strains containing the expression constructs were grown in 2 ml LB medium with antibiotics for 24 hours, followed by a 1 :500 dilution and further 24-hour incubation, aiming for an OD600 of 1. The cells were then pelleted by centrifugation at 4000 rpm for 30 minutes and resuspended in an infiltration buffer containing 10 mM MgS04, 400 pM acetosyringone, and 0.0025% Silwet L-77, normalizing all constructs to OD600 of 1.

[0360]

[0241] For plant preparation, 8 mm leaf discs were extracted from 9-day-old bush bean plants and immersed in the Agrobacterium suspension. The mixture underwent three cycles of vacuum infiltration at -30 in. Hg, with careful monitoring to prevent overflow and ensure leaf disc submersion.

[0361]

[0242] Post-infiltration, leaf discs were gently dried until a mosaic pattern appeared and placed in a 48-well plate without flattening to maintain aeration. The plate was sealed, shielded from light, and incubated in a bioassay chamber at 25°C with a 14-hour night / 10-hour day cycle and 40% humidity for a 3-day co-cultivation period. Finally, the leaf discs were transferred to 1% agar plates for bioassay, and samples were submitted for ELISA / qRT-PCR analysis 3 days after infiltration.

[0362]

[0243] For the bioassay, two fall armyworm larvae were placed on each leaf disk, sealed with film and punctured to allow air flow. Initial images were taken and then the leaf disks were placed in an incubator at 24.5°C (50% RH) with a 14: 10 light-dark cycle while monitoring environmental conditions. Plates were examined 5d post infestation for leaf consumption and insect mortality. Scoring was done manually on a 0-100% damage scale in 5% increments from 0-20% damage and 10% increments when there is >20% damage. Plates were imaged on day 3 and day 4. Insects that had not moved in 24 hours were considered dead. Stunting was measured by insect stages (i.e. LI, L2, L3) of the remaining larva. All samples were run in duplicate, which each replicate shown separately in the below table. For the mortality scoring, a means 0-16% mortality, a “+” means 17-50% mortality, a “++” means 51-75% mortality, and a “+++” means 76-100% mortality. For the leaf damage rating, a “++” is less than 20% damage, a “+” is Attorney Docket No. : PAT- 111602-WO-SEC- 1

[0363] 21-50% leaf damage, and a is greater than 50% leaf damage. As shown in Table 7, the samples with the lowest percentage of leaf damage display the highest mortality and the best protection from fall armyworm.

[0364] Table 7: Insecticidal Activity of Chimeric Proteins in a Transient Bush Bean Assay against FAW

[0365] Example 5: Vectoring of Genes for Plant Expression

[0366]

[0244] Synthetic polynucleotides comprising codon optimized nucleotide sequences encoding IC3009, IC3011, IC3012, and IC3013 were synthesized on an automated gene Attorney Docket No. : PAT- 111602-WO-SEC- 1 synthesis platform (Genscript, Inc. Piscataway, NJ). Expression cassettes were made comprising a plant expressible promoter operably linked to the engineered protein coding sequence which is operably linked to a terminator sequence. Additional expression cassettes were made comprising a plant expressible promoter operably linked to a selectable marker which is operably linked to a terminator. Expression of the selectable marker allows for identification of transgenic plants on selection media as well as in field trials. All expression cassettes were cloned into a suitable vector for Agrobacterium-mediated soybean or maize transformation.

[0367] Example 6: Maize Transformation

[0368]

[0245] Transformation of immature maize embryos is performed essentially as described in Negrotto et a .(Plant Cell Reports (2000)19: 798-803). Briefly, Agrobacterium strain LBA4404 (pSBl) comprising an expression vector described in Example 5 is grown on YEP (yeast extract (5 g / L), peptone (lOg / L), NaCl (5g / L), 15g / L agar, pH 6.8) solid medium for 2- 4 days at 28°C. Approximately 0.8X 109Agrobacterium cells are suspended in LS-inf media supplemented with 100 pM As. Bacteria are pre-induced in this medium for approximately 30-60 minutes.

[0369]

[0246] Immature embryos from an inbred maize line are excised from 8-12 day old ears into liquid LS-inf + 100 pM As. Embryos are rinsed once with fresh infection medium.

[0370] Agrobacterium solution is then added, and embryos are vortexed for 30 seconds and allowed to settle with the bacteria for 5 minutes. The embryos are then transferred scutellum side up to LSAs medium and cultured in the dark for two to three days. Subsequently, between approximately 20 and 25 embryos per petri plate are transferred to LSDc medium supplemented with cefotaxime (250 mg / L) and silver nitrate (1.6 mg / L) and cultured in the dark at approximately 28°C for 10 days.

[0371]

[0247] Immature embryos, producing embryogenic callus are transferred to LSD1M0.5S medium. The cultures are selected on this medium for approximately 6 weeks with a subculture step at about 3 weeks. Surviving calli are transferred to Regl medium supplemented with mannose. Following culturing in the light (16 hour light / 8 hour dark regiment), green tissues are then transferred to Reg2 medium without growth regulators and incubated for about 1-2 weeks. Plantlets are transferred to Magenta GA-7 boxes (Magenta Corp, Chicago Ill.) containing Reg3 medium and grown in the light. After about 2-3 weeks, plants are tested for the presence of the Attorney Docket No. : PAT- 111602-WO-SEC- 1 selectable marker gene and the disclosed chimeric gene by PCR. Positive plants from the PCR assay are transferred to a greenhouse for further evaluation.

[0372] Example 7: Soybean Transformation

[0373]

[0248] TO soybean plants are taken from tissue culture to the greenhouse where they are transplanted into water- saturated soil (Redi-Earth.RTM. Plug and Seedling Mix, Sun Gro Horticulture, Bellevue, Wash.) mixed with 1% granular Marathon.RTM. (Olympic Horticultural Products, Co., Mainland, Pa.) at 5-10 g / gal Redi-Earth.RTM. Mix in 2" square pots. The plants are covered with humidity domes and placed in a Conviron chamber (Pembina, N. Dak.) with the following environmental conditions: 24°C. day; 18°C. night; 16-hour light-8 hour dark photoperiod; and 80% relative humidity.

[0374]

[0249] After plants become established in the soil and new growth appeared (about 1-2 weeks), plants are sampled and tested for the presence of the desired transgene by TaqmanTM analysis using appropriate probes for the genes or promoters (for example prUBQ3). All positive plants and several negative plants are transplanted into 4" square pots containing MetroMixTM 380 soil (Sun Gro Horticulture, Bellevue, Wash.). Sierra 17-6-12 slow release fertilizer is incorporated into the soil at the recommended rate. The negative plants serve as controls. The plants are then relocated into a standard greenhouse to acclimatize (about 1 week). The environmental conditions are typically: 27°C. day; 21°C. night; 16-hour photoperiod (with ambient light); ambient humidity. After acclimatizing (about 1 week), the plants are ready to be tested for copy number (determined by TaqMan analysis), protein expression level (determined by ELISA), and efficacy against insect species of interest in leaf excision bioassays. Insecticidal transgenic soybean plants are grown to maturity for seed production. Transgenic seeds and progeny plants are used to further evaluate their performance and molecular characteristics.

[0375] Example 8: Transient Expression in Maize Plants

[0376]

[0250] Constructs containing expression cassettes for both full length and truncated IC3O13 were evaluated via whole plant transient expression in maize. Agrobacterium cultures (transformed with constructs of interest and appropriate negative and positive controls) were prepared by streaking on selective media. Bacterial cells were harvested, resuspended in an Attorney Docket No. : PAT- 111602-WO-SEC- 1 infection medium comprising Murashioe and Skoog salts, sucrose, MES, magnesium sulfate, and acetosyringone, and incubated at 18°C for 22 hours. Prior to infiltration, a surfactant was added to the bacterial suspension. Young maize plants were prepared for infiltration by mechanically abrading their leaves using a wire brush to create openings without severe damage. For infiltration, the plant stem was immersed in bacterial suspension, with the pot covered to prevent soil contamination, and subjected to vacuum conditions for a specified duration to enhance infiltration efficiency. Following infiltration, the plants were maintained in a controlled growth chamber under specific temperature and light / dark cycles for several days. For analysis, new leaf tissue exhibiting clear signs of successful infiltration was sampled for leaf disc insect bioassays and ELISA analysis to measure expression. Leaf disc bioassays on selected plants were completed using two leaf discs, collected from infiltrated leaves from at least two separate plants examining the same construct. Leaf discs were placed in individual wells in a 24-well tissue culture plate, with 3 fall armyworm neonates applied per leaf disc. The plates were then sealed and maintained at constant temperature and humidity, with percent leaf consumption measured 5 days post infestation. The lack of leaf consumption observed in the samples expressing the disclosed proteins indicate that they provided protection from fall armyworm in a plant tissuebased transient bioassay.

[0377] Table 8: Transient Expression with IC3013

Claims

Attorney Docket No. : PAT- 111602-WO-SEC- 1What is claimed is:

1. A nucleic acid molecule comprising a heterologous promoter operably linked to a nucleic acid sequence encoding a polypeptide having at least 90%, 95% or 100% identity to the amino acid sequence set forth in any one of SEQ ID NO: 1-4 or 13-22, wherein said polypeptide has insecticidal activity.

2. The nucleic acid molecule of claim 1, wherein a. said polypeptide comprises a transit peptide; b. said polypeptide comprises a chloroplast transit peptide; or c. said polypeptide comprises at least 90%, 95% orl 00% identity to the amino acid sequence set forth in any one of SEQ ID NO: 49-52.

3. The nucleic acid molecule of claim 1 or 2, wherein said heterologous promoter is a plant expressible promoter.

4. The nucleic acid molecule of any one of claims 1-3, wherein the nucleic acid sequence encoding the polypeptide is codon optimized for expression in a plant.

5. A vector comprising the nucleic acid of any one of claims 1-4.

6. A transgenic host cell comprising a heterologous polypeptide comprising an amino acid sequence having at least 90%, 95% or 100% sequence identity to any one of SEQ ID Nos: 1-4 or 13-22, wherein said polypeptide has insecticidal activity.

7. The transgenic host cell of claim 6, wherein a. said polypeptide further comprises a transit peptide; b. said polypeptide further comprises a chloroplast transit peptide; or c. said polypeptide comprises at least 90%, 95% or 100% identity to the amino acid sequence set forth in any one of SEQ ID NO: 49-52.

8. The transgenic host cell of claims 6 or 7, wherein the host cell is a bacterial cell.

9. The transgenic host cell of claim 8, wherein the bacterial cell is an Agrobacterium, Bacillus, or an Escherichia coli cell.

10. The transgenic host cell of claims 6 or 7, wherein the host cell is a plant cell.

11. The host cell of claim 10, wherein the plant cell is a monocot cell or a dicot cell.

12. The host cell of claim 11, wherein the plant cell is a maize cell.

13. The host cell of claim 11, wherein the plant cell is a soybean cell.Attorney Docket No. : PAT- 111602-WO-SEC- 114. An engineered polypeptide comprising an amino acid sequence having at least 90%, 95% or 100% sequence identity to any one of SEQ ID Nos: 1-4 or 13-22, wherein said engineered polypeptide has insecticidal activity.

15. A polypeptide comprising an amino acid sequence having at least 90%, 95% or 100% sequence identity to any one of SEQ ID Nos: 1-4 or 13-22, wherein said polypeptide has insecticidal activity, and wherein a. said amino acid sequence is operably linked to a heterologous transit peptide; b. said amino acid sequence is operably linked to a heterologous chloroplast transit peptide or c. said polypeptide comprises least 90%, 95% or 100% identity to the amino acid sequence set forth in any one of SEQ ID NO: 49-52.

16. A composition comprising the polypeptide of any one of claims 14 or 15.

17. The composition of claim 16, further comprising an agriculturally acceptable carrier.

18. A plant comprising a polypeptide having an amino acid sequence with at least 90%, 95% or 100% sequence identity to any one of SEQ ID Nos: 1-4 or 13-22, wherein said polypeptide has insecticidal activity.

19. The plant of claim 18, wherein a. the polypeptide is operably linked to a transit peptide; b. the polypeptide is operably linked to a chloroplast transit peptide; or c. said polypeptide comprises at least 90%, 95% or 100% identity to the amino acid sequence set forth in any one of SEQ ID NO: 49-52.

20. The plant of claims 18 or 19, wherein the polypeptide is encoded by a polynucleotide operably linked to a plant expressible promoter.

21. The plant of claim 20, wherein the polynucleotide operably linked to a plant expressible promoter is stably transformed into the genome of the plant.

22. The plant of any one of claims 18-21, wherein the plant is a monocot.

23. The plant of claim 22, wherein the plant is a maize plant.

24. The plant of any one of claims 18-21, wherein the plant is a dicot.

25. The plant of claim 24, wherein the plant is a soybean plant.Attorney Docket No. : PAT- 111602-WO-SEC- 126. A seed of the plant of any one of claims 18-25, wherein said polynucleotide operably linked to the plant expressible promoter is stably transformed into the genome of the seed.

27. The seed of claim 26, wherein said seed is a monocot.

28. The seed of claim 27, wherein said seed is maize.

29. The seed of claim 26, wherein said seed is a dicot.

30. The seed of claim 29, wherein said seed is soybean.

31. A method of producing a transgenic plant, the method comprising: a. introducing into a plant cell the nucleic acid molecule of any one of claims 1 to 4; b. selecting a plant cell comprising the nucleic acid molecule; and c. regenerating a plant from the selected plant cell.

32. A method for producing a transgenic plant, the method comprising: a. sexually crossing a first parent plant with a second parent plant, wherein the first or the second parent plant is the plant of any one of claims 18-25; and b. selecting a progeny plant with enhanced insecticidal properties, wherein the selected progeny plant comprises the polynucleotide.

33. The method of claim 32, further comprising the steps of: a. selfing the progeny plant, thereby producing a plurality of second generation progeny plants; and b. selecting from the second generation progeny plants a plant with enhanced insecticidal properties, wherein the selected second generation progeny plants comprise the polynucleotide.

34. A method of controlling a lepidopteran pest comprising delivering to the pest or an environment thereof the polypeptide of claims 14 or 15, or the host cell of any one of claims 10-13, or the plant of any one of claims 18-25.

35. The method of claim 34, wherein the polypeptide is delivered by feeding.

36. The method of claim 35, wherein the feeding comprises the pest feeding on a plant part that comprises the polypeptide.Attorney Docket No. : PAT- 111602-WO-SEC- 137. A method of controlling a lepidopteran pest comprising growing in an area of cultivation the plant of any one of claims 18-25 and controlling the population of coleopteran pests in the area of cultivation.

38. A method of identifying a candidate insecticidal toxin, the method comprising: a. providing a three-dimensional structure of a polypeptide comprising any one of SEQ ID NOs: 1-4, 13-22, or 49-52; b. identifying active regions or positions within the polypeptide amino acid sequence that contribute to insecticidal activity; c. computationally generating a plurality of putative toxin amino acid sequences, wherein the active regions or positions are maintained and at least one other portion of the polypeptide amino acid sequence is modified to include at least one modification relative to the polypeptide amino acid sequence; d. predicting three-dimensional structures for the plurality of putative toxin sequences; e. evaluating the three-dimensional structures of the plurality of putative toxin sequences, optionally by evaluating structural quality, energy minimization, and / or predicted insecticidal activity; and f. selecting candidate insecticidal toxins based on the evaluation in step e).

39. Use of the sequence of any one of SEQ ID NOs: 1-4, 13-22, or 49-52 in a bioinformatic analysis to identify an insecticidal protein.

40. Use of a polypeptide comprising the amino acid sequence of any one of SEQ ID NOs: 1-4, 13-22, or 49-52 in an insect bioassay to identify an insecticidal protein.

41. The plant, seed, host cell, polypeptide, nucleic acid or method of any of the preceding claims wherein the polypeptide consists of the amino acid sequence of any one of SEQ ID NOs: 1-4, 13-22, or 49-52.

42. A maize or a soybean plant genome comprising the nucleic acid molecule of any one of claims 1-4.

Images